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1.1. Thesis Overview 
 
This thesis begins with a systematic review (Section 2). The review aims were to identify what meta-
analytic studies of psychotherapeutic treatments for late life depression (≥55 years) had revealed with 
regards predictors and moderators of treatment effect. The review is presented in the format required 
by the journal, Clinical Psychology Review. 
Following this, Section 3 outlines the hypothesis for the meta-analysis undertaken in Section 5. 
Section 4 seeks to place both the preceding systematic review and subsequent meta-analysis in 
context. It narratively reviews the evidence-base for psychotherapeutic interventions for late-life 
depression and explores how depression may present differently in late-life: identifying both 
challenges and protective factors associated with experiences of depression in this age group.  
 Section 5 presents a meta-analysis of randomised controlled trials evaluating cognitive behavioural 
therapy for depression in older adults with co-morbid physical illness. This section is also presented 
in the format required by the journal, Clinical Psychology Review. It was not possible to include full 
details of the mathematical formulas used to undertake the meta-analysis in the journal article format. 
Section 6 therefore supplements the methods described in the journal article and facilitates replication 
of each stage of the meta-analytic process, presenting full details of the formulas and statistical 
methods employed in the meta-analysis.  















1.2. Thesis Abstract 
Aims: To examine the efficacy of CBT for late-life depression in older adults with co-morbid physical 
illness and to review what has been revealed by meta-analytic studies with regards moderators of 
treatment in psychological approaches for late-life depression.  
Method: Systematic literature search and meta-analysis of randomised controlled trials (RCT) 
evaluating CBT for depression in older adults with co-morbid physical illness and systematic review 
of meta-analyses examining psychological therapies for late-life depression. 
Results: Nine papers met inclusion criteria for meta-analysis. CBT was superior to waiting list and 
treatment as usual control conditions, showing a statistically significant pooled standardised mean 
difference (SMD) of 0.63 (95 per cent CI, 0.29 to 0.97, p = 0.0003). This was largely maintained at 
follow up (SMD 0.5, 95 per cent CI, 0.08 to 0.92). Sensitivity analysis showed individual CBT yielded a 
large, statistically significant summary effect size of 0.80 (95 per cent CI, 0.45 to 1.16), but that group 
CBT did not show statistical superiority over controls. Clinician-rated measures of depression yielded 
larger effect sizes, with a SMD of 1.57 (95 per cent CI, 0.56 to 2.59, p = 0.002) as compared with patient-
rated measures: 1.03 (95 per cent CI, 0.75 to 1.31, p = 0.0001).  
Fourteen meta-analyses met inclusion criteria for systematic review. More recent publication was 
significantly correlated with increased reporting quality and reduced analysis of moderating factors. 
Duration of treatment, treatment setting and gender of participants showed no moderating impact on 
outcome.  Depression severity, participant age, treatment modality, and study quality showed no 
consistent relationship with outcomes.  Active or placebo controls were associated with reduced effect 
sizes when compared with no treatment or waiting list controls. Patient-rated outcome measures 
were associated with reduced effect sizes as compared with clinician-rated measures. 
Conclusions: When compared with treatment as usual and waiting list controls Individual CBT is 
effective in reducing depressive symptoms for depressed older adults with an underlying physical 
illness. Meta-analytic studies of late-life depression show variable results regarding moderators of 
treatment efficacy. More high quality studies examining the effectiveness of psychological therapies 
are needed with clinically representative older populations, particularly, the older-old and those with 
co-morbid physical illnesses.  
Declaration of interests: None. 
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Abstract 
 
Objective: To systematically review predictors and moderators of treatment efficacy revealed by 
meta-analytic studies of psychotherapeutic treatments for late life depression (≥55 years). 
Methods: Electronic databases were searched to Feb 2012. Reporting quality and risk of bias were 
assessed. The relationship between publication date, study quality and number of sub-analyses was 
explored with regression analyses.  
Results:  Fourteen meta-analyses were included. More recent publication date was correlated with 
increased reporting quality and reduced analysis of moderating factors. Treatment setting, duration 
and gender of participants showed no moderating impact on outcome.  Physical co-morbidity was 
associated with reduced treatment efficacy.  Depression severity, participant age, treatment modality 
and study quality showed inconsistent relationships with outcomes.  Active or placebo controls were 
associated with reduced effect sizes compared with waiting list controls. Patient-rated outcome 
measures were associated with reduced effect sizes compared with clinician-rated measures. 
Conclusions: Results of moderator analyses in meta-analytic studies of late life depression show 
inconsistent results. More high quality studies need to be undertaken with clinically representative 
older populations, in particular, the older old, in order to better understand moderating factors of 
treatment efficacy in late-life depression. 
(Word count: 188 / maximum 200)  
Key words: (maximum 6) 













Depression is the most common psychiatric condition experienced by older people (Beekman, 
Copeland, & Prince, 1999). It is associated with increased mortality rates (Kane et al., 2010) reduced 
quality of life (Doraiswamy, Khan, Donahue, & Richard, 2002) and increased morbidity (Penninx, 
Deeg, & Eijk, 2000). Rates of suicide are higher in this group than in any other age-range  (Conwell, 
Duberstein, & Caine, 2002), and depression is identified as the leading cause of suicide (Baldwin & 
Wild, 2004). Despite this, depression is under-recognised and under-treated in older people (Karel & 
Hinrichsen, 2000). Indeed, although the efficacy of psychotherapeutic and other behavioural 
treatments in treating depressive disorders is well-established (Scogin, Welsh, Hanson, Jamie, & 
Coates, 2005) older adults are less likely than younger adults to receive adequate or appropriate 
interventions (Bartels, 2002). 
There is increasing recognition that older people should have access to the same range of 
psychotherapeutic treatments available to younger adults (Department of Health, 2001a; Scottish 
Executive, 2006; NHS Scotland, 2011). However, making evidence based clinical decisions about 
which treatment is best suited to an individual older person remains challenging.  This is, in part, 
because identifying specificity of effect in psychotherapeutic outcome studies is far from 
straightforward. Fiske’s (1977, p.24) question, asked at the beginning of the era of psychotherapy 
meta-analytic research, remains both highly relevant and fiercely contested:  “What kind of therapists 
administering what kind of psychotherapeutic treatments to what kind of patients produce what kind 
of perceived effects, both immediate and ultimate?’ 
The question seeks generalised knowledge about what is effective in relation to ‘kinds’ or 
classes of therapists, interventions, patients and outcomes. Most studies examining the efficacy of 
psychotherapeutic interventions have focused on treatment type as the main effect variable. This 
focus on ‘brand name’ therapies (Scogin et al., 2005) has occurred despite the fact that non-specific 
factors such as client hope, therapeutic alliance and the motivation and skill of both therapist and 
client, have been claimed to explain more of the variance in outcome than treatment approach (Ahn & 
Wampold, 2001). Meta-analysis has become one tool which can be employed to undertake the task of 
investigating ‘what works for whom?’ (Roth & Fonagy, 1996).  The promise of meta-analysis, is that it 
can quantify and indentify potential bias in primary research and provide more accurate 
generalizations of psychotherapy effects (Matt & Navarro, 1997). In addition, meta-analyses can 
potentially help us identify those factors which might moderate or predict treatment efficacy.  




A moderator is a pre-treatment variable which can be demonstrated to have a statistically 
significant interaction with an outcome variable (Barber, 2007). If such a relationship can be reliably 
established, the assessment of moderator variables can help match most appropriate intervention to 
specific patient needs: a core principle in the stepped care approaches which are now being driven 
forward by public health organisations (Department of Health, 2009; NHS Scotland, 2011). Meta-
analyses frequently undertake analyses of moderating factors: seeking to developing an 
understanding of  under what conditions or for whom a particular treatment should be expected to 
work (Kraemer, Wilson, Fairburn, & Agras, 2002). However such studies often yield equivocal or 
contradictory results. This review will systematically identify and evaluate those meta-analyses that 
have examined psychotherapeutic interventions for depressed older adults and ask to what extent 
they have helped us answer the question: What works for whom in this group?   
2.1.1 Rationale for review 
The need for practitioners in real-life clinic settings to draw on the current evidence-base to 
tailor psychotherapeutic interventions to the older person they are working with is recognised as a 
key component in best-practice clinical guidelines (National Institute for Health and Clinical 
Excellence, 2009; Scottish Intercollegiate Guidelines Network, 2010; NHS Scotland, 2011). However, 
despite a growing body of literature exploring how best to adapt therapeutic approaches to meet the 
differing needs of depressed older adults (Laidlaw & McAlpine, 2008; Satre, Knight, & David, 2006), 
an evidence-based understanding of those factors which moderate treatment outcome in late-life 
depression is not well developed. Although meta-analytic studies are limited in the degree to which 
they can inform an understanding of specific process issues in therapy, they can support an 
understanding of the relationship between therapy outcome and key potential moderators of 
treatment: including therapist variables, treatment modality, and characteristics of the depressed 
patient. Meta-analyses vary in quality, scope and purpose and although a number of meta-analyses 
have been undertaken in this area there has been no systematic review of these studies which seeks to 
critically evaluate and compare their findings with regard to moderators of treatment effect.  
2.2. Objectives 
This systematic review seeks to answer the following question: 
To what extent have meta-analytic studies refined our understanding of what predicts or 
moderates treatment effects in late-life depression? 




 The implications of these findings will be discussed within the broader literature which seeks 
to develop an empirical understanding of the specific factors which moderate psychotherapeutic 
efficacy. 
2.3 Methods 
2.3.1 Eligibility criteria 
Eligibility criteria for this review were developed according to methods described in The 
Cochrane Handbook for Systematic Reviews of Interventions (O’Connor, Green & Higgins 2011). 
Type of study: As the research question in this current study explicitly sought to determine to what 
extent meta-analytic techniques have helped to understand what might predict and moderate 
treatment effects, only meta-analytic studies were included. Systematic reviews, narrative reviews 
and literature summaries were excluded. There was no limit set on date of publication. Only studies 
in English were included, due to practical restraints of assessors translating other languages. Studies 
could be published or unpublished. Length of follow up of included studies was not limited.   
Participants: Only studies which examined interventions with older adults were included. 
Older adults were defined as being aged 55+ years. This broad parameter for older age prevented 
exclusion of potentially relevant studies and facilitated the inclusion of studies which might examine 
moderating factors related to age. Published research in this area has tended to recruit ‘younger-old’ 
participants and adopting this broad age cut off afforded inclusion of earlier relevant meta-analyses.  
Population: Only studies including diagnosis of depression, dysthymia or depressive 
disorders assessed by qualified clinicians or using standardised measures were included. There was 
no limit on setting (e.g. community, hospital). Meta-analyses which exclusively explored treatment 
for depression for individuals with specific co-morbid physical conditions were excluded, as the 
review question sought to identify treatment effects as they might apply to depressed elders in 
general, and combined interventions taking account of specific co-morbidities were considered 
unlikely to allow useful generalizability. 
 Intervention: Meta-analyses examining interventions without an active psychotherapeutic 
intervention were excluded, for example: exercise therapy; non directive community support, 
befriending, psychosocial support, behavioural activation.  Meta-analyses which included a 
comparison of psychotherapeutic and pharmacotherapy were also included, but only if data could be 
usefully extracted from the statistical treatment of psychotherapeutic condition. Comparisons: Studies 
were included if they involved meta-analytic comparisons between treatment modalities, treatment 
condition and controls, or undertook meta-analytic analysis of moderating factors.  




Outcomes: O’Connor et al. (2011) note that types of outcome should not necessarily be used 
to exclude studies from meta-analyses, as a variety of measures may be important in understanding 
efficacy of treatment. However as this review sought to examine treatments of depression, only those 
which included analyses of standardized rating of depressive symptoms as outcome measures were 
included. 
2.3.2. Information sources 
The search to identify studies was conducted in February 2012. The following databases were 
searched using EBSCOhost: MEDLINE with Full Text, PsycINFO, Psychology and Behavioral 
Sciences Collection, Health Business Elite, Biomedical Reference Collection: Comprehensive, Library, 
Information Science & Technology Abstracts, eBook Collection (EBSCOhost), Nursing Reference 
Center. No limit was set for date of publication. Search terms used were: older adults OR older people 
OR geriat* OR elder* OR late life OR senior; depress* OR dysthymi* OR mood; meta-analysis OR 
systematic review OR quantitative review; psychotherap* OR psychosocial OR psychological OR 
cognitive OR behavioural OR psychodynamic OR non-medical OR non-pharmaceutical OR 
counselling OR inter-personal. Reference lists from included studies were screened to identify any 
further relevant papers.  
First authors of included studies, and The Cochrane Centre for Depression, Anxiety and 
Neurosis, were contacted to establish whether any unpublished or ongoing meta-analytic studies 
existed that were relevant to the research question. The World Health Organisation (WHO) 
International Clinical Trials registry was searched for relevant ongoing studies. To minimise 
publication bias a search of grey literature was undertaken via System for Information on Grey 
Literature in Europe (http://www.opengrey.eu/); and Web of Science Conference Proceedings Citation 
Index database. The first author screened abstracts for eligibility. Figure 1 illustrates the search 
process.  The last date searched was the 28.1.12. The full search strategy is included as Appendix 2. 
Correspondences from contacted authors are included as Appendix 3. 
2.3.3. Selection 
The author conducted the electronic search and screened first by title, then abstract and 
finally by reading full texts of journal articles. Studies not meeting eligibility criteria were excluded, 
with reasons reported for those studies that were excluded at full-text stage. 
 
 




2.3.4. Data collection process and data items  
Data were extracted by the author for the following variables: Number of included studies in 
the meta-analyses1; Number of participants both total and in active intervention groups; Range of 
number of participants in component studies; Gender ratio across studies; Range of mean age of 
included studies; Overall mean age for meta-analysis; Diagnostic composition of component studies; 
Format of included studies; Inclusion criteria of meta-analysis; Number of sessions: range of mean 
across studies  and overall mean; Reporting of random assignment / blinding; Controls of component 
studies; Quality assessments used and rating co-efficient reported; Outcome measures used in 
component studies; Reporting of follow up data; Reporting of drop out data; Main findings; Results 
of any sub-group analyses.  
Any missing data were coded as such, but authors were not contacted to supplement or 
confirm this due to resource constraints of the reviewer. It was assumed that data reported in meta-
analyses with regard to primary studies was accurate, and so was not cross-referenced. This was 
again due to resource constraint. Some of the data-items were reported incompletely or in different 
form (e.g. ordinal or percentage data). No attempt was made to convert such information and it was 
included in original form. An exception was when data could easily be collated from tabular results 
(for example, if total number of participants was not explicitly reported, but could be summed from 
data reported on individual studies in tabular form). For each study the author collated, in tabular 
form and summary form, the main results, the results of any sub-analyses, and any analyses of drop-
out undertaken (Appendix 4).  
2.3.5. Risk of bias in included studies 
Studies were assessed according to the Preferred Reporting Items for Systematic reviews and 
Meta-Analyses (PRISMA) guidelines (Moher et al., 2009), which present a 27-item checklist of best-
practice for reporting of systematic reviews and meta-analyses and can be used as a framework for 
the critical appraisal of systematic reviews. The PRISMA guidelines represent a refinement of the 
previous quality of reporting of meta-analyses (QUOROM) checklist (Moher et al., 1999). The author 
coded each included meta-analysis against the 27 items set out by the PRISMA checklist (Appendix 
6). A score of zero was given if there was no evidence of reporting a particular checklist item. A score 
of one was given if the study was assessed to only partially meet the reporting guideline for a 
checklist item. A score of two was given if it was considered a reporting criterion was fully met. Items 
                                                          
1
 For those trials where only a sub-section of analyses met the eligibility criteria: such as in studies also examining 
pharmacotherapy, or reporting other outcomes such as life satisfaction, only data for this sub-section of trials was 
extracted and coded. 




five, sixteen, and twenty-three on the checklist (Table 2) were not applicable to all studies so these 
scores were not included in the comparative reporting quality score for each study. (Full details of 
scoring given for each study with rationale are included as Appendix 7). 
 
 
Figure 1. Flow of studies through the systematic review 
Those items explicitly addressing the reporting of risk of bias (items 12,15,19 and 22 in Table 
2) were collated to give an overall score relating to risk of bias. Half of the studies were selected 
randomly (http://www.random.org) and rated according to the PRISMA criteria by an independent 
assessor (CC).  Moher et al. (2009) note the PRISMA checklist is not an instrument designed to 
quantify the quality of a systematic review, rather a framework to critically appraise quality of 
reporting. As such, summary scores were not used to rate quality directly, but rather as a heuristic to 
facilitate assessment of the degree to which studies reported and critically considered the impact of: 
search and inclusion methodology; sample sizes of included studies; standardisation of 
psychotherapeutic interventions; expertise of therapists; adherence to therapeutic protocol; 
randomisation/allocation concealment; intended sub-group analysis; publication bias; risks of bias 
within meta-analytic methodology.  
 




Consideration of the adequate reporting of sources of bias was used when evaluating and 
discussing the results of studies. This systematic review did not include in its objectives quantitative 
synthesis of results, so in line with recommendations outlined by The Cochrane Handbook for 
Systematic Reviews of Interventions (Higgins & Green, 2011), no formal attempt to weight studies 
according to quality, or controlling for bias was undertaken.   
 
2.3.6. Risk of bias across studies 
Risks of bias that may affect cumulative evidence were considered and the degree to which 
each study contributes to this was considered by coding study characteristics and assessing studies 
according to the PRISMA checklist (Moher et al., 2009). The impact of risk of bias across studies was 
examined by undertaking an analysis of the relationship between moderator analysis, study quality 
and publication date and seeking to critically evaluate results in light of these factors. Risks of bias as 
a result of the methodology of this review were identified and evaluated as limitations in the 
discussion. 
2.4. Results 
2.4.1. Results of literature search  
Following removal of duplicates, the systematic search yielded a total of 269 studies. A total 
of 254 articles were excluded because they did not meet the inclusion criteria.   215 were excluded 
after screening the title, 19 after screening the abstracts. Thirty-five full-texts were evaluated and 21 of 
these excluded. A summary of reasons for exclusion of full text papers is included as Appendix 7.  
2.4.2. Study characteristics 








KEY for Table 1 ‘Characteristics of the included studies Parts 1-4’ 
ABS = Affect Balance Scale. BDI = Beck Depression Inventory. Bibl. = Bibiliotherapy. BSI-D = Brief Symptom Inventory - 
Depression Scale. BT = Behavioural Therapy.  CBT = Cognitive Behaviour Therapy. Clin = Clinical. ClinR = Clinician-rated. 
CES-D = Center for Epidemiological Studies Depression Scale. CT. = Cognitive Therapy. Dep. = Depression. Diag. = 
Diagnosis. DSM = Diagnostic and Statistical Manual.  Dysth. = Dysthymia.  F = Female. GDS = Geriatric Depression Scale. 
Gr = Group. HADS = Hospital Anxiety and Depression Scale. HDRS = Hamilton Depression Rating Scale. HSCL = Hopkins 
Symptoms Checklist. ICD-10 = International Classification of Diseases Version 10. IDS = Inventory of Depressive 
Symptomatology. Ind = Individual. IDD = Inventory to Diagnose Depression. IPT = Interpersonal Psychotherapy. LSI = Life 
Satisfaction Index. M = Mean. MA = Meta-analysis. MADRS = Montgomery-Asberg Depression Rating Scale. MACL = 
Mood Adjective Check List. MajD = Major Depression. MinD = Minor Depression. ModDep = Moderate Depression. 
MMPI-D = Minnesota Multiphasic Personality Inventory Depression Scale.  MUMS = Memorial University Mood Scale. 
MAACL-R = Multiple Adjective Affect Check List Revised. MMPI-D = Minnesota Multiphasic Personality Inventory 
Depression Scale. NR = Not reported. PGCMS = Philadelphia Geriatric Centre Morale Scale. PST = Problem Solving 
Therapy. PsychEd = Psycho-education. PsyD = Psychodynamic Therapy. QRS = Quality Rating Scale.  RA = Random 
Assignment. RCT = Randomised Controlled Trial.  Req. = Required. RT = Randomised Trial. RSS = Rosenberg’s Self-esteem 
Scale. RT = Reminiscence Therapy. SCL-20 = 20-item Symptom Checklist.  SD = Standard deviation. SevDep = Severe 
Depression. SubClin =Subclinical. SCID = Structured Clinical Interview for DSM-IV. SWB = Subjective Well-Being. TAU = 
Treatment as Usual. WL = Waiting List. Zung = Zung Self-Rating Depression Scale. 
























mean age  
Diagnostic composition of 
component studies 
Gorey & Cryns (1991) 19 809/NR  NR  60.5% F NR  69.6 NR  
Scogin &McElreath 
(1994) 
17 NR/773  16-162 43% F 62-85 70.5 
MajD =4.  Clin + SubClin =10. 
SubClin =3. 
Engels & Vermey 
(1997) 
17 471/732 4-108 
5/17 NR. 
F>Male  
but NR by 
MA  
NR  68.6 
ModDep = 103. SevDep: 258 
(participants) 
Cuijpers (1998) 14 634/799 20-162 
55%-98% 
F. 
55-83 NR  
6/14 Diag. according to 
DSM/research criteria 
Pinquart & Sorensen 
(2001) 
122 NR  







M = 71.4 
(± 7.1)  
NR  
Bohlmeijer et al., 
(2003) 






5/20 = severe. 15/20 = mild-
moderate. 
Cuijpers et al., (2006) 25 1937 14-415 NR  NR  
≥ 50 = 1 
≥ 55 = 5  
≥ 60 =10 
≥ 65 =7 
15/25 = Any diag. of Dep. 
(9 = MajD.) 10/25 diag. not 
req. 
Pinquart et al., (2006)  32/89  1407 NR  66% F NR  70.4 9/32 = MajD  
Chin (2007) 6/15 95/178 25-35 85% F 75-82 79.3 
Formal diagnosis of 
depression not required  
Pinquart et al., (2007) 57 1956 NR  67% F NR  71.77 
Self-Rated: 21/75 = MajD.  
51/75 =MajD/MinD/Dysth.   
3/75 = MinD/Dysth.  
Clin-Rated: 20/49 =MajD. 
25/49 =MajD/MinD/Dysth 
3/49 = MinD/Dysth. 
Wilson et al., (2008) 7 NR/153  30-262 
3/12 NR. 
Mean of  
9/12: 
70% F  
NR  NR  
Detailed diagnostic 
composition of each study 
recorded: Range: Dysth, 
MinD to MajD. 
Peng et al., (2009) 14 445/705  NR  NR  NR  NR  
NR (‘depression’ key word in 
search) 
Samad et al., (2011) 4 186/256 30-95 
38% - 
85% F 
66-68 NR  
2/4 = MajlD. 1/4 = HDRS≥10. 
1/4 = HDRS≥10, BDI ≥10, GDS 
≥11. 





% F One 
study: NR  
66 -84 NR  
5/6 Diag. according to 
DSM/research criteria.  2/6 
excluded severe depression. 
6/6 'mild-moderate' 
depression. 
Table 1: Summary of the characteristics of included studies: Part 1. 
 












BDI, HDRS, Zung, account for 75 % 
of measures used.  




Coded 'self' (e.g., BDI) or 'clinician' 
(e.g. HDRS)  




HDRS =4. BDI =4. BDI-short =3. GDS 
=3. 
8/17, 1month-1yr. Effect sizes 
maintained. 
4/17 studies no info given. Mean of 




BDI, HDRS, GDS, MMPI-D, Zung, 
BSI-D. Breakdown not reported. 
6/14  = 1month-2yr. 
2/14 did not report. For others: 





Self-rated Dep. = 57/122.  Clin 
rated =12/122.  Self-rated SWB =  
84. BDI=22. GDS=11. Zung =8. CES-
D =5. HDRS (7) LSI(18)RSS (12) 
PGCMS (8) ABS (5) 
Most studies with follow up didn't 
use control groups. No sig 
difference at follow up in over 50% 





BDI. HDRS, GDS MACL, Zung, 
MADRS, MUMS, MAACL-R. 
Breakdown not reported. 
NR  
5/20 NR. 4 studies dropout..25%. 
Mean dropout across studies 16%. 
Cuijpers et 
al., (2006) 
HDRS, SCID, BDI, GDS, HSCL-20, 
MMPI-d, Zung, CES-D, HADS-D, IDS, 
HDRS, MADRS, IDD. Breakdown 
not reported.  
2/25 studies included data  
comparing follow up & control. 
4/25 allowed calculation of post-
test/follow up, (range 3months -1 
yr). No analysis reached 
significance.  
10 studies =  <20%. 8 studies = 20-30%. 
5 studies= >30%. Two studies = NR.  
Pinquart et 
al., (2006)  
For all studies (including drug 
trials) HDRS =61. MADRS=4. 
BDI=21. GDS =20. Other =29. 
NR  NR  
Chin (2007)  GDS =5. BDI =1. NR  Three studies 0%. mean of others: 12% 
Pinquart et 
al., (2007) 
GDS =22. BDI =19. HDRS =17. CESD 
=6.  Zung =6. Clinical Interview =5. 
Other 'validated measures' =11. 
21% reported follow up 
18.9% of intervention participants and 




HDRS =8. GDS =7. 
One included study was a follow-
up trial. Another recorded follow 
up between 12-16 weeks. 
Drop out coded and reported for 9/12. 
2/12 dropout unclear. 1/12 not 
reported. High dropout rates across 
trials.  Difference between therapy and 
control rates reported. 
Peng et al., 
(2009) 
Including' SCL-20, HDRS, BDI, GDS.  
Breakdown not reported.  
607/705 received 'follow up' 
unclear if this actually means 
'study completers' 
Drop-out rates not reported: analysis 
undertaken: those receiving treatment 
for depression with or without 
psychotherapy( 5 studies) 
Samad et 
al., (2011) 
BDI =3. Zung =1.HDRS =4. GDS=3. 
BSI=1. 
 3-month follow up  (one study) 
considered comparable to 
immediate outcome data for 
analysis 
Reported in all four. Pooled odds ratio 
was 1.50 
(95% CI 0.32–6.96) with no significant 
difference between trials. 
Krishna et 
al., (2011) 
 (HDRS) + (GDS) + (BDI)   = 2/6.  IDS 
=1/6 .MADRS = 1/6. HDRS =1/6. 
2/6 + no follow up. 3/6 = one yr. 
1/6 = 9 months. mean 11.3 
months (SD 1.5)  
1/6 unclear. 5/6 data detailed.  
Table 1: Summary of the characteristics of included studies: Part 2. 
 




















'Other'. Numbers NR.  
NR  NR  NR  
Scogin & 
McElreath (1994) 
CBT =7.BT =4. IPT/PsyD 
=3.  RT =8. Eclectic 
therapy =1. 
All studies used control/comparison 
group: No treatment = 17. 
Attention placebo =4. Pill placebo = 
2. Supportive contact = 1. 
Comparator intervention =10. 
Suydam (1968) Nine 
dimensions.  Two 
raters: (r)  0.73.  
NR  
Engels & Vermey 
(1997) 
CT =7. BT=4.PsyD=4. 
CBT =5. 'Other' =7. 
No control =6. Artificial control 
calculated to allow synthesis of 
data. Actual controls categorized: 
'Wait list/minimum support' and 
'placebo therapy'. 
No measure. 5/17 
’poor quality’: failure 
to report drop-out or 
randomisation. 
 RA =10.  Adjusted 
randomisation =3 
Clients matched 
=2.  No info. =3 
Cuijpers (1998) 
CBT=9. PST =1. BT=1. 
PsyD =4. Bibl-CBT =2.  
Bibl-BT =1. 
Control = 8, of these waiting list =6. NR  




Breakdown NR.  
No treatment = 96. Attention 
placebo =38. 
‘3-point scale.’ 
NR, but coded in 
quality 
assessment 
Bohlmeijer et al., 
(2003) 
15/20 = RT. 7/20 = life 
review. 
No treatment =13.  Psych placebo 
=9.  WL =1.  RT =3 
4/20 Assessed as high 
quality 
RA =15 Method 
NR.  
Cuijpers et al., 
(2006) 
 CBT  = 12. BT=4. RT =4. 
IPT =4. PST =4. PsyD=2 
'Bibl =4. CT =1. 
Control =17.  WL =8. TAU =4. 
Placebo =3. Other = 3. Comparison 
between treatments =8. 
Higgins & Green 
(2005)  
 Independent RA 
=2.   13/25 
blinding of 
assessors 
Pinquart et al., 
(2006)  
Coded 'CBT' or 'other'. 
Breakdown NR.  
Drug placebo =4.  Attention placebo 
=6.TAU =2. WL=22. 
 Juni et al., (2001) 
RA =29 Method 
NR.  
Chin (2007)  RT. 
All studies used control: type not 
recorded. 
Chalmers et al .,1990.  
RA =4. Method 
NR.  
Pinquart et al., 
(2007) 
CBT =13. BT =11. CT 
=10. RT =8. PsychED 
=8. PsyD= 3. IPT =3. 
'Other' =25. 
Coded 'active placebo' or 'other' 
data NR.  
Four criteria: random 
assignment; >10 
participants in each 
group; equivalence of 
control group; exact 
effects reported. 
RA =87.9% 
Method NR.  
Wilson et al., 
(2008) 
 CT, BT, CBT, PsyD, 
Bilbl. Detailed, but not 
collated.  
All studies used control: types 
detailed, not collated. 
QRS (Moncrieff, 2001) 
RA =9 Details of 
blinding reported. 
Peng et al., (2009) 
CBT, n = 138. RT, n = 
109.  ' psychotherapy'  
n = 100. 
All studies used control: type not 
recorded. 
NR  NR  
Samad et al., 
(2011) 
BT =4. Delayed treatment =3. 
Higgins and Green 
(2008) Cochrane 
collaboration risk of 
bias tool. 
RA= 4. Method 
NR. Allocation, 
concealment or 
blinding not clear 
Krishna et al., 
(2011) 
CBT (all studies)= 6. 
Comparators: RT=2 
0ther =4. 
All studies used control/ 
comparator. RT=2.  Group visual 
imagery =1. Education =1. WL=3. 
Educational group =2.         
QRS (Moncrieff et al., 
2006) inter-rater 
reliability of k 0.76 
(95%CI: 0.48, 1.07).  
RA=6.Method NR.  
Table 1: Summary of the characteristics of included studies: Part 3. 
 












Gorey & Cryns 
(1991) 
Gr = 19. 
Not systematic: 'relevance to question'; Inclusion of data 
to allow MA. Although ≥65yrs detailed in abstract, 27% 




Gr = 10. Ind. 
=2. Self-
directed =2. 
≥60 yr; Psychosocial treatment for depression; control 
comparison; standardized depression outcome measure. 5-46 12 
Engels & Vermey 
(1997) 




No specific age criteria: ‘elderly’. Evidence of ‘depressive 
complaints'; Inclusion of data to allow MA.  
4 - 20 NR  
Cuijpers (1998) 
Gr =6. ind 
=6. Blbl =2. 
≥55 yrs. Psychological intervention for depression; Active 







≥ 55 yrs. Psychosocial or psychotherapeutic intervention 
compared to control; outcome measure of depression or 
well-being; inclusion of data to allow MA.  
1-250 Median = 9 
Bohlmeijer et al., 
(2003) 
Gr =14. Ind 
=6. 
No age inclusion criteria. Reminiscence/life review; 
Depression outcome measure; control or comparison 
group. 
9/20 =  <6. 
9/20=  7-12. 
2/20=  >7. 
NR  
Cuijpers et al., 
(2006) 
Gr =7. Ind 
=14. Bibl =4. 
≥50 yrs. RCT comparing psychological treatment to 
control or other treatment; Clinically relevant depressive 
symptoms; Inclusion of data to allow MA.  
4-20  NR  






≥ 60; Diagnosis of depressive disorder; control used; 
Inclusion of data to allow MA.  
NR  9.4  weeks  
Chin (2007)  Gr =6. 
≥50 yrs. Reminiscence; controlled trial; before 2001; life 
satisfaction, happiness, self-esteem or depression 




Pinquart et al., 
(2007) 
Gr =61.7%  
≥60 yrs; MajD/MinD or Dysth. (ICD-10, DSM-IV); 
psychological or behavioural intervention compared with 
control; sufficient data to estimate depression change 
score. 
NR  15.2 
Wilson et al., 
(2008) 
Gr =4. Ind 
=5. Bibl =3. 
≥55 yrs. RCT or cluster RT ;diagnosis of depression using 





Peng et al., 
(2009) 
NR  
≥55 yrs. RCT; drop-out rates > 50%; ‘depression' 
although not defined. NR  NR  




≥55 yrs. Behaviour Therapy; RCT; diagnosis of depression 
using standardized outcome measure/diagnostic criteria. 
10 - 20 (excl 
Bibli) 
14.6 
Krishna et al., 
(2011) 
Gr =6. 
≥50 yrs. RCT or cluster RT; formalised psychotherapeutic 
treatment; diagnosis of depression using standardized 
outcome measure/diagnostic criteria; at least one group; 
(>3) in group.  
8 =1. 10 =1. 11 





Table 1: Summary of the characteristics of included studies: Part 4. 
 




2.4.3. Risk of bias within studies. 
There was an 89% agreement between raters with a Kappa of 0.82 (95% CI 0.75 to 0.89) 
(Appendix 8). Overall, the quality of reporting was not optimum, meaning it was often not possible to 
ascertain actual methodology and therefore adequately account for potential sources of bias within 
studies.  
Search and inclusion methodology was particularly poorly reported across studies. Only 
Wilson, Mottram and Vassilas (2008) reported in such a way that would facilitate a fully systematic 
and replication of the process. One potential source of bias in Wilson et al.’s (2008) search and 
inclusion criteria was the exclusion of potentially eligible studies that were in the process of review. 
However, transparent reporting of this facilitated potential further analysis as to whether these 
named studies may have altered findings. Only four studies were judged to report on risk of bias 
adequately. Three of these studies (Krishna et al. 2011; Samad, Brealey & Gilbody, 2011; Wilson et al., 
2008) reported on the insufficiency of randomisation/allocation concealment. Other studies either 
failed to report on randomisation or reported this variable without critical appraisal of its impact on 
bias across or within studies. Wilson et al. (2008) reported on whether studies had evidenced therapist 
experience, adherence to therapeutic protocol and whether studies had evidenced standardisation of 
psychotherapeutic interventions. These factors were not considered systematically in other included 
reviews.  
All meta-analyses included primary studies with small sample sizes, but not all studies 
identified this as a source of potential bias or considered this in their conclusions. Reporting of 
intended sub-group analysis, and evaluation of risks of bias within meta-analytic methodology were 
not routinely reported in the majority of reviews. Coding for intention to treat analysis was only 
reported by Pinquart, Duberstein and Lyness (2006) and Wilson et al. (2008). 
Table 2:  Assessment of reporting quality. The scores allocated for each PRISMA 
checklist criteria 1-27 are tabulated. Detailed PRISMA criteria outlined in Moher et al., (2009). 
‘0’ = Did not meet criteria. ‘1’ = Partially met criteria. ‘2’ = Fully met criteria. Mean scores for 
each criterion across studies is listed in far right column. Items 5, 16, and 23 were not 
applicable to all studies and were therefore not included in overall ‘Quality of reporting Score’ 





































































































































































































Title                  
1 Title   2 1 1 2 2 2 2 2 2 2 2 2 2 2 1.9 
Abstract                
2 Structured summary   1 1 1 1 1 1 1 2 2 1 2 1 2 1 1.3 
Introduction                
3 Rationale   1 2 2 2 2 2 2 2 2 2 2 0 2 2 1.8 
4 Objectives   1 1 1 1 2 1 2 2 1 2 1 0 2 1 1.3 
Methods                
5 Protocol and registration  0 0 0 0 0 0 0 0 0 0 1 0 0 0 0.1 
6 Eligibility criteria   0 1 1 1 1 2 2 1 1 1 2 0 2 2 1.2 
7 Information sources   1 1 1 1 1 1 1 1 1 1 2 1 1 2 1.1 
8 Search   0 0 0 0 0 0 0 0 0 0 2 0 0 0 0.1 
9 Study selection   0 1 1 1 0 1 1 1 2 0 2 1 2 1 1.0 
10 Data collection process   0 1 1 0 0 0 0 1 2 1 2 1 2 1 0.9 
11 Data items   0 2 2 2 2 1 2 2 2 2 2 1 2 0 1.6 
12 Risk of bias within studies   1 1 0 0 1 0 0 1 1 1 2 0 2 2 0.9 
13 Summary measures  1 2 2 2 2 2 2 2 1 2 2 O 2 2 1.7 
14 Synthesis of results   1 2 1 2 2 2 2 2 2 2 2 0 2 1 1.6 
15 Risk of bias across studies  0 1 0 1 0 1 0 1 2 0 2 0 2 2 0.9 
16 Additional analyses  1 0 0 2 1 0 1 0 0 1 2 0 0 1 0.6 
Results                 
17 Study selection   1 0 1 0 0 0 2 0 1 0 1 1 2 2 0.8 
18 Study characteristics   0 1 0 2 0 2 2 0 2 2 2 0 2 2 1.2 
19 Risk of bias within studies   0 1 1 0 0 0 1 0 1  0 2 0 2 2 0.8 
20 Results of individual studies   0 1 0 1 0 0 2 0 2 1 2 0 2 2 0.9 
21 Synthesis of results   1 1 1 2 2 2 2 2 1 2 2 1 2 1 1.6 
22 Risk of bias across studies   0 0 1 0 1 0 0 0 2  1 1 0 1 1 0.6 
23 Additional analysis  1 2 2 2 2 2 2 2 0 2 2 1 0 0 1.4 
Discussion 
24 Summary of evidence   1 1 1 1 2 2 2 2 1 1 2 1 2 2 1.5 
25 Limitations   0 1 2 1 2 1 2 2 2 1 2 1 2 1 1.4 
26 Conclusions   1 2 2 2 2 2 2 2 1 2 2 0 2 2 1.7 
Funding   
27 Funding   0 0 1 0 0 0 0 2 0 0 2 0 2 2 0.6 
 































Reporting of risk of bias  1 3 2 1 2 1 1 2 6 2 7 0 7 7 3.1 
 




2.4.4. Risk of bias across studies 
In addition to the failure to report or critically evaluate adherence to therapeutic protocols in 
primary studies, detailed definition of therapeutic categories defined within meta-analyses was 
frequently not adequately outlined, or linked with primary studies.  Thus there was a risk across 
studies that interventions classed as, for example, ‘cognitive’ in one analysis, may be grouped within 
the ‘cognitive-behavioural’ category in another analysis without this being easy to explicitly cross-
reference or check. A significant number of included studies did not adequately report on outcome 
measures, drop out, control conditions or random assignment, and therefore did not critically 
appraise the possible risk of bias emerging across studies from synthesizing data without attempting 
to quantify or consider these factors.  
Significant heterogeneity was found in a large proportion of the included meta-analyses and 
meta-analytic techniques were frequently not adequately reported. There is therefore a significant risk 
that discrepant results in moderator analysis may be an artefact of methodological approaches. 
Pinquart and Sorensen (2001), for example, note that the fact that they did not find significant age 
differences in treatment effects where Engels and Vermey (1997) report a tentative finding in this 
direction, may be due to the latter authors employing a fixed, rather than random-effects analysis, 
and thus potentially over-estimating the statistical significance of their results. Many of the included 
meta-analyses included outcome studies with less than ideal quality and failed to adequately 
discriminate between poor and good quality studies when reporting data synthesis, making the 
reliability and validity of comparative analyses difficult to ascertain.   
The impact of publication bias was not represented by funnel plots in any of the included 
studies and generally poorly reported, leading to a high risk of over-estimation of effect sizes across 
the included studies (Cuijpers, Smit, Bohlmeijer, Hollon, & Andersson, 2010). Two studies (Krishna et 
al., 2011; Samad et al., 2011) reported that they had insufficient studies to undertake sensitivity and 
funnel plot analyses. Wilson et al. (2008) reported use of funnel plots, but did not report data. The 
study by Chin (2007) scored highly for its reporting of bias despite including studies of poor quality, 
as limitations related to poor quality were clearly delineated and the consequent limited capacity for 
robust conclusions detailed. 
2.4.5. Relationship between date of publication, reporting quality and number of analyses of 
predictor/moderating factors. 
 Earlier studies tended to be reported less systematically and include a greater number of 
sub-analyses. Linear regression analysis was undertaken using the ‘R’ statistical and programming 




environment (R Development Core Team, 2011). More recent publication date was significantly 
correlated with increased reporting quality (‘A’: r² = 0.33, F = 6.004 p = 0.03) and reduced analysis of 
predictors of outcome/moderating factors (‘B’: r² = 0.42, F = 8.601 p = 0.013). Reporting quality and 
number of analyses were not significantly correlated due to the disproportionate influence of a single 
outlier (Peng et al., 2009) as revealed by a Cook’s distance ≥1 (Crawley, 2009 p. 401) Excluding the 
paper by Peng et al., (2009) revealed a significant inverse relationship between reporting quality and 
number of analyses of moderating factors undertaken (‘C’: r² = 0.54, F= 13.03 p = 0.004). Plots used to 
validate the model and check for violation of assumptions of linear regression analysis are included 
as Appendix 9. 
 
2.4.6. Moderators of outcomes in the psychotherapeutic treatment of depression: results from 
the included meta-analyses. 
As seen in Table 3, treatment moderators explored by the included studies were: severity of 
depression; modality of therapy; duration of treatment; treatment setting; participant age; gender; 
presence of co-morbidities; therapist experience; social support. Other factors for which relationship 
to outcome was explored included: type of therapy; outcome measures used; type of control; study 
quality. 
2.4.6.1. Factors that consistently showed a moderating effect on treatment response 
2.4.6.1.1. Presence of co-morbidities (two analyses) 
Presence of co-morbidities showed a consistent moderating effect on treatment response, 
although this was only across two analyses. Engels and Vermey (1997) found that patients classed as 
having ‘multiple complaints’ responded less well to treatment (d = 0.14) than those diagnosed with 
either major depression (d = 0.86) and other depression diagnoses (d = 0.68) and inferred that co-
morbidity may inhibit response to therapeutic treatment. These results need to be interpreted with 
caution as non-psychological interventions were included in the analysis and the natures of 
secondary diagnoses were not detailed. Pinquart et al. (2007) found significantly weaker 
improvements of depressive symptoms were found in studies that included participants with 








Figure 2.  A: Relationship between reporting quality (as determined by PRISMA checklist 
score) and year of publication. B: Relationship between number of analyses undertaken of 
potential moderating factors and year of publication. C: Relationship between number of 
analyses undertaken of potential moderating factors and reporting quality (Dotted line 
indicates non-significant correlation before removing outlier. Outlier =triangular point). 
2.4.6.2. Factors that consistently showed no moderating effect on treatment response 
2.4.6.2.1. Duration of treatment (six analyses) 
Gorey and Cryns (1991) reported non-significance without supporting analyses or data. 
Scogin and McElreath (1994) report a non-significant association of effect size with number of 
treatment sessions (ES = -0.20, n = 12). Engels and Vermey (1997) included artificial controls in their 
analysis, but when these data were omitted the number of treatment hours was not significantly 
associated with effect size (r = 0.06). Non-psychological interventions were included in this analysis.  
A: r² = 0.33, F = 6.004 p = 0.03  
 
B: r² = 0.42, F = 8.601 p = 0.013 
 











































































Table 3: Studies arranged according to PRISMA checklist reporting quality score. Ticks 
indicate factors reported as significantly associated with treatment outcome. Crosses indicate 
factors reported as not significantly associated with treatment outcome. A dash indicates that 
this factor was not analysed. If a study undertook analysis of drop-out this is indicated with a 






























































































































































































Peng et al., (2009) 12 ✘ - - - - - - - - - - - - -  ✓ 1 
Gorey & Cryns 
(1991) 
13 ✘ ✓ - - ✘ ✓ ✓ ✘ ✘ ✘ - ✓ - ✓  ✓ 10 
Engels & Vermey 
(1997) 
24 ✓ ✘ ✓ ✓ ✘ ✓ - - ✓ ✘ ✓ - - -  - 9 
Scogin & McElreath 
(1994) 
25 ✘ ✘ - ✘ ✘ - ✘ - - - - - - -  - 5 
Cuijpers (1998) 25 ✘ ✘ - ✘ ✘ - - - ✘ ✘ - - - -  ✓ 6 
Pinquart & 
Sorensen (2001) 
25 ✓ ✓ ✓ ✓ ✘ ✘ ✘ ✘ - - - - ✓ -  - 9 
Bohlmeijer et al., 
(2003) 
25 ✘ ✓ - ✘ - - ✘ ✘ - ✘ - - - -  - 6 
Pinquart et al., 
(2007) 
27 ✓ ✓ ✘ ✘ ✘ ✓ ✓ ✘ ✘ - ✓ - - -  ✓ 10 
Pinquart et al., 
(2006) 
30 ✓ - ✓ - - - - - - - - - - -  - 2 
Cuijpers et al., 
(2006) 
32  ✘ ✘ ✘  ✘ - - - - - - - -  - 5 
Chin (2007) 34 - - - - - - - - - - - - - -  - 0 
Krishna et al., 
(2011) 
36 - - ✓ - - ✓ - - - - - - - -  - 2 
Samad et al., (2011) 44 ✘ ✓ ✓             ✓ 3 
Wilson et al., (2008) 45 ✘ - ✓ - - - - - - - - - - -  ✓ 2 
Effect found  4 5 6 2 0 4 2 0 1 0 2 1 1 1    
No effect found  8 4 2 5 6 2 3 4 3 4 0 0 0 0    
 
Cuijpers (1998) reported that regression analysis yielded no correlation between number of 
treatment sessions and effect size, although data are not reported. Pinquart and Sorensen (2001) 
compared psychotherapeutic interventions with more than nine sessions with those with nine or 




fewer sessions. Outcomes were not significantly different on either self-report (sr) or clinician rated 
(cr) measures. For interventions with more than 9 sessions, ES(sr) = 0.59, ES(cl) = 1.21. For those with 
less than nine sessions, ES(sr) = 0.40, ES(cl) = 0.76. Pinquart et al. (2007) found no significant 
correlation between number of sessions and outcome (B = -0.01, β = -0.12, t = 1.17). 
2.4.6.2.2. Treatment setting (four analyses) 
Gorey and Cryns (1991) report non-significance without reporting results of their analysis. 
Pinquart and Sorensen (2001) found mean effect sizes did not differ significantly between community 
(g = 0.51) and nursing home (g = 0.39) settings. Bohlmeijer et al. (2003) found that effect sizes for 
interventions in community and non-community settings overlapped at the 95% confidence interval: 
Community, d = 1.11, 95%CI = 0.12 to 2.10, non-community d = 0.38, 95%CI = 0.05 to 0.71. Pinquart et 
al. (2007) reported no correlation between treatment setting (inpatient versus other settings) and effect 
sizes (B = -0.19, β = -0.14, t = -1.29).  
2.4.6.2.3. Gender (four analyses) 
Gorey and Cryns (1991) reported non-significance without supporting data. Engels and 
Vermey (1997) compared treatments where the proportion of women and men was fairly equal with 
treatments with a large proportion of women. They found a non-significant difference (Z = 1.69, p = 
0.6, n = 17) but note that the results are difficult to interpret as gender had to be coded at study, rather 
than intervention level and non-psychological interventions were included in the analysis. Cuijpers 
(1998) reported gender was not significantly correlated with outcome in a regression analysis across 
studies. Bohlmeijer et al. (2003) found no significance when comparing studies with more than 72% 
females with studies with less than 72% female, with 95% confidence interval overlapping: >72% 
female, d = 0.58, 95 % CI = 0.31 to 0.84, compared with, <72 % female, d = 0.75, 95% CI = 0.21 to 1.28.  
2.4.6.3. Factors for which the majority of analyses showed a moderating effect on treatment 
response 
2.4.6.3.1. Outcome measures (8 analyses) 
Six studies found that clinician rated measures significantly increased effect sizes as 
compared with self-rated outcome measures. Engels and Vermey (1997) found the clinician-rated 
Hamilton Depression Rating Scale (HDRS) (Hamilton, 1967) significantly increased effect sizes as 
compared with all other outcome measures including self-rated outcomes such as the Becks 
Depression Inventory (BDI) (Beck, Brown, Steer, & Weissman, 1991)and the Geriatric Depression 
Scale (GDS)(Yesavage et al., 1983): HDRS d = 1.10; BDI d = 0.57; GDS d = 0.68. Paired t-tests showed 
this to be significant: HDRS vs. BDI: Z=3.30, p=0.00; HDRS vs GDS: Z=1.56, p = 0.05.  Pinquart and 




Sorensen (2001) also found that clinician rated measures significantly increased effect sizes as 
compared with self-rated outcomes across a wide range of interventions: CBT, ES(sr) = 0.64, ES(cr) = 
1.18;  Psychodynamic therapy, ES(sr)  =  0.79, ES(cr)  = 1.68; Reminiscence, ES(sr)  =  0.44, ES(cr)  =  
0.66. Pinquart et al. (2006) similarly found clinician rated depression to be associated with larger effect 
sizes for CBT: ES(sr) = -0.88, Es(cr) = -1.22. Wilson et al. (2008) using the weighted mean difference 
(WMD) found that CBT was superior to active control as measured by the HDRS: WMD = -5.69, 
95%CI = -11.04 to -0.35, N = 86) but not as measured by the GDS (WMD = 2.00, 95%CI = -5.31 to 1.32, N 
= 80). Krishna et al. (2011) found that behavioural therapy was significantly more effective than 
waiting list control as measured by the HDRS (ES = -0.95, 95%CI = -1.75 to -0.14) but not when 
measured by the BDI (ES = 0.19, 95 % CI = -0.82 to 0.45) or the GDS (ES = -0.10, 95 % CI = -0.86 to 0.37). 
Samad et al. (2011) found behavioural therapy for older people significantly more effective than wait-
list (WL) control when measured by HDRS (WMD = -5.68, 95 % CI = -7.71 to -3.66, p < 0.001, n = 117) 
but not significantly different when measured by patient self-report measures GDS and BDI (SMD = -
0.52, 95 % CI = -1.35 to 0.30, p = 0.21, n = 117). Scogin and McElreath (1994) also report increased effect 
sizes associated with clinician rated outcome measures (mean ES(cl) = 1.15, Z = 3.64, p < 0.05, 
weighted mean ES(cl) = 1.33) as compared with self-rated outcome measures (mean ES(sr) = 0.69, Z = 
3.31, p<0.05, weighted mean ES(sr) = 1.10), however, they do not report the statistical significance of 
this finding. 
Two studies found that outcome measures did not significantly predict effect sizes. Cuijpers 
et al. (2006) reported that effect sizes were comparable in studies using self-rating questionnaires and 
those where depression was defined according to diagnostic criteria, although the methodology for 
this analysis was not presented. Pinquart et al. (2007) reported overall effect sizes for self-rated and 
clinician rated depression overlapping at the 95% confidence interval: ES(sr) = 0.84, 95 % CI = 0.71 to 
0.97; ES(cr) = 0.93, 95 % CI = 0.74 – 1.11.  
 
2.4.6.3.2. Control used (six analyses) 
Four of the six analyses examining the impact of the type of control found that active or 
placebo controls were associated with reduced effect sizes when compared with no treatment or 
waiting list controls. 
Gorey and Cryns (1991) reported group therapy versus no treatment, yielded an effect size of 
d = 0.68, compared with group therapy versus placebo d = 0.09. Unfortunately no details as to the 
process of classifying controls or describing placebo interventions were outlined in the methodology, 
thus making interpretation of this result difficult. Engels and Vermey (1997) reported that 




comparisons with placebo yielded significantly lower effect sizes than no-treatment controls (Z = 2.08 
p = 0.02, N = 16) however they note that mean age varied significantly between these two conditions 
and non-psychological treatments were included in this analysis. Pinquart et al. (2007) also reported 
weaker improvement in depressive symptoms in interventions with active placebo control groups as 
compared with ‘other’ controls (β = -0.53, t = -4.97, p < 0.001). Similarly, Krishna et al. (2011) found 
that behavioural therapy was effective for older people when compared with waiting list control (MD 
= 6.29, Z = 4.63, p = 0.0001) but not more effective when compared with active controls (MD = -0.2, Z = 
0.18, p = 0.86).  
 
Two studies found that type of control used did not significantly alter effect sizes. Cuijpers et 
al. (2006) found no significant difference in effect sizes between waiting list (d = 0.72), care as usual (d 
= 0.75) and ‘other’ controls (d = 0.64). However, the study did not detail the nature of ‘other’ controls 
included, and did not undertake specific analysis between active placebo controls and non-active 
controls. Pinquart and Sorensen (2001) did not find a significant difference between changes in 
control groups using psychological placebo with changes in waiting list controls (self-rated 
depression: g = 0.12, 95% CI = 0.00 to 0.24, compared with g = 0.04, 95% CI = -0.03 to 0.11).  
 
2.4.6.3.3 Severity/presence of depression (nine analyses) 
2.4.6.3.3.1. Increased severity of depression associated with larger effect sizes. 
Gorey and Cryns (1991) found that studies ‘narratively defined’ as including mild, moderate 
or severe depression showed significant variance in outcomes, with higher levels of depression 
associated with higher effect sizes (mild, d = 0.14; moderate, d = 0.94; severe, d = 1.37). Bohlmeijer et 
al. (2003) similarly found participants with elevated depressive symptoms showed greater mean 
effect size (d = 1.23) than those without elevated symptoms (d = 0.37).  
2.4.6.3.3.2. Participants reaching diagnostic thresholds for depressive disorder compared with 
non-depressed participants. 
  Pinquart and Sorensen (2001) found significantly larger effect sizes associated with depressed 
participants in comparison to non-depressed participants on both self-report and clinician rated 
measures. Depressed participants showed mean effect sizes of ES(cr) = 1.16, ES(sr) = 0.70, compared 
with non-depressed participants: ES(cr) = 0.40, ES(sr) = 0.31. Samad et al. (2011) found that only 
including studies with a formal diagnosis of depression in their analysis reduced the effectiveness of 
behaviour therapy as compared with cognitive therapy on self-rated measures (All studies, WMD = 




0.23 versus only studies with formal diagnosis: WMD = 0.02) although this was not statistically 
significant and only included a small number of trials. 
2.4.6.3.3.3. Increased severity of depression associated with smaller effect sizes. 
 
Pinquart et al., (2007) found weaker improvements of depressive symptoms associated with  
studies including patients with diagnosis of major depression as opposed to other mood disorders: 
minor depression, mixed depressive symptoms and dysthymia (B = -0.26, β = -0.22, t = -2.21, p < 0.05).  
 
2.4.6.3.3.4. Depression severity showed no moderating effect. 
 
Four studies found that depression severity did not predict effect sizes. Scogin and McElreath 
(1994) reported similar mean effect sizes when comparing studies including severe depression (ES = 
0.76) with those only including mild or sub-clinical depression (ES = 0.79). Engels and Vermey (1997) 
compared mild/moderate depression with severe depression and found depression severity to be a 
non-significant predictor of effect sizes in both controlled (Z = 0.44, p = 0.33) and all studies with 
artificial controls (Z = 0.83, p = 0.20). Cuijpers (1998) compared studies with a formal diagnosis of 
depression with studies without this requirement and found a non-significant difference between 
effect sizes: d = 1.25 versus d = 0.9.  The remaining meta-analyses did not undertake analysis of 
depression severity. Cuijpers et al. (2006) comparing studies including only patients diagnosed with 
major depressive disorder, (MDD) with studies including patients with a range of depressive 
symptoms did not find any significant difference (MDD, d = 0.84, 95 %CI, 0.56 to 1.11, versus ‘Other’ 
d = 0.67, 95% CI, 0.49 to 0.85). 
 
2.4.6.4. Factors which the majority of analyses found to be non- significant in predicting 
treatment outcome 
2.4.6.4.1. Treatment type (14 analyses) 
Eight of the fourteen meta-analyses found that type of therapy did not predict treatment 
response as measured by effect sizes. Gorey and Cryns (1991) did not present methodology for sub-
group analysis and it is therefore difficult to evaluate the validity of their findings. Scogin and 
McElreath (1994) independently compared cognitive and behavioural approaches with ‘other 
approaches’ (treatment orientations defined as: behavioural, cognitive, psychodynamic and eclectic). 
Cuijpers (1998) compared CBT with ‘other therapies’ and behaviour therapy with ‘other therapies’. 
Bohlmeijer et al. (2003) compared reminiscence with life review. Cuijpers et al. (2006) compared CBT 




to ‘other treatments’. Wilson et al. (2008) compared cognitive with behavioural approaches and 
cognitive with psychodynamic approaches. Peng et al. (2009) compared CBT with reminiscence 
approaches. Samad et al. (2011) sub-divided the analysis according to self-rated and clinician rated 
outcome measures and compared behavioural therapy with cognitive therapy and behavioural 
therapy with brief psychodynamic therapy. None of the above comparisons revealed treatment type 
to be a significant predictor of outcome. 
 
Four meta-analyses found that type of therapy was significant in predicting outcome. Engels 
and Vermey (1997) found that cognitive therapy (CT) and behaviour therapy (BT) were 
independently more effective than therapies which were defined as both cognitive and behavioural in 
their orientation (CBT). CT, d = 0.78; BT, d = 0.85; CBT, d = 0.12. Unfortunately the methodology for 
classifying treatment orientation was not adequately reported so it is difficult to evaluate the 
implications or validity of this finding. Engels and Vermey (1997) also found both cognitive and 
behavioural approaches to be more effective than ‘other’ therapies, but the latter category included 
poor quality studies examining non-psychological approaches making it difficult to draw any 
meaningful conclusions from this analysis.  
 
Pinquart and Sorensen (2001) found that CBT and Psychodynamic approaches were 
associated with significantly higher effect sizes than reminiscence approaches: CBT, ES = 0.64, 95% CI 
= 0.5 to 0.78; Psychodynamic therapy, ES = 0.79, 95% CI = 0.37 to 1.21; Reminiscence, ES = 0.44, 95% CI 
= 0.30 to 0.58. Significant heterogeneity was noted in the findings for CBT but not psychodynamic 
therapy. Pinquart et al. (2007) found reminiscence, and cognitive behavioural approaches to show 
large effect sizes. Moderate effect sizes were found for psychodynamic therapy: Reminiscence, ES = 
1.00, 95% CI = 0.73 to 1.27; Cognitive behavioural approaches, ES = 1.06, 95% CI = 0.87 to 1.26; 
Psychodynamic therapy, ES = 0.76, 95% CI = 0.31 to 1.21.  
 
Two of the studies (Cuijpers, 1998; Samad et al., 2011) that did not find treatment type to be a 
significant predictor of outcome overall nonetheless found some evidence that treatment type was a 
significant variable. Cuijpers (1998) found CBT to be a predictor of increased effect sizes with multiple 
regression analysis whilst Samad et al. (2011) found that the effectiveness of behavioural therapy as 
compared to cognitive therapy was reduced (although this did not reach significance) when studies 
without a formal diagnosis of depression were excluded and outcome was measured via self-report 
measures.  
 




2.4.6.4.2. Modality (seven analyses) 
Modality (group or individual) was found not to be related to treatment outcomes in five out 
of seven analyses (Bohlmeijer et al., 2003; Cuijpers, 1998; Cuijpers et al., 2006; Pinquart et al., 2007; 
Scogin & McElreath, 1994). Two studies found therapy modality to be a predictor of treatment 
efficacy. Engels and Vermey (1997) found individual therapy to be more effective than group therapy 
iIndividual d = 0.76, group d = 0.38). However neither the relative quality of studies included in each 
category nor the proportion of psychological/non-psychological studies contained within each 
category were detailed, making it difficult to interpret this result. Pinquart and Sorensen (2001), 
including only psychotherapeutic interventions, found individual interventions to be significantly 
more effective than group interventions with both self-rated and clinician-rated outcome measures: 
Individual, ES(sr) = 0.70, ES(cr) = 1.56; Group, ES(sr) = 0.44, ES(cr) = 0.68. 
2.4.6.4.3. Age of participants (four analyses) 
Three studies found that age was not significantly associated with effect sizes. Gorey and 
Cryns (1991) report non-significance without supporting data. Regression analysis undertaken by 
Cuijpers (1998) showed age to be a non-significant predictor of effect size across fourteen studies. 
Regression analysis by Pinquart et al. (2007) also yielded non-significant results for age effects. Engels 
and Vermey (1997) employed a methodology which included artificial controls and note that the 
mean age of clients in the controlled studies was 70 years (range 65-81) and in the studies with 
artificial controls, 64 years (range 52-68). Including all studies they found a non-significant 
relationship between age and outcome (r = 0.03, p = 0.41, n = 28). However, only including studies 
with real controls yielded a significant result with younger age associated with better outcome (r = 
0.33, p = 0.01, n = 20).  
 
2.4.6.4.4. Study quality (five analyses) 
Three studies found that study quality was not associated with effect size. Scogin and 
McElreath (1994) found no correlation between study quality and effect size (r = 0.19, n = 14) in 
treatment versus no-treatment or placebo comparisons. Pinquart and Sorensen (2001) divided studies 
into three quality categories and found no significant relationship between study quality and effect 
size (low ES = 0.35; medium ES = 0.56; high ES = 0.56). Bohlmeijer et al. (2003) identified high quality 
studies and compared these with the remaining studies. They found that effect sizes overlapped 
significantly at the 95% confidence interval meaning study quality was not a reliable predictor of 
effect size: High quality: d = 0.92 (95% CI = 0.28 to 1.56); other studies: d = 0.60, (95% CI = 0.33 to 0.88).  




Two studies found a significant relationship between study quality and effect sizes. Gorey and Cryns 
(1991) reported that effect sizes attenuated by two thirds as study quality increased from the lowest to 
highest: F(3,18) = 9.90, p < 0.001. Pinquart et al., (2007) similarly found studies of higher quality were 
associated with lower effect sizes. Β = -0.23, t = -2.25 p <  0.05).  
 
2.4.6.5. Factors only examined by one study 
Gorey and Cryns, (1991) found smaller groups (<6 d=1.38) to be more effective than larger 
groups (6-14, d = 0.81) and found that studies with more than a quarter of participants living alone 
yielded a greater effect size than studies where less than a quarter lived alone (d = 1.42, compared 
with d = 0.84, p = 0.041). However, methodology to control for potential confounding factors was not 
evidenced. Pinquart & Sorensen (2001) examined the impact of therapist variables on outcome. They 
divided interventions into those delivered by: graduate level therapists or paraprofessionals; 
therapists with advanced degrees; therapists with advanced degrees plus significant gerontological 
experience. The latter category was associated with significantly higher effect sizes (N = 108, mean ES 
= 0.81, 95% CI = 0.56 to 1.06) as compared with the other two categories. There was no statistical 
significance found between the effect sizes associated with both graduate level paraprofessionals (N = 
161, mean ES = 0.28, 95% CI = 0.07 to 0.28) and those with advanced degrees (N = 316, means ES = 
0.40, 95% CI = 0.24 to 0.56). 
 
2.4.7. Predictors of drop-out 
Six studies included analysis of drop-out. Gorey and Cryns (1991) found that studies with 
drop-out ranges of 0-15 % produced a higher mean effect size (d = 1.26) than studies with 16-50% 
drop-out (d = 0.31). They infer that subject attrition was likely selective: those who may benefit most 
being also those more likely to drop out. Cuijpers (1998), transforming the binary drop-out data to 
undertake a regression analysis, found four significant variables which accounted for 94 % of the 
variance (F = 28.47, p = 0.0002): group interventions (B = 0.36, SE = 0.06); CBT interventions (B = 0.29, 
SE = 0.05); treatments with a higher percentage of female participants (B = 0.02, SE = 0.003); 
interventions offering more sessions (B = 0.04, SE = 0.01). Variables that were not associated with 
increased drop-out included individual therapy, behavioural therapy bibliotherapy, pre-test BDI 
scores and age. Pinquart et al. (2007) also found higher dropout rates in group interventions (B = 0.49, 
β = 0.36, t = 2.45 p = 0.05) and in longer interventions (B = 0.01, β = 0.25, t = 1.99 p = 0.05). Mean age, 
type of control condition, study quality, depression severity, therapy setting and presence of co-
morbidities were not correlated to drop-out.  




Wilson et al. (2008) found that CBT was associated with higher drop-out when compared 
with control conditions (OR = 0.43). However this comparison showed significant heterogeneity (χ2 = 
14.9, p = 0.01) and when compared with active controls CBT was not associated with higher drop-out 
(OR = 1.19). Comparing cognitive therapy with behavioural therapy and CBT with psychodynamic 
therapy, treatment approach was not shown to predict drop-out. Peng et al. (2009) pooled the results 
of drop-out across five studies examining treatment with anti-depressant medication with or without 
psychotherapy and found that adjunct psychotherapy did not predict drop-out (OR = 1.03, p = 0.92). 
Samad et al. (2011) calculated the pooled drop-out ratio of cognitive therapy versus behaviour 
therapy (OR = 2.04, 95% CI= 0.87 - 4.78, p = 0.10) and for behavioural therapy versus brief 
psychodynamic therapy (OR = 1.50, 95% CI = 0.32 – 6.96, p = 0.61). Both results were non-significant.  
2.4.8. Relevant evidence from studies not included in the systematic review. 
A non-systematic meta-analytic review by Kiosses et al. (2011) examined predictors of 
treatment outcome and moderators of treatment effect in late-life major depressive disorder. They 
reviewed four studies. Depression severity did not moderate outcome in two studies (Alexopoulos et 
al., 2011; Arean et al., 2010), but showed significance in the other two: Thompson et al. (2001) found 
that patients with high baseline depression, compared with patients with low baseline depression, 
may have improved outcomes when treated with a combination of CBT and desipramine as opposed 
to desipramine alone. van Schaik et al. (2006) found that patients with a high baseline depression 
showed increased response to interpersonal therapy as compared with patients with low depression 
scores.  Elsewhere, in a meta-analysis which did not limit its criteria to late life depression, Payne and 
Marcus (2008) found group psychotherapy to be less effective with older adults than with younger 
cohorts. A recent meta-regression analysis which did not limit its analysis to late-life depression, 
found no differential efficacy between CBT, problem solving therapy and inter-personal therapy for 
both younger and older adults with depression. Employing a multivariate analysis which controlled 
for participant characteristics, intervention and study design, no significant difference between 
psychotherapy efficacy for younger and older adults was found, although the authors note that 
heterogeneity was high in most analyses undertaken and warn that caution should therefore be 









Table 4: Summary of main findings and further analyses for included studies 




Psychosocial interventions more 
effective than no-treatment or 
placebo in decreasing depressive 
symptoms in older adults. Effect size: 
0.78 
Neither type of therapy, severity of depression, 
therapeutic modality, duration of therapy nor study 




Overall effect sizes: Cognitive therapy 
d= 0.78; Behaviour therapy, d = 0.85; 
Cognitive and Behaviour Therapy, d = 
0.12; Psychodynamic therapy, d = 
0.61  
Individual rather than group treatment and use of 
clinician rated outcome (HRSD) rather than self-rated 
(BDI/GDS) measures were significantly associated with 
greater effect sizes. Comparisons with placebo yielded 
significantly lower effect sizes than no-treatment or 
waiting list controls. No evidence of moderating effect 
for severity, age, gender, length of treatment. Those 
with multiple complaints were found to respond less 
well to treatment. Age: The mean age in controlled 
versus uncontrolled studies differed significantly. 




Psychological treatment for 
depressed elders in the community is 
effective: d = 0.77. 
Regression analysis showed CBT to be a predictor of 
increased effect size. Format, number of sessions, 
depression severity, gender and mean age were non-
significant predictors. CBT not significantly more 
effective when compared with other approaches.  Drop 
out significantly larger in: group interventions; CBT 
interventions; interventions with more sessions; 




CBT and Psychodynamic approaches 
were associated with significantly 
higher effect sizes than reminiscence 
approaches: CBT, ES= 0.64; 
Psychodynamic therapy, ES = 0.79; 
Reminiscence, ES = 0.44. However, 
significant heterogeneity was found in 
most analyses. The main effect for 
psychodynamic therapy (self-rated 
measures) was not subject to 
significant heterogeneity. 
Individual interventions, Interventions with depressed, 
rather than non-depressed elders and use of clinician 
rated (HRSD) rather than self-rated (BDI/GDS) outcome 
measures were significantly associated with greater 
effect sizes. Therapists with advanced degree plus 
gerontological experience associated with significantly 
higher effect sizes as compared with those with just 
advanced degree / graduate / paraprofessionals.   
 Type of control, study length, study quality and setting 




Overall effect size for 
Reminiscence/life review therapy d = 
0.84   although test for heterogeneity 
indicated significant variance 
attributable to the systematic effects 
of covariates. 
Larger effect in subjects with increased depressive 
symptoms as compared to other subjects.  All other 
sub-group comparisons were non-significant and 
overlapped at 95% CI:  Reminiscence versus life review; 
high versus  low quality; group versus individual; 
community versus non-community; studies >72% 
women versus  <72% women; published versus 
unpublished.  
Cuijpers et 
al., (2006)  
Psychological treatments have 
moderate to large effects on late-life 
depression. Overall effect d = 0.72.  
Equivalence of effect found between individual, group 
or bibliotherapy formats and between CBT and other 
types of psychological treatment. Severity of 
depression did not predict outcome. The effects were 
comparable between self-rated and clinician-rated 
depression outcomes. No impact of control group on 
effect size found. 
 







Psychotherapy and pharmacotherapy 
did not show strong difference in 
effect sizes: Both moderately large. 
Greater clinician-rated depression improvement seen in 
mild to moderate depression, for psychotherapy group 
as compared with drug therapy. This was not found on 
self-rated measures. Effect size for CBT as rated on 
clinician-rated measures was greater than the effects of 
other forms of psychotherapy.  Results for self-rated 





Self-rated depression d = 0.84. 
Clinician-rated d = 0.93. Both showed 
significant heterogeneity. CBT and 
reminiscence yielded large effect 
sizes. Psychodynamic therapy a 
medium effect size. 
Weaker improvements of depressive symptoms were 
found in studies with active control group; physical co-
morbidity; cognitively impaired patients; major 
depression (versus other mood disorders); studies of 
higher quality. Age, format, duration, outcome measure 
used and treatment setting did not show treatment 
effects.  Higher dropout rates found in group 
interventions and in longer interventions.  
Wilson et 
al., (2008)  
CBT more effective than waiting list 
controls.   (WMD -9.85, 95% CI -11.97 
to -7.73)  No significant difference 
between psychodynamic therapy and 
CBT.   
Bibliotherapy more effective than waiting list controls. 
CBT superior to active control when using the  HRSD, 
but equivalent when using the GDS. Treatment 
approach did not predict dropout.  
Peng et 
al., (2009)  
CBT, Reminiscence and 'General 
Psychotherapy' more effective than 
placebo/no intervention in decreasing 
depression scores.  
CBT: SMD= -1.34. 95% CI, -1.89 to -0.79. Reminiscence:  
SMD= -0.64. 95% CI, -1.04 to -0.25.  'General 
Psychotherapy': SMD= -1.00. 95% CI, -1.40 to -0.59. 
Krishna et 
al., (2011)  
Group psychotherapy was an effective 
intervention for late-life depression 
compared with waiting list controls 
(very modest effect size). Group 
intervention versus active 
interventions did not reach statistical 
significance indicating no effect of the 
intervention versus all variations in 
the active control conditions. 
Waiting list control had significantly fewer losses to 
follow up than intervention groups. HDRS outcome 
measure found significant difference favouring the 
group therapies compared to active controls but this 
was not found with BDI and GDS outcome measures. 
Samad et 
al., (2011)  
Behavioural therapy for older people  
significantly more effective than 
waiting list control when measured by 
clinician-rated measure (HRDS)WMD 
=  -5.86 95%CI -1.35 to 0.30 but not 
significantly different when measured 
by patient self-report (BDI & GDS): 
WMD = -0.52 95%CI -7.71 to -3.66.  
Excluding studies without a formal diagnosis of 
depression at baseline reduced the effectiveness of 




2.5.1. Moderating factors: patient characteristics 
With regards to moderators of treatment associated with patient characteristics, this study 
confirmed results from previous reviews that have found no overall effect of gender or age on 
therapeutic outcome (Department of Health, 2001b), but did not add significantly to our 
understanding of how chronicity, relapse, and recovery may show variation across the age range 
(Alexopoulos et al., 1989).  Apart from age and gender, few patient characteristics were routinely 




coded by the included meta-analyses, reflecting the general paucity of such data historically reported 
in primary studies.  Clinical guidelines frequently identify the importance of tailoring therapeutic 
interventions to fit with an individual’s unique presentation, however, research into the impact of 
patient characteristics is not well-developed with much evidence from single studies without 
replication (Department of Health, 2001b). 
 Beutler et al. (1991) found that depressed patients’ predisposing coping styles, significantly 
predicted differential response to differing treatment modalities. In a small trial comparing 63 
patients with major depressive disorder, ‘Externalising’ patients improved more than ‘internalising’ 
patients in cognitive therapy, whereas the latter improved more in response to supportive, self-
directed therapy. ‘High defensive’ patients showed greater improvement in supportive, self-directed 
therapy, whilst ‘low defensive patients’ improved more in cognitive therapy. Lower educational 
achievement has been found to increase the risk of discontinuation in self-directed therapy, whereas 
higher scores on a measure of ‘learned resourcefulness’ is a predictor of improved outcome in such 
approaches (McKendree Smith & Floyd, 2003). Whisman (1993) found that depressed patients with 
higher dysfunctional attitude scores showed poorer outcomes in cognitive therapy, whilst Piper et al. 
(1998) found that reduced capacity for interpersonal relating was found to be associated with poorer 
outcomes in psychodynamic therapy, as compared with supportive therapy.  
 Brand and Clingempeel (1992) reported that patients who had higher baseline positive social 
behaviours, combined with reduced physical co-morbidity and increased contact with family 
members, showed most benefit from group behavioural therapy for late-life depression. Allowing 
patient’s to choose therapeutic modality was found to reduce drop-out, but had no impact on 
outcome (Rokke et al., 1999). Little evidence currently exists with regard to the management of older 
adults who would meet criteria for a diagnosis of personality disorder (Payman, 2011).  
Meta-analytic investigation of which patient characteristics may function as moderators is 
limited by the data collected by primary studies. When factors such as ethnicity, socio-economic 
status and personality factors are not comprehensively detailed in primary studies, meta-analyses are 
limited in the claims that can be made with regard to the generalisability of intervention effects. 
Severity of presenting problem is the most frequent patient characteristic examined in moderator 
analyses. Results from this review yielded contradictory results as to the relationship between effect 
sizes and the severity of depression. The method of classification of depression severity within studies 
is a likely confounding factor in this analysis and may explain some of the inconsistency. It is not 
possible to establish for example, whether studies defined narratively as ‘mild’ depression in one 
study equate to a diagnosis of ‘dysthymia’ in another study. The analysis by Samad et al. (2011) 




revealed diagnosis of depression to show interaction with treatment approach, with inclusion of 
studies with a criteria of major depression reducing the comparative efficacy of behavioural therapy 
as opposed to cognitive therapy. However, very few studies were included in the analysis and it did 
not reach statistical significance. The inconsistency of results regarding the impact of depression 
severity on outcome found by the current review is reflected in the wider literature.  
 Increased severity of depression has been found to be associated with slower response to 
treatment (Dew et al., 1997; Gildengers et al., 2005), poorer outcomes  (Karp et al., 2005; Watt & 
Cappeliez, 2000; Thase et al., 1997) or has not shown any significant relationship with outcome, 
(Mintz et al., 1992; Lenze et al., 2001; Robinson et al., 1990). More recently, Driessen et al. (2010)   
undertaking a ‘number needed to treat analysis’ (Kraemer & Kupfer, 2006) found that, for less 
severely depressed patients compared with controls such as pill placebos, clinicians would need to 
treat eight patients, whilst for severe depression this number reduced to only three patients.   
Poorer health has been found to be predictor of less successful outcome in younger adults but 
not in older adults (Harpole et al., 2005; Hughes et al., 1993). This finding was not supported by this 
current review, which found some limited evidence that co-morbidity may attenuate effectiveness of 
interventions for late-life depression. However these findings were based on only two post-hoc 
analyses and so little can be inferred with regard to the specific mechanism by which co-morbidities 
may moderate treatment efficacy and claims with regard to the generalizability of these findings must 
be tentative at best. 
2.5.2. Moderating factors: treatment characteristics 
The absence of a relationship between treatment duration and treatment effect found by this 
review is perhaps surprising but is supported by previous findings (Molenaar et al., 2011; Robinson et 
al., 1990). This review of meta-analyses did not find consistent support for the finding that individual 
therapy is generally more effective than group approaches (Cuijpers, van Straten & Warmerdam, 
2008). In addition, treatment setting was not found to have any measurable independent impact on 
treatment outcomes. Only one study examined the impact of therapist experience, finding specific 
gerontological expertise was associated with greater clinical improvement (Pinquart & Sorensen, 
2001) a relationship also found by Cuijpers et al. (2008) undertaking a meta-regression analysis  of 
characteristics associated with effective psychological treatments of depression, who found that 
studies with less experienced therapists yielded lower effect sizes.  However in Pinquart and 
Sorensen’s study (2001) it is not clear to what extent possible confounding factors such as therapeutic 
alliance or adherence to treatment protocol were controlled for, making it difficult to critically 




evaluate claims made by other authors that variance within treatments due to therapist factors is 
greater than variance between treatments (Crits-Christoph, 1997; Wampold & Serlin, 2000). 
2.5.3. Treatment approach 
Results from this review of meta-analyses indicate that neither direct comparisons between 
treatment approaches nor meta-regression analyses yield consistent evidence for the superiority of 
any one therapeutic approach. The failure to find differential treatment effects might be due to factors 
associated with primary studies: they may be underpowered to detect the differential impact of 
treatment approach (Kazdin & Bass, 1989; Norcross, 1995) or fail to adequately control for important 
non-specific factors (Baskin et al., 2003). Alternatively it might be that the ‘active ingredients’ 
proposed by the various treatment approaches to be responsible for amelioration of depressive 
symptoms may not be the primary factors in effecting change. The proposed meditational effect of 
depressogenic cognitions posited by cognitive therapy for example, have been  demonstrated in 
analyses of mediating factors (Knoop et al., 2012). However, such mediation has not consistently been 
found in the general adult population and the mediational effects of dysfunctional attitudes, as 
measured by the Dysfunctional Attitudes Scale (Beck et al., 1991) has found to be reduced in older 
adults (Whisman, 1993).  
Reasons proposed to explain this age difference have included the impact of common factors 
and but also the specific need to address hopelessness in late life depression (Floyd & Scogin, 1998).  
Blazer (2003) in his comprehensive review of the literature for late-life depression proposes that the 
equivalence of therapeutic efficacy found for various treatment modalities, may in fact be the result of 
psychotherapeutic approaches sharing a central core mechanism: that of developing meta-cognitive 
awareness (Teasdale et al., 2002). This is the process by which patients ‘step-back’ from negative 
cognitions and begin to respond to them as mental events, rather than as the inherent aspects of the 
self.   
Other possible explanation for the discrepancy between the differential treatment effect 
frequently reported in primary research, and the broad equivalence of effect often reported in meta-
analytic studies include the impact of investigator allegiance. Robinson (1990), reviewing the 
literature across the age-range for treatments of depression, found that apparent differences in 
efficacy between treatment modalities disappeared once the moderating factor of investigator 
allegiance was included in the analysis. Although the adequacy of randomisation and concealment 
was explored in a minority of included meta-analyses, Investigator allegiance was not explicitly 
analysed as a potential moderating factor in any of the meta-analyses included in this review.   




 2.5.4. Factors associated with study design 
Two of the more robust findings of this study do not relate to variation in the clinical 
intervention or the participant but the increase in effect sizes associated with use of clinician rated 
outcome measures rather than self-rated measures and the use of waiting list control groups rather 
than active or placebo controls. The latter finding is consistent with results from a recent meta-
regression analysis examining the characteristics of effective treatments for depression  (Cuijpers et 
al., 2008) which found that effect sizes were reduced in studies using treatment as usual or placebo 
controls as opposed to waiting list controls. Although these findings do not directly shed light on 
what might work for whom, they do highlight the need to critically evaluate the reactivity of outcome 
measures and the adequacy of psychological controls when interpreting claims with regard to 
treatment efficacy of specific interventions.  
Another important factor to consider is the significant heterogeneity seen in most of the meta-
analyses seeking to differentiate between treatment approaches. This heterogeneity suggests that  
treatment effects are, to some significant extent, associated with uncoded and possibly confounding 
factors that remain poorly understood (Matt & Navarro, 1997).   
2.5.5. Drop-out 
With regard to predictors of drop-out, two meta-analyses found that patients were more 
likely to drop out of group interventions rather than individual interventions but again it is not 
possible to discern the impact of possible confounding factors or determine specific factors associated 
with drop out (Davis & Hooke, 2006). Further replication of this finding would be required to 
facilitate conclusions with regard to its generalizability. 
 
2.5.6. Limitations of this study 
The aim of this review was not to systematically review what is currently known with 
regards what works for whom in late life depression, but rather to explore to what extent meta-
analyses have informed our understanding of this question. Systematic criteria were applied in order 
to limit the risk of reporting bias. However, the focus on meta-analytic studies meant potentially 
relevant studies were excluded. Examples include the non-meta-analytic review by Kiosses et al. 
(2011) examining predictors of treatment outcomes and moderators of treatment effect in late-life 
major depressive disorder. Similarly evidence from individual studies reporting predictors of 
outcomes and moderating factors were also excluded, as was evidence from the expanding literature 




seeking to develop and adapt evidence-based psychotherapeutic interventions for older adults in the 
context of conceptual and theoretical constructs of ageing (Knight & Poon, 2008; Laidlaw, 2001; 
Laidlaw & McAlpine, 2008; Satre et al. 2006). This is a rich and expanding area which to date has been 
theoretically driven, with only limited useful data emerging from meta-analytic studies that could 
inform clinical and process issues within therapy.  
The failure of this review to include an independent researcher to search, retrieve and screen 
studies introduces a significant risk of bias.  Reporting bias may also have been introduced to the 
methodology of this study through the use of PRISMA checklist as a framework for evaluation of 
study quality and risk of bias. Although a proportion of studies were independently assessed 
according to the PRISMA guidelines quality rating was potentially a significant source of reporting 
bias due to the subjective nature of this process. 
The significant relationship found between publication date, increased reporting quality and 
reduced analysis of predictors of outcome/moderating factors, indicates that reporting bias is likely an 
important factor in critically evaluating the data. Two potential hypotheses could explain such a 
finding. It may be that older studies, in the absence of quality reporting guidelines and with 
considerable pressure on word-limits, may have simply failed to systematically report sound 
methodology, focusing rather on reporting moderator analyses. Similarly, more recent meta-analyses, 
with an increased requirement to report methodological factors systematically, may simply have 
omitted examining moderating factors due to pressures of space. 
Alternatively, if we hypothesize a true correlation between methodological rigour and 
reporting rigour, we might conclude that sub-analyses were less frequent in later studies due to the 
increased cognisance of the risks of type 1 and type 2 errors when undertaking sub-group analyses in 
relatively small heterogeneous data sets. As such, unplanned post-hoc analyses that were potentially 
undertaken in earlier studies may have been avoided in later, better quality studies.  
How we interpret the relationship between date, reporting quality and number of moderator 
analyses influences the degree of scepticism we bring to evaluating the validity of moderator analysis 
in earlier studies. If we conclude the relationships are better explained as an artefact of reporting 
conventions rather than methodological improvements, then we may be at risk of overvaluing 
potentially unreliable data.  Conversely if we believe that fewer moderator analyses were undertaken 
in more recent meta-analyses due to appropriate methodological constraints being observed, then we 
risk undervaluing earlier data that may indeed be robust. The present analysis rather than weight 
studies according to reporting quality, has therefore sought to highlight some of the difficulties of 




such weighting by undertaking regression analyses to draw attention to the relationship between 
these interconnected factors. 
Another source of potential bias, and a limitation to this study was the focus on depression 
ratings as the only measure of treatment effect. It could be argued that a narrow focus on symptom 
reduction prevents comparison of treatment efficacy across other potential treatment goals in therapy, 
such as quality of life, self-efficacy, personal insight or functional independence (Philips, 2009). It 
could also be argued that a narrow focus on symptom reduction places essentially heterogeneous 
depressive presentations along a reductive severity dimension, limiting the capacity for differential 
treatment responses to be identified (Parker, 2004). 
Choosing an inclusion criterion of studies with a mean age of ≥55 yrs must also be considered 
a significant limitation of this study. This was undertaken because research in this area has tended to 
recruit ‘young-old’ samples. The alternative, more appropriate, cut-off at ≥65 yrs would have meant 
excluding the majority of studies undertaken into late-life depression. Indeed, none of the included 
meta-analyses set age inclusion criteria of ≥65 yrs. Referring back to Table 1, part 4, we can see that 
only three studies used a  ≥60 yrs cut-off, with eight studies using an age of ≥55 yrs or lower. Indeed, 
three of the studies which met the criterion of mean age of participants of ≥55 yrs, actually set their 
own inclusion criteria at ≥50 yrs. Although this current study and previous analyses (Department of 
Health, 2001b) indicate that age may not be a significant predictor of therapeutic outcome, it is not 
clear whether there may be other consequences and limitations of using data from ‘young-old’ 
cohorts to understand late-life depression.  This systematic problem in late-life depression research 
therefore means generalizing from current data to real-life clinical settings must be undertaken with 
great caution. 
Finally, this review excluded meta-analyses which focused explicitly on treatments for 
depression in the context of significant medical co-morbidities. In light of the finding that the 
presence of co-morbidities showed a consistent impact on effect sizes (albeit with only two included 
analyses), the inclusion of studies that specifically addressed depression in the context of co-
morbidities would have broadened the relevance and scope of the studies. 
2.5.7. Implications of this review  
This review highlights a number of important factors for healthcare providers, users, and 
policy makers.  Firstly, psychotherapeutic interventions for late-life depression consistently show 
moderate to high effect sizes thus efforts should be made to increase access to psychological therapies 
for older adults who, to date, have experienced inequitable access to psychotherapeutic interventions 




as compared with younger adults (NHS Scotland, 2011; Age Concern, 2008; Bartels et al., 2002). 
Secondly, this study demonstrates that our current understanding of moderating factors in treatments 
for late-life depression is very limited. As such, this study points to the need for primary studies in 
this area which employs larger sample sizes, systematically reports a much wider range of patient 
and intervention factors and includes dismantling or additive designs that adequately attempt to 
quantify the impact of potential moderating factors  (Ahn & Wampold, 2001). Thirdly, this study 
highlights a significant relationship between reporting quality of meta-analytic studies investigating 
psychotherapeutic interventions for late-life depression, and both date of publication and number of 
sub-analyses undertaken. It therefore highlights the need to critically evaluate claims with regard to 
differential treatment efficacy made by included studies in light of potentially higher risk of bias in 
older studies. Lastly, this review identified that psychotherapy effects appear to be attenuated when 
outcome studies employ self-rated rather than clinician-rated outcome measures and when active 
placebo controls are employed as opposed to comparisons with a no treatment groups. Implications 
for study design and critical appraisal of outcome studies, include the need to further investigate and 
refine psychological placebo conditions in order to more effectively discriminate differential efficacy 
with intervention groups, (Baskin et al., 2003; Serfaty et al., 2011) and the need for authors to critically 
appraise the sensitivity and suitability of outcome measures and their potential impact on estimations 
of effect size (Helmreich et al., 2011). 
 
Developing an empirical understanding of the specific factors which make psychotherapy 
effective is far from straightforward. Ever since Smith & Glass (1977) undertook the first meta-
analysis in this area and found negligible differences in the effects produced by different types of 
therapy, there has been a lively critical debate as to what exactly is working, and for whom, when 
psychotherapy is evidenced to be effective. Two broad schools of thought have emerged: those who 
claim that the evidence for differential efficacy of differing approaches is poor and that most 
psychotherapeutic approaches demonstrate broad equivalence in efficacy due to shared and powerful  
‘common factors’ (Lambert, 2005; Luborsky, 2002; Messer, 2002; Wampold, 2005) and those which 
claim that the evidence for differential efficacy is well-established and linked to  ‘specific factors’ that 
can be codified and systematically applied, often using treatment manuals (American Psychological 
Association, 1993; Chambless, 2002; DeRubeis & Crits-Christoph, 1998; Derubeis et al., 2005; Waltz et 
al., 1993; Wilson, 1996). The latter ‘specific factor’ paradigm is perhaps a better fit with the empirical 
methods and ontological assumptions of pharmaceutical research which seek to isolate the effect of 
discrete biochemical agents and consider variables such as ‘dose response’, ‘active ingredients’ and 
‘placebo effects’.  




Such language is now commonplace in psychotherapy research and points to shared 
methodological assumptions with regards to the ability  to control for moderating and mediating 
factors and ascribe changes in the dependent variable (usually reduction in symptoms) to changes in 
the independent variable (usually treatment type). However, adequately controlling for hidden 
confounding factors in psychotherapy research is far from straightforward (Dunn & Bentall, 2007). In 
practice, this means it has been easier to demonstrate a particular intervention works in a particular 
circumstance than it has been to demonstrate that a ‘common factor’ is the shared independent 
variable across varying approaches in differing circumstances. It could be argued that rejecting the 
null hypothesis that specific ingredients are not responsible for treatment effects (Wampold, 2005) 
requires modelling treatment effect heterogeneity in such a way that treatment outcome can reliably 
and independently  ascribed to discrete and measurable variables.  It could be further argued that 
such rejection of the null hypothesis is an important first step in understanding not only ‘what’ is 
working in psychotherapy but also ‘how’ it might be working.  
One perhaps unfortunate consequence of the methodological complexity that such an 
understanding seems to demand is the reductive focus on ‘treatment type’ and the emergence of what 
some have called a ‘search for winners’ (Stiles et al., 1986) with competing ‘brand-name’ therapies 
(Scogin et al., 2005) seeking to demonstrate relative superiority over each other. This emphasis on 
type of therapy has tended to  de-emphasize the dilemma that  establishing causality is far harder 
than demonstrating mediator status (Kraemer et al., 2002) and  perhaps hindered rigorous research 
which seeks to experimentally define and manipulate both moderating and mediating factors in order 
to  better understand potential common factors.  
Meta-analytic investigation is not well suited to shedding light on the specific mechanisms of 
psychological change involved in treatment efficacy. Nonetheless to the extent that meta-analyses can 
reveal information about what might predict and moderates treatment response for specific disorders 
in specific patient groups they promise to facilitate the discrimination between moderators of 
treatment and mediators of treatment: i.e. separating those factors which might be the necessary 
conditions for a treatment to work from those factors which help elucidate how and why treatments 
works  (Kraemer et al., 2002). Other approaches are better suited to examining questions with regard 
to mediating factors. Dismantling studies separate the existing components of effective therapies and 
seek to quantify to what extent each component is responsible for clinical change whilst  experimental 
studies manipulate discrete independent variables thought to be active agents in therapeutic change 
and record any correlation with symptom change (Watkins, 2009). The use of dismantling studies and 
designs tailored to  identify potential moderating and mediating factors (Kuyken et al., 2010; Labelle 




et al., 2010; Lemmens et al., 2011; Warmerdam et al., 2010)  are useful recent developments in 
psychotherapy research which may increase our ability to reject the null hypothesis that specific 
ingredients are not responsible for treatment effects.  
The first systematic analysis of the efficacy of psychosocial interventions for late life 
depression concluded that it could be reported with some confidence that psycho-social interventions 
were effective for depression in late-life, but that the ‘elusive active ingredients’ and mechanisms of 
this efficacy were still poorly understood (Scogin & McElreath, 1994 p.73). 
2.6. Conclusion 
The current review has sought to assess to what extent meta-analyses have increased our 
understanding of what predicts or moderates treatment effects in late-life depression. In summary, it 
has failed to find consistent or robust data indicating a clear role for identifiable factors that might 
predict or moderate treatment efficacy, neither has it found a robust link between outcome variance 
and specific treatment approaches. With regards the question of how reliably evidence from 
controlled research can be generalized to clinical populations, (Barkham et al., 2008) the current 
review found that little information can be been gleaned with regard to the specific needs of people of 
differing socio-economic status, those of differing ethnicity or cultural heritage, or the older old.  This 
study has therefore highlighted, not only a need for more high quality studies to be undertaken with 
clinically representative older populations (Shadish et al., 2000), but also for future research to 

































• No consistent relationship between study quality and outcomes. 
• No consistent relationship between depression severity or age and outcomes. 
• Treatment setting, duration and gender of participants did not moderate outcomes. 
• Patient-rated measures yielded smaller effect sizes than clinician-rated measures. 
• Comparison with active controls yielded smaller effect sizes than waiting list controls. 
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3. Thesis Hypotheses 
 
The preceding systematic review excluded meta-analyses examining psychotherapeutic treatments 
for older adults with specific underlying somatic diseases. Such studies were excluded to reduce the 
potential confounding impact of specific illnesses on the assessment of general treatment outcomes 
and moderating factors in psychotherapeutic treatments for late-life depression.  However, late-life 
depression most frequently occurs in the context of chronic medical illness and cognitive impairment 
(Alexopoulos, 2005) and randomized controlled trials such as those included in the previous study, 
are not typically composed of clinically representative samples. It could therefore be argued that the 
findings of the previous analysis are limited with regard to drawing generalized conclusions about a 
clinical population where co-morbid illness is common.  
Clearly, understanding the relationship between co-morbidity and depression is a key goal in 
effectively designing interventions for this age group. Cognitive behavioural therapy has been the 
most comprehensively evaluated intervention for late-life depression and has the strongest evidence 
base amongst psychological therapies (Bartels et al., 2003; Gatz, 2007; Laidlaw, 2001; Scogin et al., 
2005).  Numerous studies have been undertaken examining the efficacy of CBT to treat depressive 
symptoms in older adults with co-morbid physical illnesses. However, to date there has been no 
attempt to synthesize this data in a meta-analysis.  
One of the challenges of undertaking such an analysis is the considerable heterogeneity in patient 
characteristics and intervention that such a synthesis would likely involve. However, one of the 
benefits of undertaking such a study would be its potential to inform our understanding of the 
effectiveness of CBT for depression in older adults across a diversity of physical illnesses, and as such, 
present data with regards the generalizability of CBT to real-life clinical settings.  
The preceding review found some limited evidence to suggest that co-morbidity may moderate 
treatment efficacy in late-life depression. The meta-analysis in section 5 therefore aims to examine the 
effectiveness of CBT for late-life depression in people with a diversity of underlying physical 
illnesses.  Results will be discussed in light of comparative evidence developed with AWA and 






































4.  Psychotherapeutic Interventions for Late-life Depression: Evidence Based Practice in 
Context. 
4.1. Introduction  
Evidence based practice (EBP) has been described as the integration of individual clinical expertise 
with the best external clinical evidence from systematic research (Sackett, 1996). The aim of EBP is to 
increase the application of clinical interventions that are known to be effective, and identify and end 
practices that are discovered to be ineffective. Empirical support for clinical interventions can be 
derived from a wide-range of sources. Well-designed, sufficiently powered randomized controlled 
trials which have been replicated by independent investigators represent the best primary evidence 
for the efficacy of any particular intervention. Systematic and meta-analytic reviews of such studies 
further extend our understanding of potential moderating factors and enhance our ability to draw 
conclusions about how such data can be generalized to broader clinical populations. 
However, although such studies are vital in developing an empirical understanding of what might 
work for whom in clinical practice, in many areas, including late-life depression, there are 
considerable practical difficulties in implementing such rigorous methodologies with representative 
patient groups. Such limits have meant that controlled trials of interventions for late-life depression 
have disproportionately tended to recruit young-old, healthy, white participants, (Karel & 
Hinrichsen, 2000) limiting the degree to which the evidence generated by such studies can be reliably 
generalized to real life clinical settings. 
Organisations such as the American Psychological Association (APA) National Institute for Health 
and Clinical Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN) have been 
key drivers of the implementation of evidence-based practice. Clinical guidance produced by such 
bodies presents best-practice recommendations based on systematic reviews of the evidence base. 
However, the absence of evidence for a particular intervention is by no means evidence of its 
ineffectiveness, and inevitably the evidence-base for some psychological therapies has been more 
extensively studied than for others. Although the erroneous conflation of lack of evidence with 
ineffectiveness is explicitly acknowledged and warned against in such guidance, it has been argued 
that there has been a disproportionate emphasis on particular therapeutic modalities being endorsed 
by organisations such as NICE (New Savoy Partnership, 2011).  Gaps in the evidence base not only 
occur due to the absence of eligible trials for specific approaches, but also frequently reflect a 
poorness of fit between the demands of empirical criteria and the actual clinical needs being met in 
health and social care settings. Margaret Gatz (2007) highlights the fact that in practice settings with 
older adults, combinations of pharmacotherapy and psychotherapy may be frequent, interventions 




for emotional disorders may involve concurrent environmental adaptations and systemic 
interventions with care-givers, and individuals may present with a range of physical and cognitive 
co-morbidities. 
Tailoring interventions to best meet the clinical needs of a diverse and heterogeneous client group 
such as depressed older adults, therefore involves not only drawing upon evidence generated from 
high quality clinical trials, but also integrating insights from gerontological theories of aging and 
understanding to what extent evidence generated for other groups, for example adults of working 
age (AWA), can be applied to this population. Synthesizing individual clinical expertise with the best 
external clinical evidence from systematic research therefore requires an understanding of some of the 
unique challenges faced by depressed older adults and specifically what might distinguish late-life 
depression from depression in other age groups. The next section will therefore examine important 
contextual factors which might differentiate the experience and presentation of depression in older 
adults, before reviewing the evidence-base for late-life depression and those approaches considered 
to have been demonstrated as efficacious treatments.   
4.2. Late-life Depression: A Complex Picture 
Laidlaw (2001) has warned against the perception that depression is a natural response to old-age. 
This ‘fallacy of good reasons’ (Unützer et al., 1999) and the resulting risk of ‘therapeutic nihilism’  is 
perhaps beginning to be challenged (Teri et al., 2004) but may be a factor in understanding why 
depressed older adults continue to receive poorer care than their younger counterparts (Bartels, 2002). 
Iliffe (2009) points out that seeing late-life depression as an understandable response to the challenges 
of aging risks confusing the natural human response of ‘sadness’ with clinically significant depressive 
symptoms. However, making sense of emotional suffering in late-life involves acknowledging the 
many challenges that may be encountered. Older adults face an increased likelihood of experiencing 
physical ill-health, dementia, chronic pain and neuropsychological changes. In addition role 
transitions, social isolation, and personal loss are often more salient. Contextual stressors, such as the 
increased likelihood of experiencing long-term residential or hospital care are also common. Sadavoy 
(2009) draws attention to the complex and reciprocal interplay between personality, physiology, 
neuroimmunological changes, environment and life events that need to be considered when assessing 
and treating late-life depression. He describes the five C’s of working with older adults as complexity, 
chronicity, co-morbidity, continuity and context: highlighting the need for clinicians to be able to 
formulate a sensitive and detailed understanding of late-life depression in light of a broad range of 
relevant factors. Fiske et al. (2010) similarly describe a ‘life span developmental diathesis stress model’ 
and emphasize that, to adequately account for the reduced prevalence of major depression seen in 




later years, there is a need to understand both risk and protective factors associated with advancing 
years. 
4.2.1. Prevalence and severity of depression in late-life 
Depression is a heterogeneous and broad diagnosis and estimates of prevalence vary considerably 
depending on the severity of depression assessed and measures used. A number of depressive 
disorders are described in the Diagnostic and Statistical Manual for Mental Disorders: fourth edition 
(American Psychiatric Association, 2000) and the International Classification of Diseases 10th revision 
(World Health Organisation, 1992) ranging from major depressive disorders to mild depression and 
dysthymic disorders. Reviewing thirty-four studies, Beekman et al. (1999) presented estimates of 
depression in community dwelling older-adults ranging between 0.4 and 35 per cent. A prevalence of 
1.8 per cent for major depression and 9.8 per cent for minor depression was found, whilst depressive 
symptoms deemed ‘clinically significant’ yielded an average prevalence of 13.5 per cent. ‘Clinically 
significant’ in this context remains somewhat ill-defined. Some researchers, finding that functional 
impairment increases linearly with symptom severity, identify clinically significant symptoms above 
a certain, sub-syndromal, threshold on depressive symptom checklists (Judd & Akiskal, 2002). Such 
approaches propose a dimensional rather than categorical quality to depressive conditions (Slade, 
2007). Other taxometric investigations conversely support a categorical model of major depressive 
disorder (Ruscio et al., 2007).  
 
Such nosological questions as to whether depression is a homogenous (dimensional) disorder or 
heterogenous (categorical) disorder are relevant because community dwelling older adults 
consistently show reduced prevalence rates for major depression as compared with those found in 
adults of working age (Hasin et al., 2005; Kessler et al., 2003),  whilst also showing increased rates of 
sub-threshold, clinically significant symptoms (Fiske et al., 2010). It has been proposed that this 
pattern is may be artefact of the diagnostic criteria for major depressive disorders which emphasize 
dysphoria: a symptom less readily endorsed by older adults, whilst requiring clinicians to exclude 
symptoms that may be attributed to recent bereavement or medical condition, both factors more 
common in later years (Fiske et al. 2010) Conversely, depressive symptom checklists also often include 
symptoms associated with ill-health or bereavement, possibly  increasing the risk of inflated sub-
threshold depression scores (Blazer, 2003). Others have argued that reduced prevalence rates 
observed for major depression, rather than reflecting artefacts of diagnostic practices or differences in 
cohort attributions, actually reflect protective factors associated with ageing (Blazer, 2010). 





Despite the ongoing nosological debate the impact of clinically significant depressive symptoms are 
not in doubt.  Blazer (2003)  reports approximately 15 per cent of community dwelling older adults to 
be experiencing clinically significant depressive symptoms, whilst a report of the surgeon general 
(U.S. Department of Health and Human Services, 1999) noted a higher prevalence and impact of ‘sub-
threshold’ symptoms characterising this age group.  Sub threshold symptoms are often chronic 
(Beekman et al., 1999) and an estimated 8-10 per cent of older people with such symptoms go on to 
develop ‘major depression’ (Blanchard, 1996). For older adults, the burden of  ‘sub-threshold’ 
symptoms can be as disabling as major depression, with comparable levels of functional impairment 
(U.S. Department of Health and Human Services, 1999), disability days and impact on self-rated 
health (Blazer, 2003; Hybels et al., 2001).  The increased recognition that depressive symptoms below 
the DSM-IV and ICD-10 threshold criteria can have considerable impact on functioning is now 
reflected in evidence-based treatment recommendations (National Institute for health and Clinical 
Excellence (NICE), 2009). Sub-threshold symptoms have been found to be correlated with  a prior 
history of depression, neuroticism, poor physical health and disability (Blanchard, 1996) and occur 
more commonly in long-terms care settings than in community settings (Meeks et al., 2011).  
 
Beekman et al. (1999) found higher prevalence rates of depression for women and those older adults 
experiencing adverse socio-economic circumstances. Prevalence rates of 16 per cent were found in a 
London inner-city sample where around two-thirds of the sample group were female (Livingston et 
al., 1990) Medical burden, low social support and disability have also been identified as important 
risk factors (Meeks et al., 2011) with depression estimated to be at least twice as frequent among 
patients in hospital or nursing homes (Baldwin & Wild 2004) with a recent report by Age Concern 
(2008) estimating that two in five care home residents experience depression.  Gellis et al. (2007) found 
a prevalence rate of 13.7% for major depression and 27.5% for clinically significant depressive 
symptoms in community dwelling older adults receiving care at home. Osborn et al. (2002) found a 
prevalence rate of 13.1 per cent for community residents aged 75 and over, whilst Stek et al. (2004) 
found even higher prevalence rates (15.4 per cent) in the oldest-old living in the community. For this 
older group depression was correlated with cognitive and functional impairment. However, although 
depressive symptoms appear more commonly in the oldest old, when prevalence rates are adjusted to 
account for the higher proportion of women, physical disability, lower socio-economic status, and 
cognitive impairment, no significant correlation between increased age and depression is found 
(Blazer et al., 1991) 




In summary, whilst rates of major depressive disorder seem to be less prevalent in older adults, the 
burden and prevalence of mild and sub-threshold symptoms may be disproportionately higher in this 
age group.  Despite the high prevalence of such clinically significant depressive symptoms in older 
adults, the detection rate of depression in primary care has been found to be very low, (Crawford et 
al., 1998) with depression remaining worryingly under-diagnosed and under-treated (Age Concern, 
2008; Bruce et al., 2002; Lebowitz et al., 1997; Royal College of Psychiatrists, 2011; Wilson et al., 2008). 
4.2.2. Cohort specific risk factors 
Factors which increase the risk of developing depression for AWA continue into later life, including 
being female, socially isolated, unmarried, poor, and having a previous history of depression 
(Bisschop et al., 2004; Meeks et al., 2011; Unützer et al., 1999) Further risk factors disproportionately 
faced by older adults include loss and bereavement, sleep disturbance, and disability (Cole & 
Dendukuri 2003) with the risk of depression particularly elevated amongst elder carers of others with 
serious medical or conditions (Russo et al., 1995). The death of a spouse increases the risk of 
developing major depression and impacts particularly on older adults who have reduced social 
support or live alone (Knight & Poon, 2008). The increased likelihood of significant physical co-
morbidity and neurobiological change are also significant factors.  
4.2.3. Cohort beliefs, expectations and attributions 
Today’s older adults seek psychological support less readily than their younger counterparts but this 
may be changing as attitudinal differences have been observed across older adult cohorts, with 
younger members expressing more positive attitudes to mental health services than their elders 
(Currin et al., 1998; Segal et al., 2005).  It is relatively rare for older adults with depression to be offered 
psychological interventions (Baldwin & Wild 2004) but one large scale RCT found that, when 
treatment options are offered, at least half of older people experiencing depression expressed a 
preference for psychological treatment over drugs (Unützer et al., 2002): a preference confirmed by a 
number of previous studies (Areán & Cook, 2002; Landreville et al 2001; Rokke & Scogin 1995). 
Landreville et al. (2001) found that severity of depressive symptoms affected the acceptability of 
differing treatment modalities: Cognitive therapy and cognitive bibliotherapy were rated as more 
acceptable than anti-depressant medication for patients with mild to moderate depression, whilst 
cognitive therapy was rated as more acceptable than both anti-depressant medication and cognitive 
bibilotherapy for severe depression. Similarly, Hanson and Scogin (2008) found that older adults 
expressed a preference for combination of psychotherapy and anti-depressant medication rather than 
medication alone for treatment of late-life depression. 




In a study comparing community based cognitive behavioural interventions with younger and older-
adults, older adults demonstrated a relative preference for non-pharmacological interventions and 
had significantly better attendance and drop-out rates. Efficacy of intervention was comparable across 
the age range including those over seventy-five (Walker & Clarke, 2001). The authors note that the 
relative increased engagement of older adults in this study may have been due to the availability of 
home assessment. Practical and physical barriers to engagement have been proposed as contributing 
factors to the inequitable service provision and relative underutilization of mental health services in 
late life (Yang & Jackson 1998).   
Compared with adults of working age, older adults are more likely to underestimate and downplay 
depressive symptoms or ascribe them to physical complaints (Blazer, 2003; Robb et al., 2003). They are 
also less likely to report sadness as the predominant feature during a depressive episode (Lebowitz et 
al., 1997). Among the older-old (80+ years) subjective well-being is less correlated with physical and 
functional health than for those between 60-80 years of age. In fact, for the older-old, subjective well-
being and mental health are more closely correlated than for their younger counterparts (Pinquart, 
2001). 
4.2.4. Risk of suicide  
Suicidal ideation is closely associated with severity of depressive symptoms in older adults 
(Alexopoulos et al., 1999) with  major depression  a significant predictor of suicide in this age group 
(Waern et al. 2002). Older adults are almost twice as likely to commit suicide than AWA (Alexopoulos, 
2005) and this elevated risk is largely due to increased rates amongst elder white males.  (Kung et al., 
2008) Although suicidal ideation decreases with age, older people are more likely to act on such 
thoughts with fatal consequences (Beeston, 2006; Conwell et al., 1998; Conwell et al., 2002). Depressive 
syndromes are found in 80 per cent of those over 74 years who commit suicide (Conwell et al., 1996) 
and the risk of suicide is shown to be increased for those experiencing minor depression or dysthymic 
disorder (Conwell et al., 2002). Hawton and Harriss (2006) following up 700 older people admitted to 
hospital following a suicide attempt, found physical health problems to be the most frequent life 
problem associated with the admission (46.1%).  Social isolation, relationship problems and 
bereavement and loss are other common life problems associated with suicide attempts in older 
adults (Harwood et al., 2006; Hawton & Harriss, 2006) with disruption of inter-personal relationships 
associated with  risk of suicide independently of depression severity (Alexopoulos, 2005). Hirsch and 
Duberstein (2009) seeking to understand the relationship between suicidality, depression and 
physical health problems in older adults, found that amongst almost 2,000 primary care patients, 




positive mental health was a significant protective factor in reducing suicidality for older adults 
experiencing physical health problems.  
4.2.5. Co-morbidity and neurological changes 
Perhaps the most important factor to understand in assessing and treating late-life depression is its 
relationship with physical illness and disability. Functional impairment and medical co-morbidity 
increases the risk of depression across a wide range of disorders including diabetes (Blazer, 2002) 
chronic obstructive pulmonary disease (Yohannes et al., 1998) heart conditions (Ariyo et al. 2000) 
Depression predicts both cardiac morbidity and mortality (Carney 2003) and has been found to be 
associated with reduced bone mineral density, and increased risk of osteoporosis (Robbins et al., 
2001).  A number of possible physiological mechanisms for the association between depression and 
chronic ill-health have been explored. Depression often involves reduced appetite which can lead to 
reduced resilience and frailty (Blazer, 2003). A ‘vicious cycle’ has been proposed in which chronic 
pain may cause reduced deep stage sleep, worsening depressive symptoms, which then in turn 
further impact on sleep patterns thus reducing energy and motivation and to undertake protective 
activities such as moderate exercise (Unützer et al., 1999). Increased platelet activation has been 
observed in depressed patients, indicating a possible mechanism for increased risk of ischaemic 
damage (Whyte et al. 2001) whilst impaired immune response has also been observed in elders 
experiencing chronic mild depressive symptoms (Blazer, 2003). 
 
Patients experiencing their first episode of depression in later life are likely to have a more chronic 
course than those of the same age with a recurrent presentation, and such late onset depression has 
been associated with neurobiological changes, specifically white matter hyperintensities and 
ventriculomegaly (Lebowitz et al. 1997)  Possible neurobiological links have been proposed between 
stroke and depression (Baldwin & Wild 2004) and around a fifth of Alzheimer patients are estimated 
to experience major depression (Blazer, 2003). Depressive symptoms thought to be linked to vascular 
changes in the brain, so called ‘vascular depression,’ (Alexopolous et al., 1997) have been linked with 
specific deficits in executive functioning (Steffens 2004) and other structural brain changes including 
enlargement of lateral ventricles; cortical atrophy; increased likelihood of basal ganglia lesions and 
reduced putamen and caudate (Unützer et al., 1999). Co-morbid cognitive dysfunction increases risk 
of mortality in depressed older adults (Kane et al., 2010).  Some authors have proposed that medical 
co-morbidities such as Parkinson disease, thyroid pathologies and diabetes, amongst others, can 
function to mask depression (Colasanti et al., 2010) with depressive symptoms erroneously ascribed to 
medical complaints. It is suggested that this ‘masked depression’ can be particularly important when 




considering that older people who may meet the criteria for a depressive condition are themselves 
more likely to report somatic complaints rather than mood disturbance (Christensen et al., 1999). 
4.2.6. Cohort specific protective factors 
Wisdom has long been a quality traditionally associated with advancing years, and more recently a 
subject for empirical study (Baltes & Staudinger, 2000). Despite the high incidence of physical illness, 
social isolation, and personal losses often encountered in late-life, lower rates of major depression are 
consistently found in older adults as compared with AWA. Theories of wisdom and emotional 
development across the lifespan have been one means to understand this apparent paradox (Blazer, 
2010).  
Baltes & Staudinger (2000) have defined and operationalised qualities which might be associated with 
wisdom:  recognising and managing uncertainty; placing concerns and worries within a lifetime 
temporal perspective; acknowledging and accept the relativity of values; drawing upon a rich store of 
procedural and factual knowledge to solve problems. Such qualities might be understood to 
moderate the impact of difficult life circumstances and represent important protective factors that 
may develop with advancing years. (Windle & Woods 2004) found that a sense of environmental 
mastery mediated the impact of deteriorating physical health and housing concerns on overall life 
satisfaction whilst Baltes and Baltes (1990) have proposed that ‘successful ageing’ may involve the 
selection of appropriate goals, the optimization of current skills to minimise losses and the adoption 
of alternative strategies to compensate for changing abilities (SOC model). Socioemotional selectivity 
theory (Carstensen et al., 2000) proposes that limits on perceived available time leads to the 
prioritizing of emotional goals: with increasing years, comes greater awareness of the finitude of life 
and an increasing motivation (and hopefully capacity) to engage with goals or activities which are 
emotionally rewarding in the present rather than activities which defer satisfaction in the service of  
long-term goals or responsibilities. One consequence of the development of such skills may be 
improvements in emotional regulation. Older adults have been found to be less reactive than younger 
adults to distressing event, particularly inter-personal stressors (Neupert et al., 2007) and have been 
found to experience less affective reactivity than younger adults when faced with cognitively 
challenging tasks (Chow et al., 2007).   
In addition to demonstrating improved emotional regulation when dealing with the usual stressors of 
day-to-day life, Blazer (2010) draws attention to the fact that many of the more significant challenges 
of late-life are to some extent anticipated. As such older adults may be better prepared, both 
emotionally and practically, for personal losses and impaired functioning and thus demonstrate 




greater resilience and acceptance. For individuals who are able to foster such  positive attitudes 
towards late life, the potential challenges and losses may engender reduced cognitive dissonance and 
reduced subjective dissatisfaction with physical decline (Ron, 2007). 
4.2.7. Summary  
Considering whether depression in late life is somehow distinct, it is perhaps important to 
acknowledge that whilst the qualitative experience of depression as an older adult may indeed vary 
from that of a younger adult, such differences should not be considered to be consequence of any 
normative developmental or aging processes but due to the fact that depressed elders face different 
challenges than their younger counterparts: They are more likely to experience medical co-
morbidities, neurobiological changes, sleep disturbance, functional impairment, disability  and loss, 
all of which increase the risk of developing depression. As we have seen, for those living in the 
community, depressive disorders are no more frequent in late life than in midlife (Blazer, 2003), 
however the impact of sub-threshold depressive symptoms may in fact be greater in this age group, 
and the risk of suicide much increased. For individuals experiencing long-term residential or hospital 
care the risk of depressive symptoms is much greater. As previously noted, research studies on late-
life depression have tended to focus on relatively young, white, well educated, healthy cohorts (Karel 
& Hinrichsen, 2000) and there is therefore a need for studies which more specifically address how 
age-associated factors impact on late-life depression in ‘real-life’ community and clinical settings  
(Bartels et al., 2003). 
4.3. Late-life Depression: The Current Evidence Base 
As reported in the preceding systematic review, meta-analytic studies have found a range of 
psychotherapeutic interventions to be more effective than treatment as usual in treating late-life 
depression. Results from the review also show that, where analyses are undertaken comparing the 
relative efficacy of differing treatment approaches, they tend not to find evidence for the superiority 
of any particular approach. Possible reasons for this were touched upon in the preceding review and 
reflect the fact that the preponderance of outcome variance in trial data is not usually  accounted for 
by the differing treatments themselves (Scogin et al. 2005). However, relative equivalence of efficacy 
in meta-analytic studies does not necessarily mean relative equivalence in the quality of evidence that 
generated this data. One way to assess the quality of empirical support for a particular intervention 
and so critically evaluate the outcome of such meta-analytic findings has been to establish criteria by 
which to code the empirical rigour of primary studies. Such criteria have been developed by the 
American Psychological Association in America (Chambless & Hollon 1998) and bodies such as NICE 
and SIGN in the UK.  Interventions are assessed as ‘evidence-based’ depending on whether studies 




demonstrating their efficacy reach certain quality thresholds and are adequately replicated (Yon & 
Scogin 2007). The first attempt to undertake an assessment of the evidence for late-life depression was 
undertaken by Gatz et al. (1998) using the American Psychological Association’s criteria (Chambless & 
Hollon, 1998) for assessing efficacy of psychosocial interventions. They concluded behavioural, 
cognitive, brief psychodynamic therapy and life review/reminiscence were ‘probably efficacious.’ To 
reach the threshold for ‘well established,’ an intervention was required to out-perform a good quality 
psychological placebo or control treatment or demonstrate equivalence to an already well established 
intervention.  A subsequent  review by  Areán and Cook (2002) found Cognitive Behavioural Therapy 
(CBT) , Problem Solving Therapy (PST) and the combined effect of IPT with medication (CAMP-IPT) 
to  be efficacious in treating ambulatory older adults with major depression, noting that brief 
psychodynamic therapy (BPT) required only one additional independent trial to be considered an 
efficacious treatment according to the criteria developed by Chambless and Hollon (1998). An update 
of this review (Mackin & Areán, 2005) concluded that BPT in addition to  CBT, Reminiscence Therapy 
(RT),  and the CAMP-IPT had achieved evidence-based status. 
In the context of criticism that the American Psychological Association’s original system was 
insufficiently codified or transparent, the guidance was refined and simplified from a two-tier model 
(‘probably efficacious’ and ‘well-established’) to a single-level endorsement of ‘beneficial’. Scogin et al. 
(2005) applying these updated criteria identified six psychological treatments they considered 
showed sufficient evidence of efficacy to be classed as evidence-based treatments for late-life 
depression: behaviour therapy, cognitive behaviour therapy, cognitive bibliotherapy, problem solving 
therapy, brief psychodynamic therapy and reminiscence therapy.  Subsequently, an independent 
interdisciplinary expert panel convening in April 2006 to develop recommendations for community-
based treatment of late-life depression (Frederick et al. 2007) found that there was only sufficient 
evidence to recommend depression care management and individual CBT. 
The development of evidence-based lists which create dichotomous groups of ‘unsupported’ or 
‘supported’ treatments has been criticised  on both pragmatic and theoretical grounds (Beutler, 1998; 
Westen & Bradley 2005). Westen et al. (2004) argue that data from meta-analytic studies consistently 
points to the need for a more nuanced assessment of treatment efficacy, and argue there is a poorness 
of fit between the demands of RCT methodology and most psychotherapeutic interventions (with the 
notable exception of exposure-based treatments for specific anxiety symptoms). Beutler (1998) points 
out that, in part, the endorsement of named, manualised therapies, emerged in response to changes in 
health care funding in the United States and was therefore not entirely driven by empirical or clinical 
demands. Scogin et al. (2005) point out that criticism of such practices has been somewhat less 




vociferous in the area of gerontology and proposes that this has been due to the opportunity that such 
lists have provided to substantiate the efficacy of interventions with older adults in the context of a 
historical and inaccurate consensus which viewed psychological treatments with this group to be less 
effective than those provided to AWA. 
Such lists run the risk of misrepresenting the breadth of available evidence, and reifying certain 
approaches that do not accurately address the complexity of real-life clinical circumstances, (Westen 
& Bradley 2005) perhaps consolidating a gap between efficacy (as established in controlled trials) and 
the effectiveness of treatments in real-life clinic settings (Unützer et al., 1999).  However, the American 
Psychological Association’s guidelines for psychological practice with older adults ( Teri et al., 2004) 
are cognisant of such limitations and identify that no single treatment is preferable for depressed 
older-adults and that developing individualised treatment approaches requires consideration of a 
wide range of biological, psychological and social factors. Guidelines issued by NICE (2009) further 
note that such factors are not well captured by current diagnostic criteria and can have a significant 
impact on the course of depression and response to treatment.  
Neither NICE nor SIGN have developed specific clinical recommendations for late-life depression, 
however clinical recommendations outlining a ‘Matched/Stepped -Care’ approach to treating late life-
depression have recently been published as part of the MATRIX: A Guide to delivering evidence-
based Psychological Therapies in Scotland (Scottish Government, 2011).  These guidelines follow the 
hierarchical format of endorsing specific treatments according to the quality of evidence available, but 
authors note that such recommendations must be considered in the context of the conceptual and 
methodological constraints discussed above (K. Laidlaw, personal communication 2nd May 2012).  
Having acknowledged some of the limits of developing such lists of evidence-based treatments, the 
next section will provide a brief outline of those treatments currently considered beneficial, and 
further identify other treatments for which there is a developing evidence base. 
4.3.1. Evidence-based psychotherapeutic approaches for late life depression 
4.3.1.1. Cognitive behavioural psychotherapies 
The term ‘Cognitive Behavioural Therapy’ can be used to describe a range of interventions derived 
from both behavioural and cognitive psychological models of human behaviour and development. 
Most frequently, both behavioural and cognitive components are combined in CBT interventions. 
However, both behaviour therapy and cognitive therapy are also practised as distinct disciplines. 
Behaviour therapy for depression draws upon theories of classical and operant conditioning and 
focuses on the relationship between subjective mood and pleasant and unpleasant events experienced 




by the individual. It emphasizes the role of social learning and reinforcement in the maintenance of 
depressive symptoms and aims to reduce negative affect by developing skills in identifying, planning 
and increasing pleasurable activities. Cognitive therapy, on the other hand, draws upon extensive 
research into the mediating role of cognitions in the development and maintenance of emotional 
disorders. It is an active, time-limited and directive problem solving approach which involves 
identifying and monitoring distorted negative thinking, and applying techniques to challenge and 
moderate these thoughts. In both cognitive and behavioural approaches, individuals are expected to 
undertake structured tasks between sessions to consolidate and practice skills. In practice, CBT is 
often used to describe therapeutic interventions that are predicated on scientific principles and which 
pragmatically combine both behavioural and cognitive techniques.  
4.3.1.2. Cognitive behavioural therapy 
Reviews of the evidence base for late-life depression have consistently found cognitive behavioural 
approaches to have the most developed empirical base amongst psychological therapies for late-life 
depression (Bartels et al., 2003; Gatz, 2007; Laidlaw, 2001; Scogin et al., 2005).  Scogin et al., (2005) 
identified seven studies demonstrating the efficacy of CBT for late-life (Campbell, 1992; Floyd et al., 
2004; Gallagher & Thompson, 1982; Gallagher-Thompson & Steffen, 1994; May et al., 2006; Rokke et 
al., 1999; Thompson et al., 1987). Since this review, an RCT undertaken by Laidlaw et al. (2008) found 
both treatment as usual and CBT to be effective treatments for mild to moderate late-life depression 
and Serfaty et al. (2009) undertaking the largest RCT of individual CBT for late-life depression in 
primary care to date, found CBT to an effective treatment as compared with a well-designed talking 
control and usual GP care.  However a recent pilot randomised controlled trial failed to report 
effective reduction of depressive symptoms using a brief group cognitive behaviour therapy 
intervention with community dwelling older-adults (Wilkinson et al. 2009).  
4.3.1.3. Behavioural therapy 
Scogin et al., (2005) identified five studies with a total of 111 participants, showing that behaviour 
therapy was superior control conditions and as effective as CBT or brief psychodynamic 
psychotherapy in treating late-life depression (Floyd et al., 2004; Gallagher & Thompson, 1982; 
Lichtenberg et al., 1996; Teri et al. 1997; Thompson et al., 1987). A recent meta-analysis by Samad et al. 
(2011) (reviewed in the preceding systematic review) found behavioural therapy to be superior to 
wait list controls and as effective as cognitive therapy and brief psychodynamic therapy. 
 
 




4.3.1.4. Problem solving therapy 
Problem solving therapy (PST) is a brief cognitive-behavioural approach typically between 4-6 
sessions (Mynors-Wallis 2001) which seeks to improve patients’ ability to understand the link 
between current symptoms and everyday problems and then learn skills to solve these in a structured 
way (Hawton & Kirk, 1989). PST proposes that deficits in problem-solving skills, specifically in inter-
personal contexts, enhance the risk for developing depressive conditions. Arean et al. (1993), 
undertaking a randomised controlled trial, found problem solving therapy to be more effective than 
both reminiscence therapy and waiting list control for late life depression. It has also been shown to 
be more effective than supportive therapy in treating depression with older adults with executive 
dysfunction (Alexopoulos et al., 2011) and an effective component of collaborative care in the 
treatment of depression with sustained long-term benefits when compared with treatment as usual 
(Hunkeler et al., 2006).  However, one study comparing the efficacy of paroxetine, PST and placebo 
pill over a course of six treatment sessions failed to find any benefit of PST over placebo (Williams et 
al., 2000).   
4.3.1.5. Cognitive bibliotherapy 
Cognitive Bibliotherapy (CB) is a self-directed treatment based on cognitive principles which involves 
the patient reading standardized treatment material and undertaking exercises focused on modifying 
maladaptive cognitive processes. In a review Scogin et al., (2005) identified four eligible studies (Floyd 
et al., 2004; Landreville & Bissonnette, 1997; Scogin et al., 1987; Scogin et al., 1989) with a total of 48 
participants. All four studies found CB to be more effective than waiting list control for patients in the 
mildly depressed range. However, Landreville and Bissonnette (1997) found that post-treatment 
scores for the CB group remained in the mildly-depressed range and showed only slight 
improvement compared with untreated patients. In a two-year follow up to their 2004 study (Floyd et 
al., 2004) comparing the efficacy of individual cognitive therapy and bibliotherapy, Floyd et al. (2006) 
found gains were maintained and equivalent for both forms of therapy, but found that relapse rates 
amongst the bibliotherapy group were significantly higher (5/11) as compared with the individual 
therapy groups (1/12). In conclusion, the efficacy of CB for moderate or severe depression has yet to 
be demonstrated (Frazer et al., 2005) and bibliotherapy may be less effective than individual therapy 
in preventing relapse of depressive symptoms in older adults. 
4.3.1.6. Brief psychodynamic therapy 
Brief psychodynamic therapy is a time limited approach, typically lasting three to four months (U.S. 
Department of Health and Human Services, 1999). Current problems are explored in the context of 




prior developmental experiences, and current relationships. It draws upon psychoanalytic theory, 
examining unconscious motives, needs and defences and how these present within the dynamics of 
the client/therapist relationship. (Evans & Garner, 2004) Two studies have shown psychodynamic 
therapy to be as effective as  other evidence based treatments such as CBT for treatment for late-life 
depression (Gallagher-Thompson & Steffen, 1994; Thompson et al., 1987) with results maintained at 
follow up after two years (Gallagher-Thompson et al., 1990). The efficacy of brief dynamic therapy 
compared with antidepressant medication has not been explored with older adults (Areán & Cook, 
2002). 
4.3.1.7. Reminiscence therapy 
Reminiscence therapy involves guided reflection upon both positive and negative life experiences 
with the aim of promoting cognitive and emotional engagement with self-narratives as a means to 
overcoming feelings of despair and low mood (Arean et al., 1993). It is an intervention developed 
specifically for older adults and a number of studies support its application as an evidence-based 
treatment (Arean et al., 1993; Serrano et al., 2004; Watt & Cappeliez, 2000; Yen-Chun Lin et al., 2003) In 
a meta-analysis Bohlmeijer et al., (2003) (reviewed in section 1)  found  a large overall effect size for 
Reminiscence/life review but found significant heterogeneity: indicating significant variance 
attributable to the systematic effects of covariates. Reviewing the literature, Arean and Cook (2002) 
noted that controlled trials identified were underpowered, lacked formal diagnostic testing and often 
had small sample sizes but a recent RCT with 125 participants reported that group reminiscence 
therapy resulted in a significant reduction of depressive symptoms in community dwelling elders 
(Zhou et al., 2012). 
4.3.1.8. Interpersonal therapy 
Interpersonal therapy was developed as a time-limited treatment for depression in AWA and focuses 
on role disputes, role transitions, interpersonal deficits and grief. It has been proposed that it may be 
particularly suited to older adults given the higher likelihood of role changes, losses and social 
isolation in this group (Miller, 2008) and adaptations to the approach have been made to work with 
individuals with cognitive impairment (Miller & Reynolds, 2007). A number of reviews have 
identified  Interpersonal therapy (IPT) as a probably effective treatment for late-life depression 
(Frazer et al., 2005; Karel & Hinrichsen, 2000; Lebowitz et al., 1997) However, although the evidence-
base for IPT as a treatment for depression in AWA is considered well-established (SIGN, 2010; 
Scottish Government, 2011) there is a lack of studies demonstrating its efficacy for treatment of 
depression in older adults. Much of the IPT literature has examined its efficacy as a maintenance 
treatment in combination with medication or pill placebo, and as such it has been difficult to isolate 




IPT’s stand-alone efficacy or ascertain its effectiveness as an initial treatment for index episodes of 
depression.  (Reynolds et al. 2010; Reynolds et al. 2006; Reynolds et al. 1999) The current evidence 
therefore indicates that IPT is effective as an adjunct to anti-depressant medication in reducing 
recurrence of depressive symptoms in late life, of but that further large RCTs are required for it to be 
considered an evidence-based stand alone treatment for depressed older adults. 
4.3.1.9. Other approaches 
Other approaches, for which the data are not yet well developed, but which have shown some 
empirical support for treatment of late-life depression, include: Relational/Insight therapy  (Gallagher 
& Thompson, 1982); Longer-term CBT and psychodynamic therapy (Steuer et al., 1984); Personal 
Construct Therapy (Viney et al.,1989); Behavioral Bibliotherapy (Scogin et al., 1989); Family Therapy 
(Benbow et al., 1990); Coping Skills Group Therapy (Dhooper et al., 1993); Interpersonal Counselling 
(Mossey et al., 1996); Goal-focused Therapy (Klausner et al., 1998); Psycho-educational 
Groups(Schimmel-Spreeuw et al., 2000) Dialectical behaviour therapy (Lynch et al., 2007; Lynch, et al., 
2003)  
In addition, long-term outcome results from large scale collaborative care approaches (Alexopoulos et 
al.,  2009; Hunkeler et al., 2006; Unützer, et al., 2002) have indicated the efficacy of enhanced care 
management tailored to individual needs which combine psychotherapeutic and behavioural 
interventions with anti-depressant medication. Such large scale, multi-site studies address some of 
the limitations of more typical RCT designs: they typically involve more representative samples and 
embed interventions within existing primary care services. As such, they potentially narrow the 
potential gap between experimental efficacy and real-life effectiveness (Unützer, et al., 1999). 
However, it is of course impossible to isolate the specific impact of the psychotherapeutic intervention 
in such approaches, and as such they have not been included in the current review. 
4.4. Summary 
As reviewed in the preceding systematic review, meta-analyses have consistently found 
psychological treatments have moderate to large effects on late-life depression (Cuijpers, 1998; 
Cuijpers et al., 2006; Engels & Vermey, 1997; Krishna et al., 2011; Pinquart & Sorensen, 2001; Pinquart 
et al., 2007; Samad et al., 2011; Scogin & McElreath, 1994). Effect sizes  are equivalent to those found 
for pharmacotherapy (Pinquart et al., 2006) and studies with AWA (Cuipers et al., 2009) with 
individual therapy found to be more effective than group approaches (Cuijpers et al., 2008). Cognitive 
behavioural approaches have been the most systematically evaluated and empirically validated 
approaches. Cognitive Bibliotherapy has shown efficacy for mild depressive symptoms, with 




problem-solving therapy, behaviour therapy and cognitive behavioural therapy showing efficacy for 
more severe depressive presentations. IPT has demonstrated efficacy as an adjunct to anti-depressant 
medication and promising results with AWA indicate it is likely to be an efficacious treatment for 
older-adults, however further stand-alone RCTs are needed to confirm this. Studies of reminiscence 
therapy and life review approaches also show promising results but sufficiently powered, better 
quality trials are required to consolidate initial indications of its efficacy for late-life depression. BPT 
has been found to be as effective as CBT in a small number of RCTs, but more studies are required to 
establish a robust evidence-base for this approach. 
There are limits of the generalizability of the data: further studies need to be undertaken in long-term 
care settings (Powers, 2008) with older adults with cognitive impairment (Areán & Cook, 2002) and 
the oldest-old (Blazer, 2003). In addition the evidence-base with regards to treatments of late-life 
depression in the presence of significant co-morbidities is not well developed. RCT’s examining late 
life depression frequently use exclusion criteria based on ‘clinical co-morbidity’: when the presence of 
one disorder alters the normal course of the other (Stover et al., 2003; McCusker et al., 2005). However, 
the vast majority of older patients in primary care settings experience co-morbid illness with  rates of 
depression increasing with higher co-morbidity (Charlson & Peterson 2002; NICE 2009). Frequently 
the degree and nature of co-morbidity in experimental samples is not well reported, meaning it is 
difficult to ascertain either the moderating impact of co-morbidities, or the relative efficacy of 
differing treatment approaches.  
In light of these issues, the following meta-analysis will examine the efficacy of the best evidenced 
approach to depression in this age group, CBT, as it has been applied with older adults experiencing 
co-morbid physical illnesses. 
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Objective:  Examine the efficacy of cognitive behavioural therapy (CBT) for late-life depression in 
older adults with co-morbid physical illness. 
Method: Systematic literature search and meta-analysis of randomised controlled trials (RCT) 
evaluating CBT for depression in older adults with co-morbid physical illness.  
Results: Nine papers met inclusion criteria. CBT was superior to waiting list and treatment as usual 
control conditions, showing a statistically significant pooled standardised mean difference (SMD) of 
0.63 (95%CI, 0.29 to 0.97, p = 0.0003). This was largely maintained at follow up (SMD 0.5, 95% CI, 0.08 
to 0.92). Sensitivity analysis showed individual CBT yielded a large, statistically significant summary 
effect size of 0.80 (95% CI, 0.45 to 1.16), but that group CBT did not show statistical superiority over 
controls. Clinician-rated measures of depression yielded larger effect sizes, with a SMD of 1.57 
(95%CI, 0.56 to 2.59, p = 0.002) as compared with patient-rated measures: 1.03 (95% CI, 0.75 to 1.31, p = 
0.0001).  
Conclusions: CBT is effective in reducing depressive symptoms for depressed older adults with an 
underlying physical illness when compared with waiting list controls and treatment as usual.  
Word count: 183/ maximum 200 
Declaration of interest: None. 
Key words: (maximum 6) 














Depression in late-life frequently occurs in the context of co-morbid physical illness 
(Alexopoulos et al. 2002) and is associated with significantly reduced quality of life (Doraiswamy et 
al. 2002) poorer medical prognosis (Pennix et al., 2000) increased mortality (Kane et al. 2010) and 
significant increases in economic costs (Katon et al., 2003).  Reported prevalence rates for major 
depression in medically ill older adults vary between 5% and 45% with rates for sub-syndromal or 
minor depression showing even greater variability (McCusker et al. 2005). Despite such variability, it 
is clear that physical co-morbidity greatly increases the likelihood of an individual becoming 
depressed (Alexopoulos, 2005; Charlson & Peterson, 2002; Fiske, Wetherell, & Gatz, 2010) with higher 
rates found in patients with cardiovascular disease (Carney, 2003), diabetes, (Lustman et al. 2000) 
stroke (Strober & Arnett 2009), Parkinson’s disease (Reijnders et al. 2008) and Alzheimer disease (Park 
et al. 2007). 
Psychological and pharmacological treatments have been found to be equally efficacious in 
treating late-life depression (Pinquart, Duberstein, & Lyness, 2006), but due to concerns with regards 
drug interactions, trials of anti-depressants have often excluded individuals with co-morbid physical 
illnesses (Stover et al. 2003). Psychological treatments may therefore be more suitable in this 
population and are certainly found to be frequently preferred by patients (Areán & Cook, 2002; Rokke 
& Scogin, 1995, Unützer et al., 2002). A number of previous meta-analytic studies have examined 
psychotherapeutic interventions for depression in individuals with physical illnesses (Sheard & 
Maguire 1999; Astin et al. 2002; Beltman et al. 2010; Dusseldorp et al. 1999; Himelhoch et al. 2007;  
Lustman et al. 2000; Linden et al. 2007; Meyer & Mark 1995; Tatrow & Montgomery 2006). Such 
studies have either limited their analysis to specific disorders, included a wide range of 
psychotherapeutic approaches or failed to distinguish between adults of working age (AWA) and 
older adults. Cognitive behavioural therapy (CBT) has the most developed empirical base amongst 
psychological therapies for late-life depression (Bartels et al. 2003; Gatz, 2007; Laidlaw, 2001; Scogin et 
al. 2005) and  there is a growing body of evidence examining its application specifically in the context 
of medical co-morbidity. However, no meta-analyses have been undertaken examining the efficacy of 
CBT for this group. We conducted a meta-analysis examining the effectiveness of CBT for depression 
in older adults with co-morbid physical illness. We hypothesized that individual CBT would 
demonstrate similar efficacy to group approaches,  (Cuijpers et al. 2008a) clinician-rated measures 
would yield greater effect sizes than patient-rated measures  (Cuijpers, Li, Hofmann, & Andersson, 
2010) and that depression severity would not moderate treatment efficacy (Driessen et al. 2010)  
 





5.2.1. Identification of suitable studies 
Electronic databases were searched until April 2012 using EBSCO host: CINAHL Plus; 
MEDLINE; PsycINFO; Psychology and Behavioral Sciences Collection; Biomedical Reference 
Collection. A boolean/phrase search mode limited to English language using text keywords with 
truncation and wild cards was used, structured as three concepts: Disorder (depress* OR dysthymi* 
OR mood); Intervention (psychotherap* OR cognitive therapy OR behavi* therapy OR CBT OR 
Problem Solving OR Stress Management); Design (Randomi?ed Controlled Trial OR RCT OR 
Controlled Trial). Terms relating to physical illness or age were not included to prevent exclusion of 
possibly relevant studies. Titles were screened to identify relevant studies. Somatic illnesses were 
identified. The Cochrane Library was searched, adding the dimension of specific underlying physical 
illnesses:  (cancer OR COPD OR diabetes OR heart OR dementia OR Alzheimer* OR coronary OR 
Parkinson* OR arthritis OR HIV OR chronic health OR physical *morbidity OR multiple sclerosis OR 
irritable bowel OR physical illness OR epilepsy). Reference lists of existing systematic reviews and of 
identified studies were hand searched, and authors of included studies were contacted. (Appendix 10 
gives details of correspondence with authors). To minimise publication bias, a search of grey 
literature was undertaken (via www.opengrey.eu/). To identify relevant ongoing clinical trials The 
World Health Organisation (WHO) International Clinical trials registry platform search portal was 
searched. Abstracts and full texts of included studies were screened for eligibility by one author (DH) 
in consultation with a second author (KL) (Full search strategy is outlined in Appendix 11). 
5.2.2. Inclusion criteria 
Studies meeting the following criteria were included1: 
1. Use of a randomised controlled research design. 
2. Mean age ≥55years. 
3.  Inclusion of participants with an underlying physical illness. 
4. Inclusion of a treatment arm with CBT, defined as a protocol- based clinician delivered 
intervention including clear well-described cognitive and behavioural components: problem-
solving therapy, cognitive–behavioural stress management and mindful-based CBT 
interventions meeting these criteria were therefore eligible.  
5. Treatment protocol described components explicitly focused on amelioration of depressive 
symptoms.  
                                                          
1
 Guidelines devised by the Cochrane Collaboration were used to develop inclusion criteria (O’Connor,Green & Higgins, 
2011)  




6. Valid outcome measures used:  self-report (e.g. Beck Depression Inventory (BDI); Beck et al. 
1961), clinician-rated (e.g. Hamilton Depression Rating Scale (HDRS); Hamilton, 1967) or 
structured diagnostic interviews according to DSM-IV-TR criteria (American Psychiatric 
Association, 2000). 
Studies were excluded where effect of CBT intervention could not be isolated from other 
treatment components such as anti-depressant medication or collaborative care management. Studies 
examining conditions without a definitive somatic origin were excluded (e.g. fibromyalgia, ME, pain 
management, or executive dysfunction in the absence of a diagnosed underlying illness). Studies 
employing guided self-help based on CBT principles were excluded.  
5.2.3. Outcome measures 
The primary outcome measure was change in depression symptoms assessed by clinician- 
rated (e.g. HDRS) or self-rated (e.g. BDI) measures using continuous data (mean and standard 
deviation).  Validated self-report measures tend to yield smaller estimations of effect sizes in studies 
of late-life depression (Cuijpers, et al., 2010) and so a conservative approach was taken, with self-rated 
measures given precedence in studies where both were reported. Dropout rates from treatment were 
recorded as dichotomous data as a proxy for treatment acceptability.  
5.2.4. Assessment of risk of bias 
Risk of bias was assessed for each eligible study by two independent raters (DH & KL) using 
the Cochrane Collaboration risk of bias tool (Higgins & Green, 2008). Study Quality was assessed 
using the Cochrane Collaboration for Depression and Anxiety group Quality Rating Scale (QRS) 
(Moncrieff & Churchill, 2001) by two independent raters (DH & AL). The degree of the agreement 
between the authors was expressed as a percentage and a Kappa statistic. These tools were used to 
assess whether studies adequately concealed and randomized allocation to treatment, whether there 
was appropriate blinding of assessors, to identify risks of associated with incomplete data and 
selective reporting and assess the fidelity of interventions relative to described treatment protocols. 
Potential threats to study validity and risks of bias are discussed narratively.    
5.2.5. Data extraction 
For each eligible study, one author (DH) extracted information regarding methods, 
participants, intervention and outcomes. Data was checked by a second author (KL) and authors were 
contacted via e-mail to retrieve any missing data. 
 




5.2.6. Data synthesis 
To allow analysis of continuous measures of depressive symptoms across different scales, the 
standardized mean difference (SMD) between the intervention and control or comparison group was 
calculated for both clinician-rated and patient-rated scales where available. Mean scores and standard 
deviation on validated depression measures were used. The SMD expresses the size of the treatment 
effect for each trial relative to variability observed, enabling different scales to be pooled into one 
outcome measure. As Freedland et al. (2009) reported standard error scores with covariate-adjusted 
least-squares means, Cochrane Collaboration Review Manager Software (RevMan version 5.1, 2011) 
was used to transform standard error data into standard deviation data. Cohen’s d (Cohen, 1987) was 
calculated by subtracting the average post-test score of the control group from the average post-test 
score of the experimental group and dividing the result by the pooled standard deviations of both 
groups. This was transformed into Hedge’s g to adjust for possible bias resulting from small samples 
(Borenstein et al., 2009). Data were interpreted according to the convention: small (0.2) medium (0.5) 
and large (0.8) (Cohen 1992).  
As heterogeneity was anticipated among the studies a random-effects meta-analysis was 
undertaken using the Cochrane Collaboration Review Manager Software (RevMan version 5.1, 2011). 
This involves the mean effect size of each study being weighted by the inverse of its variance to 
generate an overall weighted mean. Analyses were undertaken with intent-to-treat data where 
possible. Further details of methods are outlined in section 6. 
5.2.7. Exploration of heterogeneity 
The I² statistic, which expresses the percentage of variability in an effect size that can be 
ascribed to study heterogeneity rather than to chance (Higgins & Thompson 2002), was used to 
explore statistical heterogeneity. Low heterogeneity is indicated by I² values of 25%, moderate, 50% 
and high, 75% (Higgins et al. 2003). Potential sources of heterogeneity identified a priori were 
modality of intervention (group or individual) and depression severity at baseline. Sensitivity 
analyses were undertaken to assess the impact of sources of heterogeneity on overall treatment effects 
(Higgins & Thompson 2002). Depression severity at baseline was determined according to widely 
accepted thresholds on patient-rated measures: GDS-15 (Almeida &  Almeida, 1999)  BDI (Beck et al., 
1961) and  BDI-II (Beck et al., 1996). Due to anticipated variation in treatment delivery (group vs 
individual, number and length of sessions) data were pooled using a random effects model with 95% 
confidence intervals (Sutton et al., 1998). The likelihood of participants dropping out of the 
intervention group as compared with the comparison group was presented with odds ratios (OR). 
Publication bias was subjectively assessed by plotting the standardized mean difference (SMD) of 




each study against standard error (SE) and reporting any observed asymmetry. Fail-safe N was 
calculated using methods outlined by Rosenberg (2005). Further details of methods are outlined in 
section 6. 
5.3. Results 
5.3.1. Results of systematic search 
A systematic search of electronic databases identified 2546 studies (Figure 1). Of these, 2162 
were excluded by screening titles and 289 by screening abstracts. A total of 102 full papers were 
retrieved and assessed for eligibility. (Reasons for exclusion included as Appendix 12). Thirteen 
randomised controlled trials (RCT) were identified which met the inclusion criteria. Of these, 5 did 
not include sufficient data to allow meta-analytic synthesis. Attempts were made to contact the 
relevant authors. Two replied and one of these was able to supply the necessary data. Three could not 
be contacted.  
5.3.2. Study characteristics 
The main characteristics of the nine included RCT’s which collectively included 1104 
participants are detailed in tables 1 to 3. Table 1 shows that the majority of studies undertook intent-
to-treat analyses, used similar outcome measures and included patients of a similar age (mean: 63.6, 
SD 6.5) with moderate levels of depressive symptoms. There was considerable variation in the 
percentage of women in included studies and in the mode of delivery: Five studies examined 
individual, and four studies group interventions. Table 2 shows that the intensity of intervention also 
varied from four, hour-long sessions over three weeks (Dao et al. 2011) to 20 two-hour sessions over 
the course of a year (Koertge et al., 2008). Eight studies compared CBT to treatment as usual (TAU) 
(Dao et al., 2011; Dobkin et al., 2011; Freedland et al., 2009; Gellis et al., 2008; Hynninen et al., 2010; 
Koertge et al., 2008; Lincoln & Flannaghan, 2003) whilst Foley et al. (2010) used a wait-list control. 
Dobkin et al. (2011) and Hynninen et al. (2010) supplemented TAU with minimal telephone contact to 
monitor depressive symptoms. Lincoln & Flannaghan (2003) also employed an attention placebo 
comprised of ten hour-long visits from a clinician focused on discussions of day-to-day occurrences 
and the physical effects of stroke. Two studies compared CBT with another intervention. Freedland et 
al. (2009) included a stress management condition which involved weekly hour-long individual 
sessions focused on relaxation techniques such as controlled breathing and progressive muscular 
relaxation.   Kunik et al. (2008) compared CBT with a COPD education intervention comprising eight 
hour-long sessions focused on disease management and education. Table 3 details the outcomes for 
each study. 




Figure 1. Flow chart illustrating literature search process 
 
Three studies were not included in analysis of follow up data because time from end of 
treatment to follow up was insufficient (Dao et al., 2011; Dobkin et al., 2011) or because follow up data 
was only reported for intervention group and not control (Foley et al., 2010). 
5.3.3. Risk of bias in included studies 
There was good agreement between the independent authors regarding study quality (88%, 
Kappa 0.75, 95% CI, 0.61 to 0.88) and the included studies achieved reasonable QRS scores of between 
29 and 39 out of a maximum score of 46 with a mean score of 33.4 (SD 4.10) Agreement regarding risk 
of bias yielded a fair agreement (56%, Kappa 0.26, 95% CI, 0.04 to 0.47). Final ratings were agreed 
through discussion. (Authors’ conclusions regarding risk of bias and study quality are detailed in 
Appendices 13 and 14). 




Overall risk of bias can be seen in Figure 2. Adequate randomization was reported by seven 
studies, with risk of allocation bias unclear in Hynninen et al. (2010) due to insufficient information 
on procedure and in Koertge et al. (2008) due to the potential impact of pre-screening for participants’ 
ability to attend twenty sessions. Five studies did not report sufficient detail of allocation concealment 
(Dao et al., 2011; Freedland et al., 2009; Hynninen et al.,2010; Koertge et al., 2008; Kunik et al., 2008). 
Due to the nature of the studies participant/clinician blinding was not possible,  however, only two 
studies provided sufficient information to evidence that blinding of outcome assessors was 
undertaken in a way that would ensure detection bias was minimised (Dobkin et al., 2011; Foley et al., 
2010).  
Gellis et al. (2008) failed to employ intent to treat analysis in the presence of significant 
attrition indicating a high risk of attrition bias. Kunik et al. (2008), although using ITT methods, 
reported extremely high attrition without clear reporting as to reasons between groups and was 
considered, with  five further studies to show unclear risk of attrition bias (Freedland et al., 2009; 
Hynninen et al., 2010; Koertge et al., 2008; Lincoln & Flannaghan, 2003;Foley et al., 2010). Dao et al. 
(2010) and Dobkin et al. (2011) showed a low risk for attrition bias, reporting low, non-skewed, 
attrition rates with clear reasons for drop-out. Pre-published trial protocols were not found for any of 
the included studies, meaning it was not possible to assess the risk of reporting bias.  
Six studies were considered to show a high risk of bias due to other factors and these are 
recorded as ‘Other Bias’ in Figure 2.  Hynninen et al. (2010) and Kunik et al. (2008) recruited using 
advertisements, with the resultant risk of non-representative samples. Failure to record, control or 
analyse potential impact for anti-depressant use was a significant risk of bias in five studies (Foley et 
al., 2010; Gellis et al., 2008; Hynninen et al., 2010; Koertge et al., 2008; Kunik et al., 2008).  Inadequate 
test for treatment fidelity was evident in four studies (Gellis et al., 2008; Hynninen et al., 2010; Koertge 
et al., 2008; Lincoln & Flannaghan, 2003) and in the study by Lincoln and Flannaghan (2003) this was 
in the context of limited clinician training. Full details of all sources of bias identified, including ‘other 










Table 1: Characteristics of Included Studies: Methods and Participants 
Methods
Authors (Date)
Blinding of outcome 
assessor
Intent to treat
Test of treatment 
fidelity




Y. (Integrity not tested) N*
Not described
TAU / †Attention placebo
Gellis et al., (2008) Y. (Integrity not tested) N Not described TAU
Koertge et al., 
(2008)
N. (Self-rated measures) Y Not described TAU
Kunik et al. 
,(2008).
Y. (Integrity not tested) Y Y †COPD education
Freedland et al., 
(2009)
Y. (Integrity not tested) Y Y TAU / †Stress management
Foley et al., 
(2010). 
Y. (Integrity tested) Y Not described WL
Hynninen et al., 
(2010)
N. (Self-rated measures) Y
SPV but fidelity not 
confirmed.
TAU ( + minimal clinical 
monitoring )
Dao et al., (2011) N. (Self-rated measures) N* Y TAU
Dobkin et al., 
(2011)
Y. (Integrity tested) Y Y 


















15.1   
13.2   
12.7   
Stroke ‘Moderate’ (BDI)
Gellis et al., 
(2008)




Koertge et al., 
(2008)




Kunik et al., 
(2008).
238 4 118 - 120 66.3 10.2  COPD ‘Moderate’  (BDI-II)
Freedland et al., 
(2009)




11   
10   





Foley et al., 
(2010). 
115 76 55 60 -




Hynninen et al., 
(2010)
51 51 25 26 -
CBT: 59.3
CG: 62.6
7. 6 / 41-74
9.9 /  41-78
COPD ‘Mild’ (BDI-II)
Dao et al., (2011) 100 22 50 50 -
UC: 64.2
MADES:62.8
11.9   




Dobkin et al., 
(2011)





KEY: * Although no intent to treat analysis undertaken these studies had >95 completer data. † Only for those studies in which it was reported. AP = Attention 
Placebo. BDI = Beck’s depression Inventory. CBT = Cognitive Behavioural Therapy. CG = Control Group. COPD = Chronic Obstructive Pulmonary Disease. HDRS = 
Hamilton Depression Rating Scale. MADES = Managing Anxiety and Depression using Education and Skills. MCBT = Mindfulness based CBT. SPV = supervision. SSM = 
Supportive Stress Management. TAU = treatment as usual. UC = Usual Care. WL = Waiting list. 
 


























Manualised CBT: education, activity scheduling, 
graded task assignment, identification and 








Gellis et al., 
(2008)
PST. Involved education re: signs and symptoms of 
depression, developing specific problems solving and 
coping strategies. Using diaries and increasing daily 








Koertge et al., 
(2008)
CBT stress management. Involved strategies to 
identify and moderate maladaptive cognitive, 
affective and behavioural patterns: assertive 
communication, strategic problem–solving skills, 
thought challenging and relaxation practice. 





10 weekly, then 
10 monthly
15.4 17 (Mean; 
1-2 years)
Kunik et al. 
,(2008).
CBT for both anxiety and depression including 
psycho-education on anxiety and depression, 
behavioural activation, problem solving techniques, 
cognitive techniques, sleep management and  
planning for maintenance of gains. Delivered by  









Manualised CBT Involved problem solving, 
behavioural activation,  cognitive techniques, and 
relapse-prevention. Provided by two clinical social 







Foley et al., 
(2010). 
MBCT. Involved mindful mediation practice with 
psycho-education on the relationship between 
thinking and mood with a specific focus on the role 
of cognitions in maintaining depressed mood. 









Manualised CBT Involved strategies to modify beliefs 
and change behavioural patterns that may maintain 








Dao et al., 
(2011)
Brief manualised  CBT: Involved psycho-education, 
developing problems list, setting behavioural goals, 
develop cognitive strategies, and reviewing progress. 





within 3 weeks 
3.0 ~ 0.5
Dobkin et al., 
(2011)
Manualised CBT. including behavioural activation, 
thought restructuring, exercise,  relaxation training, 
sleep hygiene and worry control.  Also, four 
individual caregiver educational sessions (30–45 
minutes) to support consolidation of CBT 








KEY: CBT = Cognitive Behavioural therapy. PST = Problem Solving Therapy. MBCT = Mindfulness based cognitive therapy.
  











Pre- Post Follow up
CBT Control Comp. CBT Control Comp. CBT Control Comp.
Lincoln & 
Flannaghan (2003) 






























































































































































KEY: * = median not mean: Standard Deviation not reported. BDI = Beck’s depression Inventory. CBT = Cognitive Behavioural Therapy . Comp = Comparison 
Intervention. HDRS = Hamilton Depression Rating Scale. GDS = Glasgow Depression Scale.  Standard Deviation shown in brackets. †Data for Freedland et al., (2009) is
the covariate-adjusted least-squares mean. Reported standard deviation  shown in brackets was from standard error data.
. 






Figure 2. Risk of bias graph: review raters’ judgements about each risk of bias item presented 
as percentages across all included studies 
5.3.4. Effectiveness of CBT compared with treatment as usual (TAU) / Wait-list (WL) controls at 
end of treatment 
Data were available for 8 studies. self-rated measures were used when possible: BDI (Dobkin 
et al., 2011; Freedland et al., 2009; Koertge et al., 2008; Lincoln & Flannaghan, 2003), BDI-II (Dao et al., 
2011; Hynninen et al., 2010) and GDS (Gellis et al., 2008).  Clinician-rated outcome (HDRS) was used 
for Foley et al., (2010) in the absence of self-report measures. 
Table 4 shows a medium effect favouring CBT over TAU / WL controls (pooled SMD = 0.63, 
95% CI, 0.29 to 0.97) which was statistically significant (p = 0.0003). There was significant 
heterogeneity (X² = 37.49, df = 7 (p = <0.00001), with the I² statistic indicating that between study 
heterogeneity accounted for 81% of variance in the effect size. 
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Total (95% CI)
Heterogeneity: Tau² = 0.19; Chi² = 37.49, df = 7 (P < 0.00001); I² = 81%
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5.3.5. Effectiveness of CBT compared with TAU/WL control at follow up 
Data were available for 5 studies. (Freedland et al., 2009; Gellis et al., 2008; Hynninen et al., 
2010; Koertge et al., 2008; Lincoln & Flannaghan, 2003). Follow up periods ranged from 3 months to 1-
2 years (see table 2) with a mean follow-up period of 7.3 months. Table 5 shows a significant medium 
effect size favouring CBT over control at follow up (SMD = 0.5, 95% CI, 0.08 to 0.92) Heterogeneity 
was significant (X² = 19.09, df = 4, p =  <0.0008, I² = 79%).  
Table 5. Forest plot showing effectiveness of CBT compared with TAU/WL control at follow up 
 
5.3.6. Sensitivity Analyses 
As specified apriori, the potential that differing modality of delivery and differing depression 
severity may introduce heterogeneity was explored with sensitivity analyses.  
5.3.6.1. Effectiveness of individual CBT intervention compared with group CBT 
The analysis was re-run for group and individual studies separately. Only including studies 
which compared Individual CBT with TAU/WL control (Table 6) showed a large, statistically 
significant summary effect size (SMD) of 0.80 (95 % CI, 0.45 to 1.16, p = 0.00001).  Heterogeneity was 
significant (X² = 11.49, df = 4, p = <0.02) with the I² statistic indicating that 65% of variance in the effect 
size could be attributed to heterogeneity between included studies. Further sensitivity analysis to 
explore sources of heterogeneity was undertaken as recommended by the Cochrane collaboration 
(Higgins & Green 2011). Removing Lincoln & Flannaghan (2003) data yielded a highly significant 
summary effect size of 0.97 (95% CI, -0.09 to 0.57, p=0.00001) with no significant heterogeneity (X² = 




Lincoln & Flannagan 2003
Koertge et al. 2008
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Hynninen et al. 2010
Total (95% CI)
Heterogeneity: Tau² = 0.18; Chi² = 19.09, df = 4 (P = 0.0008); I² = 79%
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Table 6. Forest plot showing effectiveness of individual CBT intervention compared with 
control 
 
Referring to table 8 we can see a small, non-significant effect (p = 0.18) favouring group CBT 
over TAU / WL control (SMD = 0.35, 95% CI, -0.15 to 0.85).  Heterogeneity was significant (X² = 10.34, 
df = 2, p = <0.006) with the I² statistic indicating that 81% of variance in the effect size could be 
attributed to heterogeneity between included studies. 
Table 7.  Forest plot showing effectiveness of group CBT intervention compared with control 
 
5.3.6.2. Outcomes for mild depression compared with moderate to severe depression 
Only two studies had mean pre-treatment depression scores which fell within the ‘mild’ 
range (Hynninen et al., 2010; Koertge et al., 2008). Referring to table 8 we can see that only including 
these studies revealed no significant difference between CBT and control interventions (SMD = 0.18, 
95 % CI, -0.37 to 0.74, p = 0.52). The remaining seven studies included samples with moderate to 
severe pre-treatment depression scores. Table 9 shows that these studies yielded a large, highly 
significant summary effect size (SMD = 0.81, 95% CI, 0.58 to 1.05, p = 0.00001) with moderate 




Lincoln & Flannagan 2003
Gellis et al. 2008
Freedland et al. 2009
Dobkin et al. 2011
Dao et al. 2011
Total (95% CI)
Heterogeneity: Tau² = 0.10; Chi² = 11.49, df = 4 (P = 0.02); I² = 65%
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Table 8.  Forest plot showing effectiveness of CBT intervention compared with controls for 
studies with mean depression severity scores indicative of mild depression 
 
Table 9.  Forest plot showing effectiveness of CBT intervention compared with controls for 
studies with mean depression severity scores indicative of moderate to severe depression 
 
5.3.7. Further Analyses 
Outcome data yielded by clinician-rated measures and patient-rated measures were 
compared, as was the effectiveness of CBT when compared with ‘active controls’ as opposed to 
TAU/WL controls. 
5.3.7.1. Comparison of clinician-rated and self-rated measures of outcome 
Referring to Tables 10 and 11 we can see that three studies (Dobkin et al., 2011; Freedland et 
al., 2009; Gellis et al., 2008) used both patient-rated and clinician-rated outcome measures and so were 
suitable for a comparative analysis. At end of treatment clinician-rated measures yielded a larger 
effect size, with a SMD of 1.57 (95% CI, 0.56 to 2.59) as compared with 1.03 (95 % CI, 0.75 to 1.31). Both 
were significant (clinician-rated p = 0.002, patient rated p = 0.0001) however the clinician-rated 
measures showed significantly greater heterogeneity (X² = 21.49, df = 2, p = 0.0001, I² = 91%) than 
patient-rated measures (X² = 0.12, df = 2, p = 0.94 I² = 0 %). At follow up clinician-rated measures 
showed a reduced SMD of 1.22 (95 % CI, 0.08 to 2.36, p = 0.04) and increased heterogeneity (X² = 29.89, 
df = 2, p = 0.00001, I² = 93%). Patient-rated outcome measures at follow up also showed a reduced 
Study or Subgroup
Koertge et al. 2008
Hynninen et al. 2010
Total (95% CI)
Heterogeneity: Tau² = 0.12; Chi² = 3.33, df = 1 (P = 0.07); I² = 70%
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SMD (0.64, 95 % CI 0.27 to 1.01, p = 0.0007) with heterogeneity increasing, although not reaching 
significance (X² = 3.75, df = 2, p = 0.15, I² = 47%). 
Table 10. Forest plot showing effectiveness of CBT intervention compared with controls as 
measured by clinician-rated measures (only including those studies which employed both 
patient-rated and clinician-rated rated measure) 
 
Table 11. Forest plot showing effectiveness of CBT intervention compared with controls as 
measured by patient-rated measures (only including those studies which employed both 
patient-rated and clinician-rated measures) 
 
 
5.3.7.2. Effectiveness of CBT compared with ‘active controls’ 
Only three studies compared the efficacy of CBT with alternative interventions. Freedland et 
al. (2009) compared CBT with stress management, Kunik et al. (2008) with COPD education, and 
Lincoln & Flannaghan (2003) with an attention placebo. Table 12 shows a small, non-significant effect 
favouring group CBT over active control (SMD = 0.11, 95 % CI, -0.17 to 0.39, p = 0.44).  Heterogeneity 
was not significant (X² = 3.56, df = 2, p = 0.17) with the I² statistic indicating that 44% of variance in the 
effect size could be attributed to heterogeneity between included studies. Heterogeneity reduced at 
follow up but remained non significant (X² = 2.42, df = 2 p= 0.30, I² = 17 %) as did the summary effect 
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Table 12.  Forest plot showing Effectiveness of CBT compared with active controls 
 
5.3.8. Analysis of drop out 
 
Mean attrition across comparisons of CBT to TAU / WL control was 20%, with two studies 
showing particularly high attrition (Koertge et al., 2008; Kunik et al., 2008). Eighty four per cent of the 
7316 patients screened across all studies were excluded before randomisation. All studies provided 
data regarding drop out between baseline and treatment completion for CBT and control groups. 
Referring to table 13 we can see the pooled odds ratio was 0.73 (95% CI, 0.41 to 1.28] with patients 
more likely to drop out of control conditions, which was not statistically significant (p = 0.27). 
 
Table 13. Forest plot showing pooled odds ratio of drop-out for CBT groups and control 
groups
 
5.3.9. Tests for publication bias 
Due to the small number of included studies, visual inspection of funnel plot was considered 
an unreliable method of assessing possible publication bias (Terrin et al., 2005). (The funnel plot of 
summary effect size against standard error is included as Appendix 15). Fail-safe N data were 
calculated according to methods outlined by Rosenthal (1979) and Rosenberg (2005). Rosenthal’s fail-
safe N (Rosenthal 1979) indicated 170 unpublished studies with an effect size of zero would be 
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required to render the population effect size non-significant. This figure exceeds 5n+ 10, indicating the 
results can be considered robust to the effects of publication bias (Rosenthal 1991). A still robust fail-
safe N of 119 was found applying Rosenberg’s (2005) more conservative methods which employ a 




5.4.1. Summary of main findings 
This study found that CBT showed a medium effect (SMD = 0.63) in reducing depressive 
symptoms in older adults with underlying physical illnesses when compared with treatment as usual 
or waiting list controls and that these benefits were largely sustained at follow up (SMD = 0.50). 
Previous meta-analyses examining CBT for late-life depression, which have not explicitly focused on 
older people with co-morbid physical illnesses, have reported higher summary effect sizes for the 
impact of CBT on depressive symptoms as compared with controls: Pinquart et al. (2007), d = 1.12; 
Cuijpers et al. (2006), d = 0.70; Pinquart et al. (2006), d =  0.88. However, these studies employed 
Cohen’s d as a measure of the SMD rather than the more conservative Hedges’ g used in this study, 
making comparison misleading. In fact, Pinquart & Sorensen (2001), employing Hedges’ g, using self-
rated outcome measures and not focusing explicitly on older adults with physical illness found a very 
similar effect size (g = 0.64) for the effect of CBT on depressive symptoms in late-life depression. 
Although these results appear consistent, it is not possible to conclude from this that physical co-
morbidity has no impact on treatment outcomes. Samples of older adults in previous meta-analyses 
have tended to include significant degrees of co-morbidity, and a previous study, undertaking 
moderator analyses and including a much larger sample (Pinquart et al. 2007) found physical co-
morbidities were associated with reduced treatment effect. Nevertheless results from the current 
study indicate that CBT is more effective than treatment as usual or no intervention in reducing 
depressive symptoms in older adults with underlying physical illnesses. 
5.4.2. Exploration of heterogeneity 
In this study the summary effect size (SMD) found for CBT in reducing depressive symptoms 
in older adults with underlying physical illnesses showed significant heterogeneity. Sensitivity 
analyses showed that only including studies that employed individual rather than group CBT 
reduced heterogeneity and increased the summary effect size. These findings might suggest 
individual psychotherapy is more effective than group approaches in treating late-life depression 
(Cuijpers, et al. 2008b) however, this conclusion is not supported by a number of other previous 




studies (Bohlmeijer et al. 2003; Cuijpers, 1998; Cuijpers et al. 2006; Pinquart et al. 2007; Scogin & 
McElreath, 1994, Cuijpers et al. 2008a) and sensitivity analyses designed to explore heterogeneity 
should not be interpreted as yielding data regarding moderators of treatment.  
Further sensitivity analysis explored the role of depression severity in potentially explaining 
heterogeneity of effect sizes between studies. A distinction was made between mild depression and 
moderate to severe depression as this is the threshold at which the National Institute for Health and 
Clinical Excellence (NICE, 2009)  recommend the use of antidepressant therapy. In studies which 
included patients with mean depression scores falling in the mild range (Hynninen et al., 2010; 
Koertge et al., 2008) CBT did not show greater efficacy than controls in reducing depression 
symptoms (Table 8). However, only including studies with mean depression scores falling in the 
moderate to severe ranges, revealed a large summary effect size for the efficacy of CBT in reducing 
depressive symptoms (Table 9). This is consistent with previous findings that elevated depression 
symptoms may be associated with larger effect sizes for psychotherapeutic interventions (Beltman et 
al., 2010; Bohlmeijer et al., 2003). However this interpretation must be considered in light of the fact 
that, due to the small number of studies, the current analysis was underpowered to detect sub-group 
differences. In addition, a number of previous meta-analyses have not found such a relationship 
(Huxtable, Section 2; Cuijpers et al., 2008a)  and using cut-off scores on validated outcome measures 
to assess depression severity is potentially problematic: varying cut-offs have been proposed 
depending on the measures used and the nature of an individual’s underlying physical health 
condition (Strober & Arnett 2009) and scores on depression ratings cannot be considered equivalent to 
diagnosis using standardised assessment schedules. Although sensitivity analyses seem to point to a 
differential efficacy of CBT according to depression severity and treatment modality in older adults 
with underlying physical illnesses, further analysis including sufficient studies to allow formal sub-
group analysis would be required to confirm these initial findings. 
5.4.3. Further analyses 
This study was able to analyse three studies which compared CBT with ‘active controls’: 
Freedland et al. (2009) employed a stress management condition; Kunik et al., (2008) a COPD 
education programme; Lincoln & Flannaghan (2003) utilised an attention placebo. Although these 
comparative interventions varied considerably, and including an attention placebo with alternative 
treatments in the analysis could be considered potentially problematic, the heterogeneity of this 
comparison was not found to be significant. No significant difference was found between CBT and 
these active controls. This finding is consistent with previous meta-analyses which have not found a 
consistent difference between the effectiveness of CBT and alternative psychotherapeutic approaches 




for late life depression (Huxtable, Section 2). Attrition was explored as a proxy for treatment 
acceptability. Patients were no more likely to drop out of CBT interventions than controls. This 
indicates that CBT is potentially an acceptable form of treatment in this group of patients, however as 
comparisons were with TAU / WL controls, no conclusions regarding the relative acceptability of 
differing approaches could be made. 
Three of the included studies used both clinician-rated and self-report measures of depressive 
symptoms. The majority of previous meta-analyses examining psychotherapeutic interventions for 
late-life depression have found clinician-rated measures to yield higher effect sizes than self-report 
measures within the same studies (Huxtable, Section 2) and a meta-analysis exploring this question 
explicitly, found this differential to be statistically significant (Cuijpers, et al., 2010). Results from the 
current study were in line with these findings, with clinician-rated measures yielding a larger effect 
size than patient-rated measures at end of treatment (SMD of 1.57 as compared with 1.03).  
5.4.4. Methodological considerations 
Considering the potential heterogeneity of the patient group examined, a random effects 
model was used. It was assumed that studies were drawn from research domains that potentially 
differed systematically (in that they explored varying physical illnesses) and that variation in effect 
sizes between studies may reflect not only random error within studies, but also true variation in 
effect size between studies. In an attempt to reduce this risk of ‘comparing apples and oranges’ 
(Eysenck, 1984), this study employed a well-delineated and specific a-priori search strategy. However 
this resulted in a relatively narrow focus on a small selection of studies which potentially limited the 
degree to which the results could be understood as representative of a broader and heterogeneous 
research domain (Sharpe, 1997).   
Grouping wait-list controls and treatment as usual control together for the purposes of 
comparative analysis also must be considered critically. There is a risk those in wait-list groups may 
seek alternative, uncontrolled, interventions out with the study criteria. Cuijpers et al. (2008a) found 
that effect sizes were reduced in studies using treatment as usual as opposed to waiting list controls 
and it is likely patients’ expectations of improvement will differ between these groups. Despite these 
risks, it was judged that combining these two types of control was useful to the extent that it 
facilitated an exploratory understanding of the relative efficacy of CBT interventions when compared 
with groups receiving no psychotherapeutic intervention.  
Studies were included in this meta-analysis which evidenced core cognitive and behavioural 
interventions focused specifically on reduction of depressive symptoms. Studies employing problems 




solving approaches were included if they met this very specific criteria. However, the exclusion of 
studies employing non-specific CBT or CBT focused on anxiety symptoms significantly reduced the 
number of eligible studies. In light of evidence that anxiety and mood disorders are frequently co-
morbid (Wolitzky-Taylor et al., 2010)and that in studies excluded from the current analysis, treatment 
for anxiety frequently positively impacted on depression, (Blumenthal et al., 2005; Evers et al., 2002; 
Kunik et al., 2001; Sharpe et al., 2003; Sharpe et al., 2001) it could be argued that a meta-analysis 
exploring both conditions may have yielded more generalisable findings. 
5.4.5. Limitations and risk of bias 
The quality of included papers was not optimum, with four studies not undertaking suitable 
power analyses (Dao et al., 2011; Foley et al., 2010; Gellis et al., 2007; Koertge et al., 2008) and the 
majority of studies failing to either adequately blind outcome assessors or undertake robust tests for 
treatment fidelity. High attrition and high exclusion was seen across the included studies and reflects 
the fact that barriers to treatment are particularly significant in this patient group. These factors, 
considered in light of the variation in study design with regards length of therapy, training of 
clinicians and intensity of intervention mean generalising from these results must be undertaken 
cautiously. Particularly as the study only captured a limited range of co-morbid health conditions and 
examined a predominantly young-old patient sample. 
This study was not able to shed light on how depression may present differently in older-
adults with underlying physical health conditions (Moorey & Steiner 2007) or explore moderating 
and mediating factors. In addition, it was not possible to control for the stage of the underlying 
illness, analyse results according to a measure of overall disability or establish adequate conclusions 
with regards longer-term outcomes. 
It is possible that publication bias may have impacted overall results (Cuijpers, Smit, 
Bohlmeijer, Hollon, & Andersson, 2010) although the systematic search sought to identify 
unpublished studies, and subsequent tests for publication bias were found to be robust.  A previous 
study examining CBT for depression in adults with a somatic disease (Beltman et al., 2010) failed to 
find significant effects for the impact of CBT on depressive symptoms, once studies without intent to 
treat designs were removed from the analysis.  By way of contrast, although study quality in this 
analysis was less than optimum, eight out of the nine studies included intent to treat analyses or used 
95% completer data, indicating that the finding that CBT shows a moderately large impact on 
depressive symptom for older adults with an underlying physical illness, can be considered robust to 
the impact of attrition bias. 




5.4.6. Clinical implications 
Older adults receive poorer care than their younger counterparts (Bartels, 2002) with 
depression under-diagnosed and under-treated (Age Concern, 2008).  Functional impairment and 
medical co-morbidity increase the risk of depression for older adults (Blazer 2003) and there is a 
further risk that physical co-morbidity may confound the diagnosis of depression (Charlson & 
Peterson 2002).  Cognitive behavioural therapy  has the strongest evidence base amongst 
psychological therapies for late-life depression (Bartels et al., 2003; Gatz, 2007; Laidlaw, 2001; Scogin 
et al., 2005).  However, prior to this study, no meta-analysis had systematically examined the efficacy 
of CBT in reducing depressive symptoms in older patients with physical illnesses. A previous large 
scale study  found that co-morbid physical illnesses did not negatively impact on the efficacy of 
collaborative care interventions for depression in this age group (Harpole et al., 2005).  In light of the 
fact that, independent of medical co-morbidity, depression and depressive symptoms are associated 
with significantly higher health-care costs (Katon et al. 2003),  the finding that CBT is effective in 
reducing symptoms of depression in this group of patients means there is a strong clinical argument 
for ensuring older adults experiencing depressive symptoms in the context of physical illness, receive 
appropriate psychotherapeutic assessment and treatment with CBT considered a first-choice 
treatment option. 
5.4.7. Conclusions 
Findings from this meta-analysis indicate CBT is more effective than treatment as usual or 
waiting list controls in reducing depression symptoms in older adults with underlying physical 
illnesses. Results suggest that individual rather than group approaches may be associated with 
greater efficacy, although further studies are required to explore this hypothesis and care should be 
taken generalising results from the current study due to the small number of included studies. 
Further studies need to be undertaken to develop an understanding of what factors may moderate or 
mediate the effectiveness of CBT in this group of patients particularly as comparisons with alternative 
treatments did not find an advantage for CBT. Future studies should include standardised measures 
of illness burden to facilitate a better understanding of the interaction between psychological therapy 
and differing underlying somatic complaints. Future research should also focus particularly on the 
physically ill older-old whose needs have been inadequately addressed with good quality 
randomised controlled trials to date. 
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5.4.8. Highlights  


















• CBT reduces depression symptoms in older adults with physical illnesses 
• Small number of studies means generalising from results should be done with caution 
• Patient-rated measures yielded smaller effect sizes than clinician-rated measures. 
•There is a need for more studies of psychotherapy efficacy with the older-old. 
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SECTION 6:  Additional Methodology 
Outlined in this section are the exact methods undertaken in the meta-analysis described in Section 4, 





















6. Additional Methodology 
6.1. Calculation of the standardized mean difference 
All the included studies were randomized controlled trials, employing independent groups. A variety 
of validated outcome measures were used: BDI (Beck et al., 1961); BDI-II (Beck et al., 1996); GDS-15 
(van Marwijk et al., 1995); HDRS (Hamilton, 1967). To facilitate comparison of studies using different 
outcome measures, the standardised mean difference (δ) was calculated for each study according to 
methods outlined in Borenstein et al., (2009).  
The index δ, denotes the effect size parameter. Cohen’s ‘d’ (Cohen, 1987) on the other hand, refers to a 
specific sample estimate of this parameter. To calculate δ, the mean from the control group (  ) was 
subtracted from the mean of the intervention group (  ) and divided by the within-groups standard 
deviation, pooled across groups. All calculations were undertaken in Microsoft Excel. 
  
            
       
 
                                                                           (1.0) 
This treatment makes the common parametric assumption that both independent groups share a 
common true (population) standard deviation. However, assuming the true (population) standard 
deviation is the same, it is nonetheless likely that sample estimates of standard deviation will not be 
identical due to sampling error. Pooling them therefore gives us more data and yields a more accurate 
estimation of their common value. 
To calculate the pooled within-group standard deviation the following equation was used: 
          
          
            
 
         
 
                                                                           (1.1) 
Here, n₁ and n₂ are the sample sizes in the two groups and S₁ and S₂ are the standard deviations in the 
two groups. 
The variance of d was calculated.  
 
   
       
     
  
  
          
 
                                                                           (1.2) 
Here the first term ( 
       
     
) reflects the uncertainty in the estimate of the means difference, i.e. the 
numerator in (1.0). The second term (
  
          
) reflects the uncertainty in the estimate of        .  
The standard error of d was calculated (the square root of the variance of d). 
        




                                                                          (1.3) 
Cohen’s d has a tendency to overestimate the population parameter effect size (δ) when small 
samples are used (Borenstein et al., 2009). Converting to Hedges’ g (Hedges, 1981) corrects for this, 
and is done by employing a correction factor: J. 
 The correction factor J was calculated. 
    
 
     
 
                                                                          (1.4) 
Here, the degrees of freedom (df) is the df used to estimate         . For two independent groups (as in 
this study) df is the denominator in (1.1) i.e.           : 
    
 
              
 
                                                                          (1.5) 
Cohen’s d was then converted to Hedges’ g.  
      
                                                                          (1.6) 
The variance of d was then converted to the variance of g. 
    
     
                                                                          (1.7) 
The Standard Error of g was then calculated. 
        
             (1.8) 
Hedges’ g, with variance and standard error data were calculated for each study. Separate 
calculations were undertaken according to both self-rated and clinician-rated measures where both 
were available. Separate calculations were made for each comparison in studies which included an 
active treatment condition in addition to TAU/WL control: CBT (    was compared with treatment as 
usual (  ). And then CBT (  ) was compared with alternative treatment (  ). 
  
            
       
 
Data were then entered into the Cochrane Collaboration Review Manager Software (RevMan 5.1, 
2011) and synthesized meta-analytically. 
 





6.2. Calculation of the odds ratio 
For each study, a 2x2 table was generated with CBT and control conditions and numbers of patients 
randomised to, and dropping out of each condition.  
 n drop-out n randomised 
CBT A B 
Control C D 
 
The odds ratio for each study was calculated: 




Data from the cells was entered into RevMan 5.1 (RevMan 5.1, 2011) using a random effects model. 
Odds ratios for each study were cross checked and a summary odds ratio calculated. 
6.3. Calculation of fail-safe N: Assessing publication bias. 
Rosenthal’s fail-safe N (Rosenthal, 1979) calculates the number of additional studies (    ) with a 
mean null result that would be necessary reduce the overall significance of the mean Z score to a 
desired significance level (usually        . Data were calculated according to the below equation 
where N is the number of studies, Z(pi) is the  Z scores for individual significance values and   , the 
Z score (one-tailed) associated with the desired . 
 
  






An on-line fail-safe-N calculator described by Rosenberg (2005) was used to calculate Rosenthal’s fail-
safe N according to the above equation (http://www.rosenberglab.net/software.php#failsafe). The 
effect size (g) and variance for each study was entered into the programme. Data from CBT versus 
control (WL or TAU) at end of treatment, assessed by patient-rated depression measures were used 
for all studies except for Kunik et al., (2008) where TAU or WL control comparison was not available 
and so data for comparison to an alternative treatment (COPD education) was used.  
As Rosenthal’s (1979) methods tend to over-estimate the number of studies required to nullify 
observed results, Rosenberg’s (2005) methods were also applied. These differ in that each included 
study is weighted by the inverse of its variance. A fixed–effect model was employed. Detailed 
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agreement will ensure the widest possible dissemination of information. An e-mail will be sent to
the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing
Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal
circulation within their institutions. Permission of the Publisher is required for resale or distribution
outside the institution and for all other derivative works, including compilations and translations
(please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are
included, the author(s) must obtain written permission from the copyright owners and credit the
source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred
to: http://www.elsevier.com/authorsrights.
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Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or
preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in
the collection, analysis and interpretation of data; in the writing of the report; and in the decision to
submit the article for publication. If the funding source(s) had no such involvement then this should
be stated. Please see http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in
journals published by Elsevier, to comply with potential manuscript archiving requirements as specified
as conditions of their grant awards. To learn more about existing agreements and policies please visit
http://www.elsevier.com/fundingbodies.
Open access
This journal offers you the option of making your article freely available to all via the ScienceDirect
platform. To prevent any conflict of interest, you can only make this choice after receiving notification
that your article has been accepted for publication. The fee of $3,000 excludes taxes and other
potential author fees such as color charges. In some cases, institutions and funding bodies have
entered into agreement with Elsevier to meet these fees on behalf of their authors. Details of these
agreements are available at http://www.elsevier.com/fundingbodies. Authors of accepted articles,
who wish to take advantage of this option, should complete and submit the order form (available at
http://www.elsevier.com/locate/openaccessform.pdf). Whatever access option you choose, you retain
many rights as an author, including the right to post a revised personal version of your article on your
own website. More information can be found here: http://www.elsevier.com/authorsrights .
Language and language services
Please write your text in good English (American or British usage is accepted, but not a mixture of
these). Authors who require information about language editing and copyediting services pre- and
post-submission please visit http://webshop.elsevier.com/languageservices or our customer support
site at http://support.elsevier.com for more information.
Submission
Submission to this journal proceeds totally online and you will be guided stepwise through the creation
and uploading of your files. The system automatically converts source files to a single PDF file of the
article, which is used in the peer-review process. Please note that even though manuscript source
files are converted to PDF files at submission for the review process, these source files are needed for
further processing after acceptance. All correspondence, including notification of the Editor's decision
and requests for revision, takes place by e-mail removing the need for a paper trail.
PREPARATION
Use of wordprocessing software
It is important that the file be saved in the native format of the wordprocessor used. The text should
be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes
will be removed and replaced on processing the article. In particular, do not use the wordprocessor's
options to justify text or to hyphenate words. However, do use bold face, italics, subscripts,
superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.
The electronic text should be prepared in a way very similar to that of conventional manuscripts
(see also the Guide to Publishing with Elsevier: http://www.elsevier.com/guidepublication). Note that
source files of figures, tables and text graphics will be required whether or not you embed your figures
in the text. See also the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your wordprocessor.
Article structure
Manuscripts should be prepared according to the guidelines set forth in the Publication Manual of the
American Psychological Association (6th ed., 2009).
Manuscripts should ordinarily not exceed 50 pages. Exceptions may be made with prior approval of
the Editor in Chief for manuscripts including extensive tabular or graphic material, or appendices.
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Appendices
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in
appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix,
Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
Essential title page information
Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid
abbreviations and formulae where possible. Note: The title page should be the first page of the
manuscript document indicating the author's names and affiliations and the corresponding
author's complete contact information.
Author names and affiliations. Where the family name may be ambiguous (e.g., a double name),
please indicate this clearly. Present the authors' affiliation addresses (where the actual work was
done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after
the author's name and in front of the appropriate address. Provide the full postal address of each
affiliation, including the country name, and, if available, the e-mail address of each author within
the cover letter.
Corresponding author. Clearly indicate who is willing to handle correspondence at all stages of
refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with
country and area code) are provided in addition to the e-mail address and the complete
postal address.
Present/permanent address. If an author has moved since the work described in the article was
done, or was visiting at the time, a "Present address"' (or "Permanent address") may be indicated
as a footnote to that author's name. The address at which the author actually did the work must be
retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A concise and factual abstract is required (not exceeding 200 words). This should be typed on a
separate page following the title page. The abstract should state briefly the purpose of the research,
the principal results and major conclusions. An abstract is often presented separate from the article,
so it must be able to stand alone. References should therefore be avoided, but if essential, they must
be cited in full, without reference to the reference list.
Graphical abstract
A Graphical abstract is optional and should summarize the contents of the article in a concise, pictorial
form designed to capture the attention of a wide readership online. Authors must provide images
that clearly represent the work described in the article. Graphical abstracts should be submitted as a
separate file in the online submission system. Image size: Please provide an image with a minimum
of 531 × 1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 ×
13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office
files. See http://www.elsevier.com/graphicalabstracts for examples.
Authors can make use of Elsevier's Illustration and Enhancement service to ensure the best
presentation of their images also in accordance with all technical requirements: Illustration Service.
Highlights
Highlights are mandatory for this journal. They consist of a short collection of bullet points that convey
the core findings of the article and should be submitted in a separate file in the online submission
system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85
characters, including spaces, per bullet point). See http://www.elsevier.com/highlights for examples.
Keywords
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and
avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing
with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords
will be used for indexing purposes.
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Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first page
of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first
mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those
individuals who provided help during the research (e.g., providing language help, writing assistance
or proof reading the article, etc.).
Footnotes
Footnotes should be used sparingly. Number them consecutively throughout the article, using
superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may
be used. Should this not be the case, indicate the position of footnotes in the text and present the
footnotes themselves separately at the end of the article. Do not include footnotes in the Reference
list.
Table footnotes
Indicate each footnote in a table with a superscript lowercase letter.
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as 'graphics' or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is finalised, please 'save as' or
convert the images to one of the following formats (note the resolution requirements for line drawings,
halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text as 'graphics'.
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then
please supply 'as is'.
Please do not:
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with
the correct resolution. If, together with your accepted article, you submit usable color figures then
Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g.,
ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color
in the printed version. For color reproduction in print, you will receive information regarding
the costs from Elsevier after receipt of your accepted article. Please indicate your preference
for color: in print or on the Web only. For further information on the preparation of electronic artwork,
please see http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications which can arise by converting color figures to 'gray
scale' (for the printed version should you not opt for color in print) please submit in addition usable
black and white versions of all the color illustrations.
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Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables
below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be
sparing in the use of tables and ensure that the data presented in tables do not duplicate results
described elsewhere in the article.
References
Citations in the text should follow the referencing style used by the American Psychological
Association. You are referred to the Publication Manual of the American Psychological Association,
Sixth Edition, ISBN 1-4338-0559-6, copies of which may be ordered from http://books.apa.org/
books.cfm?id=4200067 or APA Order Dept., P.O.B. 2710, Hyattsville, MD 20784, USA or APA, 3
Henrietta Street, London, WC3E 8LU, UK. Details concerning this referencing style can also be found
at http://humanities.byu.edu/linguistics/Henrichsen/APA/APA01.html
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice
versa). Any references cited in the abstract must be given in full. Unpublished results and personal
communications are not recommended in the reference list, but may be mentioned in the text. If these
references are included in the reference list they should follow the standard reference style of the
journal and should include a substitution of the publication date with either 'Unpublished results' or
'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted
for publication.
Web references
As a minimum, the full URL should be given and the date when the reference was last accessed. Any
further information, if known (DOI, author names, dates, reference to a source publication, etc.),
should also be given. Web references can be listed separately (e.g., after the reference list) under a
different heading if desired, or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in
the text) to other articles in the same Special Issue.
Reference management software
This journal has standard templates available in key reference management
packages EndNote (http://www.endnote.com/support/enstyles.asp) and Reference Manager
(http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only
need to select the appropriate journal template when preparing their article and the list of references
and citations to these will be formatted according to the journal style which is described below.
Reference style
References should be arranged first alphabetically and then further sorted chronologically if necessary.
More than one reference from the same author(s) in the same year must be identified by the letters
"a", "b", "c", etc., placed after the year of publication. References should be formatted with a
hanging indent (i.e., the first line of each reference is flush left while the subsequent lines
are indented).
Examples: Reference to a journal publication: Van der Geer, J., Hanraads, J. A. J., & Lupton R. A.
(2000). The art of writing a scientific article. Journal of Scientific Communications, 163, 51-59.
Reference to a book: Strunk, W., Jr., &White, E. B. (1979). The elements of style. (3rd ed.). New
York: Macmillan, (Chapter 4).
Reference to a chapter in an edited book: Mettam, G. R., & Adams, L. B. (1994). How to prepare an
electronic version of your article. In B.S. Jones, & R. Z. Smith (Eds.), Introduction to the electronic
age (pp. 281-304). New York: E-Publishing Inc.
AUTHOR INFORMATION PACK 19 Jul 2012 www.elsevier.com/locate/clinpsychrev 8
Video data
Elsevier accepts video material and animation sequences to support and enhance your scientific
research. Authors who have video or animation files that they wish to submit with their article are
strongly encouraged to include these within the body of the article. This can be done in the same way
as a figure or table by referring to the video or animation content and noting in the body text where it
should be placed. All submitted files should be properly labeled so that they directly relate to the video
file's content. In order to ensure that your video or animation material is directly usable, please provide
the files in one of our recommended file formats with a preferred maximum size of 50 MB. Video and
animation files supplied will be published online in the electronic version of your article in Elsevier
Web products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your
files: you can choose any frame from the video or animation or make a separate image. These will
be used instead of standard icons and will personalize the link to your video data. For more detailed
instructions please visit our video instruction pages at http://www.elsevier.com/artworkinstructions.
Note: since video and animation cannot be embedded in the print version of the journal, please
provide text for both the electronic and the print version for the portions of the article that refer to
this content.
Supplementary data
Elsevier accepts electronic supplementary material to support and enhance your scientific research.
Supplementary files offer the author additional possibilities to publish supporting applications, high-
resolution images, background datasets, sound clips and more. Supplementary files supplied will be
published online alongside the electronic version of your article in Elsevier Web products, including
ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is
directly usable, please provide the data in one of our recommended file formats. Authors should
submit the material in electronic format together with the article and supply a concise and descriptive
caption for each file. For more detailed instructions please visit our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
Submission checklist
The following list will be useful during the final checking of an article prior to sending it to the journal
for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
• Telephone and fax numbers
All necessary files have been uploaded, and contain:
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been 'spell-checked' and 'grammar-checked'
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge)
and in print, or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black-and-white versions of the figures are also supplied for
printing purposes
For any further information please visit our customer support site at http://support.elsevier.com.
AFTER ACCEPTANCE
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI
consists of a unique alpha-numeric character string which is assigned to a document by the publisher
upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal
medium for citing a document, particularly 'Articles in press' because they have not yet received their
full bibliographic information. Example of a correctly given DOI (in URL format; here an article in the
journal Physics Letters B):
http://dx.doi.org/10.1016/j.physletb.2010.09.059
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When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to
change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in
the e-mail so that authors can download the files themselves. Elsevier now provides authors with
PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 (or
higher) available free from http://get.adobe.com/reader. Instructions on how to annotate PDF files
will accompany the proofs (also given online). The exact system requirements are given at the Adobe
site: http://www.adobe.com/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may list the corrections (including
replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections
quoting line number. If, for any reason, this is not possible, then mark the corrections and any other
comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan
the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing,
completeness and correctness of the text, tables and figures. Significant changes to the article as
accepted for publication will only be considered at this stage with permission from the Editor. We will
do everything possible to get your article published quickly and accurately – please let us have all your
corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one
communication: please check carefully before replying, as inclusion of any subsequent corrections
cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with
the publication of your article if no response is received.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an
extra charge, paper offprints can be ordered via the offprint order form which is sent once the article
is accepted for publication. The PDF file is a watermarked version of the published article and includes
a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
AUTHOR INQUIRIES
For inquiries relating to the submission of articles (including electronic submission) please
visit this journal's homepage. Contact details for questions arising after acceptance of
an article, especially those relating to proofs, will be provided by the publisher. You
can track accepted articles at http://www.elsevier.com/trackarticle. You can also check
our Author FAQs (http://www.elsevier.com/authorFAQ) and/or contact Customer Support via
http://support.elsevier.com.











































Appendix 3: Email correspondence with authors  















I am writing to you as the corresponding author for the meta-analysis: [Insert title of published meta-analysis] 
 
I am currently undertaking a systematic review of meta-analyses which examine psychotherapeutic treatments 
for late-life depression. The study is being undertaken in part-fulfilment of a Doctorate in Clinical Psychology at 
Edinburgh University. 
 
I am seeking to determine if you are aware of any ongoing or unpublished meta-analytic studies in this area 
that may inform my research question, and which I may not have been able to access via literature searches of 




1.      What have meta-analyses revealed about which psychological interventions are effective in reducing 
depressive symptoms in older adults (>55years)?  
2.      What have meta-analyses revealed about predictors of treatment efficacy in late life depression? 
3.      What have meta-analyses revealed with regard to the role of moderating factors (age, gender, participant 
characteristics, severity and chronicity of disorder, treatment length, and therapeutic alliance etc..) in the 
successful treatment of late life depression? 
 
The implications of these findings will be discussed within the broader literature which seeks to develop an 
empirical understanding of the specific factors which moderate psychotherapeutic efficacy. 
 








Author Year Contacted Reply 
Gorey, K. M., Cryns, A. G. 1991 Y Y 
Scogin, F., McElreath, L.  1994 Y  
Engels, G.I., Vermey, M., 1997 Y  
Cuijpers, P. 1998 Y  
Pinquart, M., Sorensen, S. 2001 Y Y 
Bohlmeijer, E., Smit, F., Cuijpers, P.  2003 Y  
Cuijpers, P., van Straten, A., Smit, F. 2006 Y  
Pinquart, M., Duberstein, P.R., Lyness, J.M. 2006 Y Y 
Chin, A.  2007 Y  
Pinquart, M., Duberstein, P.R., Lyness, J.M 2007 Y Y 
Wilson, K., Mottram, P.G., Vassilas, C. 2008 Y Y 
Peng, X.D., Huang, C.Q., Chen, L.J., Lu, Z.C.,  2009 Y  
Samad, Z., Brealey, S., Gilbody, S.  2011 Y Y 
Krishna, M.,Jauhari, A., Lepping, P., Turner, J., Crossley, D., 
Krishnamoorthy, A. 








Martin Pinquart [pinquart@staff.uni-marburg.de] 
Dear David, 
I am aware of one unpublished study that is under review. Unfortunately, I cannot provide information on this 
study because I reviewed the manuscript and are not allowed to share informations until the study is 
published. Note that the paper you cited was not exclusively focused on depressed older adults. The following 
papers would be more relevant Pinquart, M., Duberstein, P., & Lyness, J.M. (2006). Treatments for later life 
depressive conditions: A meta-analytic comparison of pharmacotherapy and psychotherapy. American Journal 
of Psychiatry, 163, 1493-1501. Pinquart, M., Duberstein, P. & Lynness, J. (2007). Effects of psychotherapy and 




Martin Pinquart   
 
Von:                           "Huxtable David (NHS GRAMPIAN)" <davidhuxtable@nhs.net> 
An:                             "Pinquart@staff.uni-marburg.de" <Pinquart@staff.uni-marburg.de> 
Datum:                       Fri, 30 Mar 2012 13:15:23 +0100 
Betreff:                       Enquiry re: How effective are psychotherapeutic and other 
                                 psychosocial interventions with older adults? 
 
 
Simon Gilbody [simon.gilbody@york.ac.uk] 
 
Dear David.  Alll my reviews are in the public domain.  Good luck with your doctorate.  Simon 
 
 
Kevin Gorey [gorey@uwindsor.ca] 
 
Attachments: SocWorkRes1998.pdf (561 KB ) ResAging1992.pdf (2 MB ) JGeriatPsych1990.pdf (807 KB ) 
  
Dear Mr. Huxtable: 
  
Here are a few that may be at least of tangential use to you (perhaps not)--from my gerontological research 
days.  And below is another that I no longer have copies of/nor access to.  I do not have any such unpublished 
research in my "file drawers."  Wheeler, J.A., Gorey, K.M., & Greenblatt, B. (1998). The beneficial effects of 
volunteering for older volunteers and the people they serve: A meta-analysis. International Journal of Aging 










Wilson, Kenneth [K.C.M.Wilson@liverpool.ac.uk] 
 
I  refer you on to the Cochrane centre for depression, anxiety and neurosis for this enquiry as they are in 
contact with up to date literature searches 
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Introduction
Systematic reviews and meta-analyses have become increasingly
important in health care. Clinicians read them to keep up to date
with their field [1,2], and they are often used as a starting point for
developing clinical practice guidelines. Granting agencies may
require a systematic review to ensure there is justification for
further research [3], and some health care journals are moving in
this direction [4]. As with all research, the value of a systematic
review depends on what was done, what was found, and the clarity
of reporting. As with other publications, the reporting quality of
systematic reviews varies, limiting readers’ ability to assess the
strengths and weaknesses of those reviews.
Several early studies evaluated the quality of review reports. In
1987, Mulrow examined 50 review articles published in four leading
medical journals in 1985 and 1986 and found that none met all eight
explicit scientific criteria, such as a quality assessment of included
studies [5]. In 1987, Sacks and colleagues [6] evaluated the adequacy
of reporting of 83 meta-analyses on 23 characteristics in six domains.
Reporting was generally poor; between one and 14 characteristics
were adequately reported (mean = 7.7; standard deviation = 2.7). A
1996 update of this study found little improvement [7].
In 1996, to address the suboptimal reporting of meta-analyses,
an international group developed a guidance called the
QUOROM Statement (QUality Of Reporting Of Meta-analyses),
which focused on the reporting of meta-analyses of randomized
controlled trials [8]. In this article, we summarize a revision of
these guidelines, renamed PRISMA (Preferred Reporting Items
for Systematic reviews and Meta-Analyses), which have been
updated to address several conceptual and practical advances in
the science of systematic reviews (Box 1).
Terminology
The terminology used to describe a systematic review and meta-
analysis has evolved over time. One reason for changing the name
from QUOROM to PRISMA was the desire to encompass both
systematic reviews and meta-analyses. We have adopted the
definitions used by the Cochrane Collaboration [9]. A systematic
review is a review of a clearly formulated question that uses
systematic and explicit methods to identify, select, and critically
appraise relevant research, and to collect and analyze data from
the studies that are included in the review. Statistical methods
(meta-analysis) may or may not be used to analyze and summarize
the results of the included studies. Meta-analysis refers to the use of
statistical techniques in a systematic review to integrate the results
of included studies.
Developing the PRISMA Statement
A three-day meeting was held in Ottawa, Canada, in June 2005
with 29 participants, including review authors, methodologists,
clinicians, medical editors, and a consumer. The objective of the
Ottawa meeting was to revise and expand the QUOROM
checklist and flow diagram, as needed.
The executive committee completed the following tasks, prior to
the meeting: a systematic review of studies examining the quality
of reporting of systematic reviews, and a comprehensive literature
search to identify methodological and other articles that might
inform the meeting, especially in relation to modifying checklist
items. An international survey of review authors, consumers, and
groups commissioning or using systematic reviews and meta-
analyses was completed, including the International Network of
Agencies for Health Technology Assessment (INAHTA) and the
Guidelines International Network (GIN). The survey aimed to
ascertain views of QUOROM, including the merits of the existing
checklist items. The results of these activities were presented
during the meeting and are summarized on the PRISMA Web site
(http://www.prisma-statement.org/).
Only items deemed essential were retained or added to the
checklist. Some additional items are nevertheless desirable, and
review authors should include these, if relevant [10]. For example,
it is useful to indicate whether the systematic review is an update
[11] of a previous review, and to describe any changes in
procedures from those described in the original protocol.
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Shortly after the meeting a draft of the PRISMA checklist was
circulated to the group, including those invited to the meeting but
unable to attend. A disposition file was created containing
comments and revisions from each respondent, and the checklist
was subsequently revised 11 times. The group approved the
checklist, flow diagram, and this summary paper.
Although no direct evidence was found to support retaining or
adding some items, evidence from other domains was believed to
be relevant. For example, Item 5 asks authors to provide
registration information about the systematic review, including a
registration number, if available. Although systematic review
registration is not yet widely available [12,13], the participating
journals of the International Committee of Medical Journal
Editors (ICMJE) [14] now require all clinical trials to be registered
in an effort to increase transparency and accountability [15].
Those aspects are also likely to benefit systematic reviewers,
possibly reducing the risk of an excessive number of reviews
addressing the same question [16,17] and providing greater
transparency when updating systematic reviews.
The PRISMA Statement
The PRISMA Statement consists of a 27-item checklist (Table 1;
see also Text S1 for a downloadable Word template for researchers
to re-use) and a four-phase flow diagram (Figure 1; see also Figure
S1 for a downloadable Word template for researchers to re-use).
The aim of the PRISMA Statement is to help authors improve the
reporting of systematic reviews and meta-analyses. We have focused
on randomized trials, but PRISMA can also be used as a basis for
reporting systematic reviews of other types of research, particularly
evaluations of interventions. PRISMA may also be useful for critical
appraisal of published systematic reviews. However, the PRISMA
checklist is not a quality assessment instrument to gauge the quality
of a systematic review.
From QUOROM to PRISMA
The new PRISMA checklist differs in several respects from the
QUOROM checklist, and the substantive specific changes are
highlighted in Table 2. Generally, the PRISMA checklist
‘‘decouples’’ several items present in the QUOROM checklist
and, where applicable, several checklist items are linked to
improve consistency across the systematic review report.
The flow diagram has also been modified. Before including
studies and providing reasons for excluding others, the review
team must first search the literature. This search results in records.
Once these records have been screened and eligibility criteria
applied, a smaller number of articles will remain. The number of
included articles might be smaller (or larger) than the number of
studies, because articles may report on multiple studies and results
from a particular study may be published in several articles. To
capture this information, the PRISMA flow diagram now requests
information on these phases of the review process.
Endorsement
The PRISMA Statement should replace the QUOROM State-
ment for those journals that have endorsed QUOROM. We hope
that other journals will support PRISMA; they can do so by registering
on the PRISMA Web site. To underscore to authors, and others, the
importance of transparent reporting of systematic reviews, we
encourage supporting journals to reference the PRISMA Statement
and include the PRISMA Web address in their Instructions to
Authors. We also invite editorial organizations to consider endorsing
PRISMA and encourage authors to adhere to its principles.
The PRISMA Explanation and Elaboration Paper
In addition to the PRISMA Statement, a supporting Explana-
tion and Elaboration document has been produced [18] following
the style used for other reporting guidelines [19–21]. The process
Box 1: Conceptual Issues in the Evolution from
QUOROM to PRISMA
Completing a Systematic Review Is an Iterative
Process The conduct of a systematic review depends
heavily on the scope and quality of included studies: thus
systematic reviewers may need to modify their original
review protocol during its conduct. Any systematic review
reporting guideline should recommend that such changes
can be reported and explained without suggesting that
they are inappropriate. The PRISMA Statement (Items 5, 11,
16, and 23) acknowledges this iterative process. Aside from
Cochrane reviews, all of which should have a protocol,
only about 10% of systematic reviewers report working
from a protocol [22]. Without a protocol that is publicly
accessible, it is difficult to judge between appropriate and
inappropriate modifications.
Conduct and Reporting Research Are Distinct
Concepts This distinction is, however, less
straightforward for systematic reviews than for
assessments of the reporting of an individual study,
because the reporting and conduct of systematic reviews
are, by nature, closely intertwined. For example, the failure
of a systematic review to report the assessment of the risk
of bias in included studies may be seen as a marker of poor
conduct, given the importance of this activity in the
systematic review process [37].
Study-Level Versus Outcome-Level Assessment of
Risk of Bias For studies included in a systematic review, a
thorough assessment of the risk of bias requires both a
‘‘study-level’’ assessment (e.g., adequacy of allocation
concealment) and, for some features, a newer approach
called ‘‘outcome-level’’ assessment. An outcome-level
assessment involves evaluating the reliability and validity
of the data for each important outcome by determining
the methods used to assess them in each individual study
[38]. The quality of evidence may differ across outcomes,
even within a study, such as between a primary efficacy
outcome, which is likely to be very carefully and
systematically measured, and the assessment of serious
harms [39], which may rely on spontaneous reports by
investigators. This information should be reported to allow
an explicit assessment of the extent to which an estimate
of effect is correct [38].
Importance of Reporting Biases Different types of
reporting biases may hamper the conduct and
interpretation of systematic reviews. Selective reporting
of complete studies (e.g., publication bias) [28] as well as
the more recently empirically demonstrated ‘‘outcome
reporting bias’’ within individual studies [40,41] should be
considered by authors when conducting a systematic
review and reporting its results. Though the implications of
these biases on the conduct and reporting of systematic
reviews themselves are unclear, some previous research
has identified that selective outcome reporting may occur
also in the context of systematic reviews [42].
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of completing this document included developing a large database
of exemplars to highlight how best to report each checklist item,
and identifying a comprehensive evidence base to support the
inclusion of each checklist item. The Explanation and Elaboration
document was completed after several face to face meetings and
numerous iterations among several meeting participants, after
which it was shared with the whole group for additional revisions
and final approval. Finally, the group formed a dissemination
subcommittee to help disseminate and implement PRISMA.
Discussion
The quality of reporting of systematic reviews is still not
optimal [22–27]. In a recent review of 300 systematic reviews,
few authors reported assessing possible publication bias [22],
even though there is overwhelming evidence both for its
existence [28] and its impact on the results of systematic
reviews [29]. Even when the possibility of publication bias is
assessed, there is no guarantee that systematic reviewers have
assessed or interpreted it appropriately [30]. Although the
absence of reporting such an assessment does not necessarily
indicate that it was not done, reporting an assessment of possible
publication bias is likely to be a marker of the thoroughness of
the conduct of the systematic review.
Several approaches have been developed to conduct systematic
reviews on a broader array of questions. For example, systematic
reviews are now conducted to investigate cost-effectiveness [31],
diagnostic [32] or prognostic questions [33], genetic associations
[34], and policy making [35]. The general concepts and topics
covered by PRISMA are all relevant to any systematic review, not
just those whose objective is to summarize the benefits and harms
of a health care intervention. However, some modifications of the
checklist items or flow diagram will be necessary in particular
circumstances. For example, assessing the risk of bias is a key
concept, but the items used to assess this in a diagnostic review are
likely to focus on issues such as the spectrum of patients and the
verification of disease status, which differ from reviews of
interventions. The flow diagram will also need adjustments when
reporting individual patient data meta-analysis [36].
We have developed an explanatory document [18] to increase
the usefulness of PRISMA. For each checklist item, this document
contains an example of good reporting, a rationale for its inclusion,
and supporting evidence, including references, whenever possible.
We believe this document will also serve as a useful resource for
those teaching systematic review methodology. We encourage
journals to include reference to the explanatory document in their
Instructions to Authors.
Like any evidence-based endeavor, PRISMA is a living
document. To this end we invite readers to comment on the
revised version, particularly the new checklist and flow diagram,
through the PRISMA Web site. We will use such information to
inform PRISMA’s continued development.
Figure 1. Flow of information through the different phases of a systematic review.
doi:10.1371/journal.pmed.1000097.g001
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Table 1. Checklist of items to include when reporting a systematic review or meta-analysis.




Title 1 Identify the report as a systematic review, meta-analysis, or both.
ABSTRACT
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions
and implications of key findings; systematic review registration number.
INTRODUCTION
Rationale 3 Describe the rationale for the review in the context of what is already known.
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions,
comparisons, outcomes, and study design (PICOS).
METHODS
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide
registration information including registration number.
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered,
language, publication status) used as criteria for eligibility, giving rationale.
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify
additional studies) in the search and date last searched.
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be
repeated.
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable,
included in the meta-analysis).
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any
processes for obtaining and confirming data from investigators.
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and
simplifications made.
Risk of bias in individual
studies
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was
done at the study or outcome level), and how this information is to be used in any data synthesis.
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means).
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of
consistency (e.g., I2) for each meta-analysis.
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective
reporting within studies).
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done,
indicating which were pre-specified.
RESULTS
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions
at each stage, ideally with a flow diagram.
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period)
and provide the citations.
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome-level assessment (see Item 12).
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each
intervention group and (b) effect estimates and confidence intervals, ideally with a forest plot.
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15).
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).
DISCUSSION
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their
relevance to key groups (e.g., health care providers, users, and policy makers).
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review level (e.g., incomplete retrieval of
identified research, reporting bias).
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future
research.
FUNDING
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for
the systematic review.
doi:10.1371/journal.pmed.1000097.t001
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Supporting Information
Figure S1 Flow of information through the different
phases of a systematic review (downloadable template
document for researchers to re-use).
Found at: doi:10.1371/journal.pmed.1000097.s001 (0.08 MB
DOC)
Text S1 Checklist of items to include when reporting a
systematic review or meta-analysis (downloadable tem-
plate document for researchers to re-use).
Found at: doi:10.1371/journal.pmed.1000097.s002 (0.04 MB
DOC)
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limitations are explicitly stated and their discussion required.
Funding ! This new item (27) asks authors to provide information on any sources of funding for
the systematic review.
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Appendix 6:  Rating according to PRISMA criteria (Systematic 
Review). 
 
Note: Text highlighted in red indicates PRISMA criteria which 
were assessed as being not met, or only partially met. Page 
numbers are given to facilitate cross-referencing original 
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Cuijpers, P., Andersson, 
G., Donker, T., van 
Straten, A.  
2011  Psychological treatment of 
depression: Results of a series 
of meta-analyses  
Nordic Journal of 
Psychiatry  
65(6)  354-364  Although one sub-group analysis of late-life 
depression is included this is minimal, and only 
examines general efficacy as compared with 
younger adults.  
Pinquart, M., 
Duberstein, P.R., 
Lyness, J.M.  
2006  Effects of pharmacotherapy 
and psychotherapy in late-life 
depression  





6-7  Summary of Pinquart M, Duberstein PR, Lyness 
JM (2006)  
 Cole M.G., Elie L.M., 
McCusker, J., 
Bellavance, F., 
Mansour, A.   
2000  Feasibility and effectiveness 
of treatments for depression 
in elderly medical inpatients: 
a systematic review.  
 International 
Psycho-geriatrics  
 12 (4)  453-61  Systematic summary of medication, rather than 
psychosocial interventions: also lacking meta-
analytic methods to examine treatment 
specificity when concomitant psychotherapeutic 
treatment included.  
Freudenstein, U., 
Jagger. C., Arthur, A., 
Donner-Banzhoff, N.   
2001  Treatments for late life 
depression in primary care: a 
systematic review.  
Family Practice  18(3)  321-7  Systematic summary without meta-analytic 
methods to examine treatment specificity.  
Lin Y.C., Dai, Y.T., 
Hwang, S.L.,  
2003  The effect of reminiscence on 
the elderly population: a 
systematic review  
Public Health Nursing  20 (4)  297-306  Descriptive review without meta-analytic 
methods to examine treatment specificity.  
Woods, B  2004  Review: reminiscence and life 
review are effective therapies 
for depression in the elderly.  
Evidence Based 
Mental Health  
 7 (3)     Summary article of:  Bohlmeijer et al., (2003)  
Frazer, C.J., 
Christensen, H., 
Griffiths, K.M.,  
2005  Effectiveness of treatments 
for depression in older people  
The Medical Journal 
Of Australia   
182 (12)   627-32  Only summary of evidence: no synthesis or 
further analysis with meta-analytic methods.  
Hill. A., Brettle, A.,  2005  The effectiveness of 
counselling with older people: 




5(4)  265-72  Summary of evidence. no synthesis or further 
analysis with meta-analytic methods  
Hill. A., Brettle, A.,  2006  Counselling older people: 
what can we learn from 
research evidence?  
Journal of Social 
Work Practice  
20(3)  281-97  Summary of evidence. no synthesis or further 
analysis with meta-analytic methods  







10(12)  3-4  Summary article of Treatments for later-life 
depressive conditions: a meta-analytic 
comparison of pharmacotherapy and 
psychotherapy.  
Cole, M.G.  2008  Brief interventions to prevent 
depression in older subjects: 
A systematic review of 
feasibility and effectiveness  
The American Journal 
of Geriatric 
Psychiatry  
16(6)  435-443  Examining preventative approaches: so not 
currently depressed. Also Age group 40+ also no 
meta-analytic methods to examine subgroup 
treatment specificity.  
Adamek, M.E., Slater, 
G.Y.  
2008  Depression and anxiety.  Journal of 
Gerontological Social 
Work,  
50 (S1)   153-89  No synthesis or further analysis with meta-







Authors  Year  Title  Journal  Vol.  Pages  Reason for Exclusion  
Payne, T.P., Marcus, 
D.K. 
2008 The efficacy of Group 
Psychotherapy for Older 






Not looking at Depression specifically, with no 
mediator analysis that could be usefully 
extracted with regard to treatments for 
depression. 
 Forsman, A.K., 
Schierenbeck, I., 
Wahlbeck, K.,  
2011  Psychosocial Interventions for 
the Prevention of Depression 
in Older Adults: Systematic 
Review and Meta-Analysis.  
Journal of Aging & 
Health  
23(3)  387-416  Prevention rather than treatment.  
Forsman, A.K., 
Nordmyr, J., Wahlbeck, 
K.,  
2011  Psychosocial interventions for 
the promotion of mental 
health and the prevention of 




26(1)  85-107  Prevention rather than treatment.  
Dai, B. Li, J., Cuijpers, P.  2011  Psychological treatment of 
depressive symptoms in 
Chinese elderly inpatients 
with significant medical co-
morbidity: a meta-analysis.  
BMC Psychiatry  11(1)  92  Physical co-morbidity(also poor quality of 
included trials)  
Cuijpers, P., van 
Straten, A., 
Warmerdam, L., 
Andersson, G.  
   Psychotherapy versus the 
combination of 
psychotherapy and 
pharmacotherapy in the 




26(3)  279-288  Not specifically late life depression  
Hsieh H; Wang J;  2003  Effect of reminiscence 
therapy on depression in 
older adults: a systematic 
review  
 International Journal 
of Nursing Studies  
 40 (4)  335-45  Systematic review without meta-analytic analysis  
Kiosses DN; Leon AC; 
Areán PA  
2011  Psychosocial Interventions for 
Late-life Major Depression: 
Evidence-Based Treatments, 
Predictors of Treatment 
Outcomes, and Moderators of 
Treatment Effects.  
Psychiatric Clinics of 
North America  
43(2)  377-401  No meta-analytic methods  
Koder, D,.Brodaty, H., 
Anstey, K.  
1996  Cognitive therapy for 
depression in the elderly  
International journal 
of geriatric psychiatry  
11(2)  97-107  No, effect sizes calculated for some studies, but 

































Calculation of Kappa statistic based on the PRISMA ratings, provided by two independent 






  0 1 2 Total 
Observer 2 0 37 2 0 39 
 
1 5 45 5 55 
 
2 0 9 86 95 
 
Total 42 56 91 189 
 
Calculations, following Viera & Garrett (2005) 
Observed agreement 
Po 0.888888889 




Number of agreements expected by chance: 70.7 (37.41% of the observations) 
 
Kappa 
K = (Po - Po)/(1- Po ) = 0.822479649 
 
Calculations corroborated at:  
http://graphpad.com/quickcalcs/kappa1.cfm?K=3    
Number of observed agreements: 168 ( 88.89% of the observations)     
Number of agreements expected by chance: 70.7 ( 37.41% of the observations)   
Kappa= 0.822      
SE of kappa = 0.036       
95% confidence interval: From 0.751 to 0.894      




Viera, A.J., & Garrett, J.M. (2005). Understanding interobserver agreement: the kappa statistic. 



































Reporting Quality / Year of Publication 
 
Call: 
lm(formula = Rep_Qual ~ Year) 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-22.282  -2.462   1.166   2.274  12.614  
 
Coefficients: 
              Estimate Std. Error t value Pr(>|t|)   
(Intercept) -1765.4521   732.0817  -2.412   0.0328 * 
Year            0.8953     0.3654   2.450   0.0306 * 
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
Residual standard error: 8.376 on 12 degrees of freedom 
Multiple R-squared: 0.3335,     Adjusted R-squared: 0.2779  
F-statistic: 6.004 on 1 and 12 DF,  p-value: 0.03058 
 
Y = mX + c    
Rep_Qual  = 0.8953     x Year + -1765.4521    















Number of Analyses / Year of Publication 
 
Call: 
lm(formula = Analyses ~ Year) 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-3.7678 -1.9018  0.1199  0.8661  6.2322  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)   
(Intercept)  710.323    240.507   2.953   0.0121 * 
Year          -0.352      0.120  -2.933   0.0125 * 
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
Residual standard error: 2.752 on 12 degrees of freedom 
Multiple R-squared: 0.4175,     Adjusted R-squared: 0.3689  
F-statistic: 8.601 on 1 and 12 DF,  p-value: 0.01254 
 























Number of analyses / Reporting Quality   
 
Call: 
lm(formula = Analyses ~ Rep_Qual) 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-6.6244 -1.5102  0.4924  2.1462  4.7948  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)    
(Intercept)  9.28764    2.73863   3.391  0.00535 ** 
Rep_Qual    -0.15120    0.09158  -1.651  0.12462    
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
Residual standard error: 3.255 on 12 degrees of freedom 
Multiple R-squared: 0.1851,     Adjusted R-squared: 0.1172  
F-statistic: 2.726 on 1 and 12 DF,  p-value: 0.1246 
 







Model validation plots 









Number of analyses / Reporting Quality without 
Peng 2009 (outlier)  
Call: 
lm(formula = Analyses ~ Rep_Qual) 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-4.0882 -1.5220 -0.0333  2.0260  3.9301  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept) 13.71370    2.42242   5.661 0.000146 *** 
Rep_Qual    -0.28310    0.07844  -3.609 0.004102 **  
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
Residual standard error: 2.403 on 11 degrees of freedom 
Multiple R-squared: 0.5422,     Adjusted R-squared: 0.5006  
F-statistic: 13.03 on 1 and 11 DF,  p-value: 0.0041027 
 





























Appendix 10:  Email correspondence with authors  



























I am undertaking a meta-analysis examining CBT for depression with older adults with co-morbid 
physical illness. This is in part-fulfilment of a Doctorate in Clinical Psychology at Edinburgh 
University. 
 
Your paper: [.......................................] meets the inclusion criteria. 
  
I was wondering if you were aware of any unpublished/current RCT trials examining CBT treatment 
for depression in older adults with a physical illness, which I may not have been able to find via 
comprehensive literature searches of available databases. My criteria are: mean age ≥55yrs; CBT 
treatment for mood disorder; co-morbid physical illness; validated outcome measure for depressive 
symptoms. 
 






David Huxtable Specialist Psychological Practitioner Older Adult Psychology Dept Royal Cornhill 




Authors and Year Contacted Reply 
Gellis, Z. D., McGinty, J., Tierney, L., Jordan, C., Burton, J., & Misener, E. (2007  Y N 
Dao, T. K., Youssef, N. a, Armsworth, M., Wear, E., Papathopoulos, K. N., & Gopaldas, R. (2011).  
Y N 
Freedland, K. E., Skala, J. A., Carney, R. M., Rubin, E. H., Lustman, P. J., Da, V. G. (2009).  
Y Y 
Hynninen, M. J., Bjerke, N., Pallesen, S., Bakke, P. S., & Nordhus, I. H. (2010) Y Y 
Koertge, J., Janszky, I., Sundin, O., Blom, M., Georgiades, a, László, K. D., Alinaghizadeh, H., et al. 
(2008).  
Y N 
Kunik, M. E., Veazey, C., Cully, J. A., Souchek, J., Graham, D. P., Hopko, D., Carter, R., et al. (2008).  Y Y 
Lincoln, N.B. Flannaghan, T. (2003).  Y Y 
Lustman, P. J., Griffith, L. S., Freedland, K. E., Kissel, S. S., & Clouse, R. E. (1998).  Y N 
Moorey, S., Cort, E., Kapari, M., Monroe, B., Hansford, P., Mannix, K., Henderson, M., et al. (2009) Y N 
Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., & Bienfait, K. L. (2011)  Y N 
Pibernik-Okanovic, M., Begic, D., Ajdukovic, D., Andrijasevic, N., & Metelko, Z. (2009).  Y Y 















Kunik, Mark Edwin [mkunik@bcm.edu]  
Sent: 01 May 2012 17:30 
To: Huxtable David (NHS GRAMPIAN) 
Subject: RE: research related to: COPD education and cognitive 
behavioral therapy group treatment for clinically significant symptoms 
of depression and anxiety in COPD patients: a randomized controlled trial. 
 
My colleague, Jeff Cully, PhD is doing a study that would be of interest to you. 




Mark E. Kunik, M.D., M.P.H. 
Associate Director Houston VA Health Services Research and Development Center of Excellence Associate 
Director for Research Training, South Central MIRECC Professor, Menninger Department of Psychiatry and 






From: Kia Minna Johanna Hynninen [Minna.Hynninen@psykp.uib.no] 
Sent: 04 May 2012 10:09 
To: Huxtable David (NHS GRAMPIAN) 
Subject: RE: research related to:A randomized controlled trial of 




We do not have any unpublished RCT trials going on, and I am not aware of other such studies. 
 







From: David C Mohr [d-mohr@northwestern.edu] 
Sent: 02 May 2012 13:44 
To: Huxtable David (NHS GRAMPIAN) 
Subject: RE: query re: The Effect of Telephone-Administered 
Cognitive–Behavioral Therapy on Quality of Life among Patients with 
Multiple Sclerosis 
 
Attachments: 2005 Arch Gen Psychiatr.pdf 
 
Hi, 
















From: Freedland, Ken [freedlak@bmc.wustl.edu] 
Sent: 02 May 2012 20:35 
To: Huxtable David (NHS GRAMPIAN) 
Subject: RE: research related to: Treatment of Depression After Coronary 




Our ongoing randomized trial of CBT for depression in patients with heart failure fits your criteria.  We're still 
enrolling patients and haven't done any analyses yet.  You can find more info about it at clinicaltrials.gov . 
 
You might also want to check with David Mohr at Northwestern University in Chicago.  d-
mohr@northwestern.edu 
 




Kenneth E. Freedland, PhD 
Professor of Psychiatry 










Huxtable David (NHS GRAMPIAN) 
Sent: 08 May 2012 20:33 
To: pibernik@idb.hr 
Subject: request for data: 'Psychoeducation versus treatment as usual in 
diabetic patients with subthreshold depression: preliminary results of a 




I am undertaking a meta-analysis examining cognitive-behavioural treatments for depression in older adults 







I was wondering if you might be able to assist me. Your paper: 'Psychoeducation versus treatment as usual in 
diabetic patients with subthreshold depression: preliminary results of a randomized controlled trial' meets the 
inclusion criteria for my study. I am keen to include the paper; however, I require some additional information. 
 
In table 2 you report changes in CES-D scores in this format:  26 (22–30) to 18 (12.5–28.5). I understand this to 
be the Median (25–75) 
 
To include the data my analyses I require mean and standard deviation data for baseline and outcome scores 
on the CES-D for both intervention and control groups. 
 
If you were able to give me these data, it would be fantastic, and allow me to include your paper in my study. 
 
Any help would be much appreciated. 
 
David Huxtable Specialist Psychological Practitioner Older Adult Psychology Dept Royal Cornhill Hospital, 
Aberdeen, AB25 2ZH   




From: Nadina Lincoln [Nadina.Lincoln@nottingham.ac.uk] 
Sent: 06 May 2012 07:53 
To: Huxtable David (NHS GRAMPIAN) 




I am happy to provide the data. However, I am about to go away for 3 weeks, so it will not be until I get back 







From: Huxtable David (NHS GRAMPIAN) 
Sent: 06 May 2012 15:18 
To: Nadina Lincoln 
Subject: RE: request for data re: Cognitive Behavioral Psychotherapy for 













David Huxtable Specialist Psychological Practitioner Older Adult Psychology Dept Royal Cornhill Hospital, 
Aberdeen, AB25 2ZH 







From: Nadina Lincoln [Nadina.Lincoln@nottingham.ac.uk] 
Sent: 23 May 2012 08:21 
To: Huxtable David (NHS GRAMPIAN) 
Subject: RE: request for data re: Cognitive Behavioral Psychotherapy for 
Depression Following Stroke  
 







Professor of Clinical Psychology 
University of Nottingham 
International House 
Jubilee Campus 
Nottingham NG8 1BB 
 







From: Huxtable David (NHS GRAMPIAN) 
Sent: 08 May 2012 20:33 
 
To: pibernik@idb.hr 
Subject: request for data: 'Psychoeducation versus treatment as usual in 
diabetic patients with subthreshold depression: preliminary results of a 





I am undertaking a meta-analysis examining cognitive-behavioural treatments for depression in older adults 
with co-morbid physical illness. This is in part-fulfillment of a Doctorate in Clinical Psychology at Edinburgh 
University. 
 
I was wondering if you might be able to assist me. Your paper: 'Psycho education versus treatment as usual in 
diabetic patients with sub threshold depression: preliminary results of a randomized controlled trial' meets the 
inclusion criteria for my study. I am keen to include the paper; however, I require some additional information. 
 
In table 2 you report changes in CES-D scores in this format:  26 (22–30) to 18 (12.5–28.5). I understand this to 
be the Median (25–75) 
 
To include the data my analyses I require mean and standard deviation data for baseline and outcome scores 
on the CES-D for both intervention and control groups. 
 
If you were able to give me these data, it would be fantastic, and allow me to include your paper in my study. 
 






David Huxtable Specialist Psychological Practitioner Older Adult Psychology Dept Royal Cornhill Hospital, 
Aberdeen, AB25 2ZH   
(01224) 557 497 
 
From: Mirjana Pibernik-Okanovic [pibernik@idb.hr] 
Sent: 09 May 2012 17:52 
To: Huxtable David (NHS GRAMPIAN) 
Subject: Re: request for data: 'Psychoeducation versus treatment as 
usual in diabetic patients with subthreshold depression: preliminary 




I have added the information about means and standard deviations in the CESD scores obtained at baseline, 6 
month- and 12-month follow up. 
Intervention arm: 
baseline M=27.3+/-7.8 
6 months M=20.1+/-12.7 




6 months M=20.7+/-10.5 
12 months M=20.3+7-12.3 
 





From: Huxtable David (NHS GRAMPIAN) 
Sent: 13 May 2012 22:41 
To: Mirjana Pibernik-Okanovic 
Subject: A couple more things... 
 
Hi, 
That is great,  
 
Can I ask a couple more things: were the intervention and control groups both N=25, and do you have data 
with regard to any drop-out? If there were drop-outs are the means and SD given below based on intention to 
treat analyses, or based on completer samples?   
 
Also with regard to the skew of the obtained data, are you referring to the differences in education, diet and 
physical functioning?  
 






David Huxtable Specialist Psychological Practitioner Older Adult Psychology Dept Royal Cornhill Hospital, 
Aberdeen, AB25 2ZH 














Huxtable David (NHS GRAMPIAN) 
Sent: 08 May 2012 20:19 
To: lteri@u.washington.edu 
Subject: request for data: 'Behavioral treatment of depression in 





I am undertaking a meta-analysis examining cognitive-behavioural treatments for depression in older adults 
with co-morbid physical illness. This is in part-fulfillment of a Doctorate in Clinical Psychology at Edinburgh 
University. 
 
I was wondering if you might be able to assist me. Your paper: 'Behavioral treatment of depression in 
dementia patients: a controlled clinical trial' meets the inclusion criteria for my study. I am keen to include the 
paper, however, I just need to clarify the data and perhaps require some additional information. 
 
In table 1 of your study, baseline scores are reported in this format:       HDRS     16.3 ± 5.3    I would like to 
confirm that the initial number is the mean score and the second number, the standard deviation. It would be 
great if you could confirm that this is the case. If so, I do not need to request this data for baseline measures. 
 
Secondly, in table 2 you have reported 'Changes in Outcome Measure Scores from Pre- to Post-treatment'.  
e.g.   HDRS    -5.3  ±  4.0.  I am able to calculate the outcome score (e.g. 11) but I need standard deviation  data 
for the mean outcome scores, and am not clear if the data presented (e.g. ± 4.0) is the SD of the outcome 
scores, or in fact SD  in the changes of between baseline and outcome scores. If it is the former it would be 
great if you could confirm this, and I can then use the data as is...If it is the latter I would need you to give me 
the SD data for the mean outcomes scores. 
 
( I hope this is clear!) 
 
Anyway, In summary I need: 
Mean and standard deviation of  baseline and outcome scores for  both HDRS and BDI depression measures 
across all four conditions. 
 
If you were able to clarify whether these are the data reported, or give me these data, it would be fantastic, 
and allow me to include your paper in my study. 
 




David Huxtable Specialist Psychological Practitioner Older Adult Psychology Dept Royal Cornhill Hospital, 
Aberdeen, AB25 2ZH   












Huxtable David (NHS GRAMPIAN) 
Sent: 01 May 2012 16:14 
To: stirling.moorey@slam.nhs.uk 
Subject: request for data: A cluster randomized controlled trial of 







I am undertaking a meta-analysis examining CBT for depression with older adults with co-morbid physical 
illness. This is in part-fulfillment of a Doctorate in Clinical Psychology at Edinburgh University. 
 
Your paper: ‘A cluster randomized controlled trial of cognitive behaviour therapy for common mental 
disorders in patients with advanced cancer’ meets the inclusion criteria.  
 
However, to include it in the meta-analysis, I would need intent-to treat mean outcome HADS depression 
scores with standard deviation for both CBT and Control conditions. If you were able to share this data it 
would be fantastic, as it would allow me to include your paper in my analysis.  
 
Also, I was wondering if you were aware of any unpublished/current RCT trials examining CBT treatment for 
depression in older adults (>55yrs) with a physical illness, which I may not have been able to find via 
comprehensive literature searches of available databases. 
 
Currently I have not found any other RCT trials looking at CBT for depression in patients with co-morbid cancer 




David Huxtable Specialist Psychological Practitioner Older Adult Psychology Dept Royal Cornhill Hospital, 
Aberdeen, AB25 2ZH   








Huxtable David (NHS GRAMPIAN) 
Sent: 01 May 2012 15:34 
To: lustmanp@wustl.edu 
Subject: FW: request for data re: Cognitive Behavior Therapy for 









I am undertaking a meta-analysis examining CBT for depression with older adults with co-morbid physical 
illness. This is in part-fulfillment of a Doctorate in Clinical Psychology at Edinburgh University. 
 
Your paper: 'Cognitive Behavior Therapy for Depression in Type 2 Diabetes Mellitus' meets the inclusion 
criteria. However, I was wondering if you had  mean BDI scores with standard deviation data at baseline, 10 
weeks and 6 months, for both CBT and control groups. If you were able to give me this data, it would be great, 
and it would allow me to include the paper in my analysis. 
 
Also, I was wondering if you were aware of any unpublished/current RCT trials examining CBT treatment for 
depression in older adults with a physical illness, which I would not have been able to find via comprehensive 
literature searches of available databases. 
 




David Huxtable Specialist Psychological Practitioner Older Adult Psychology Dept Royal Cornhill Hospital, 
Aberdeen, AB25 2ZH 













































1. EBSCO HOST: Last date searched: 8.4.2012                                                                                           







3. OPEN GREY: Last date searched: 6.5.2012 
Open Grey (http://opensigle.inist.fr/ ) http://www.opengrey.eu/ 
Search terms:  
(depress* OR disthymi* OR mood)  
AND (psychotherap* OR psychosocial OR psychological OR cognitive OR behav* OR stress)  
AND (cancer OR COPD OR diabetes OR heart OR dementia OR Alzheimer* OR coronary OR 
Parkinson* OR arthritis OR HIV OR chronic health OR physical *morbidity OR multiple sclerosis 
OR irritable bowel OR physical illness) 
AND (controlled trial)  
Search results:  1 
WORLD HEALTH ORGANISATION INTERNATIONAL CLINICAL TRIALS REGISTRY PLATFORM SEARCH PORTAL: Last 
date searched: 6.5.2012 
http://apps.who.int/trialsearch/default.aspx 
Search terms:  
Title: depress* OR disthymi* OR mood 
Condition: cancer OR COPD OR diabetes OR heart OR dementia OR Alzheimer* OR coronary OR 
heart OR Parkinson* OR arthritis OR HIV OR chronic health OR physical *morbidity OR multiple 
sclerosis OR irritable bowel OR physical illness OR epilepsy 
Intervention: psychotherap* OR psychosocial OR psychological OR cognitive OR behav* OR stress 
OR Problem Solving  






















































































































































Appendix 15:  Funnel plot of standard error (SE) against 
























Funnel plot of standard error (SE) against effect size (SMD) from data comparing CBT with 
treatment as usual or waiting list control for all studies at end of therapy (patient-rated 
depression outcome measures were used in preference to clinician-rated outcomes when 
available). 
 
 
 
